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ABSTRACT 
 
The overall objective of this thesis was to identify the role of host genetics in 
susceptibility to viral disease in pigs, using experimental infection with porcine 
reproductive and respiratory syndrome (PRRS) virus (PRRSV). Co-infection with PRRS 
virus (PRRSV) and porcine circovirus type 2b (PCV2b) was also investigated, since pigs 
are rarely infected with PRRSV alone. The study reported in the first chapter was 
designed to investigate the role of host genetics in response to PRRSV-infection in pigs 
divergently selected for feed efficiency. Contrary to our hypothesis that the more feed 
efficient pigs would be more susceptible to disease as a correlated response, results 
showed that the feed efficient pigs were less affected by the PRRS challenge. Subsequent 
studies were designed to further investigate the role of host genetics in response to 
PRRSV-infection by estimating the effect of the guanylate binding protein 5 (GBP5) 
region (the putative causative gene for a major quantitative trait locus for host response to 
PRRS) on PRRS vaccination response and host response to PRRSV/PCV2b co-infection. 
Additional objectives were to identify regions other than GBP5 associated with 
vaccination and co-infection and regions with a significantly different effect on co-
infection response, depending on previous vaccination for PRRS. Results from these 
studies showed that the GBP5 region had a significant effect on PRRS vaccination viral 
load (VL), PRRS VL, and PCV2b VL (for pigs previously vaccinated against PRRSV).  
Regions other than GBP5 were not significantly associated with vaccination VL or PRRS 
VL, but several single nucleotide polymorphisms (SNPs) near the major 
histocompatibility complex were significantly associated with PCV2b VL. Multiple SNPs 
were also associated with growth rate following vaccination and co-infection, including 
 xiii 
two SNPs with a significantly different effect on growth, depending on previous 
vaccination for PRRS. Another objective was to assess the ability of genomic prediction 
using SNPs within the GBP5 region only versus SNPs across the genome versus SNPs 
outside of the GBP5 region to predict: 1) host response to PRRSV/PCV2b co-infection 
when using a PRRSV-only infected training population and 2) host response to infection 
with a field isolate of PRRSV (by PRRSV-only infection or PRRSV/PCV2b co-infection) 
using a PRRS vaccinated training population. Results from this study showed that using 
SNPs within the GBP5 region had moderate predictive ability for VL traits, but low to no 
predictive ability for growth rate in an unrelated, co-infected population. Collectively, 
these studies further validated the effect of the GBP5 region on host response to PRRS. 
However, prior to this thesis, little was known regarding the effect of the GBP5 region on 
economically important traits under non-challenged conditions. Therefore, the final 
objective was to estimate the effect of the GBP5 region on traits under selection in 
commercial pigs under non-challenged conditions. Results showed that few significant 
associations with the GBP5 region were detected and the magnitude of the effects that 
were identified were not large enough to be practically relevant. In addition, no effect of 
the GBP5 region on overall selection index value was identified. To conclude, the GBP5 
region was significantly associated with VL traits following vaccination and co-infection 
and can be used to predict host response to PRRSV-only infection or co-infection with 
moderate predictive ability. However, using SNPs across the genome had superior 
predictive ability for growth rate, which agrees with the non-significant effect of the 
GBP5 region on growth post co-infection. Therefore, pre-selection for the GBP5 region, 
followed by selection based on genomic estimated breeding value for growth rate 
 xiv 
following PRRSV-infection is a promising PRRS control strategy that can be used to 
breed pigs for improved host response to PRRS.  
 1 
CHAPTER 1: GENERAL INTRODUCTION 
 
Economic losses due to disease outbreaks are a major cost of pork production. It has 
been hypothesized that increased susceptibility to disease in modern domesticated 
livestock species is a result of increased selection pressure on performance traits. 
Resource Allocation Theory proposes that animals have a limited number of resources 
available for all biological processes. Therefore, if additional resources are allocated 
towards performance, then fewer resources are available for other processes, such as 
mounting and maintaining an immune response (Rauw, 2007). For example, pigs selected 
for increased feed efficiency may be more susceptible to disease as a correlated response.   
Of all diseases that threaten the swine industry, porcine reproductive and respiratory 
syndrome (PRRS) is considered the most economically important. Since its emergence in 
the late 1980s, PRRS has resulted in economic loses of roughly $664 per year (Holtkamp 
et al., 2013). PRRS affects pigs during all stages of production by causing reproductive 
failure (i.e. stillbirths, late-term abortions, and/or mummified piglets) in infected sows 
and respiratory symptoms, such as sneezing and coughing, in growing and finishing pigs 
(Straub, 1993; Rossow, 1998).  
The causative agent of PRRS is the PRRS virus (PRRSV). PRRSV has a high 
mutation rate, meaning that many different strains of PRRSV exist and is part of the 
reason that the disease continues to threaten the industry 30 years after the first reported 
case in the U.S. With the continued emergence of new PRRSV strains, pigs previously 
infected with PRRSV are likely not protected against subsequent PRRSV-infections. 
Development of an efficacious, cross-protective PRRS vaccine has also been largely 
 2 
unsuccessful to date. Apart from vaccination, other disease control strategies for PRRS 
exist, including biosecurity practices, herd management strategies, and the 
implementation of regional disease control programs. However, no single, effective 
PRRS control strategy is yet in use.  
An alternative to the abovementioned disease control strategies is to use genomic 
tools to identify individuals with increased natural resistance to infection with the 
ultimate goal of using these regions to breed animals for improved host response to 
disease. Perhaps the first indication of a host genetics component to PRRS resistance was 
the observation that certain breeds of pigs fared better following PRRSV-infection than 
others (Ait-ali et al., 2007). This finding was motivation for the initial objective of the 
PRRS Host Genetics Consortium (PHGC), which was to identify genes and/or genomic 
regions associated with resistance/susceptibility to PRRSV-infection.  
The PHGC is a group of individuals from academia, industry, and the USDA with a 
common interest in identifying a host genetics component for PRRS resistance (Lunney 
et al., 2011). The ability to identify regions of the genome associated with response to 
diseases, such as PRRS, has been made possible by the development of high-density 
single nucleotide polymorphism (SNP) panels. Another use for high-density SNP 
genotypes is genomic prediction, which is performed by estimating the effect of each 
SNP on a trait of interest using a training population to predict the genomic merit of 
individuals within a validation population.  Over the past decade, the PHGC has 
conducted a series of trials in which groups of approximately 200 commercial nursery 
pigs were experimentally infected with a specific strain of PRRSV and followed for 42 
days. During the experimental infection period, repeated weight and serum samples were 
 3 
collected on each individual. Perhaps the most important finding from these experimental 
trials was the identification of a region on chromosome 4 that was found to be associated 
with 15.7% and 11.2% of the total genetic variation in PRRS serum viremia and weight 
gain, respectively, following experimental PRRSV-infection (Boddicker et al., 2012). 
The SNP WUR10000125 (WUR), located within this region, has since been used as a 
genetic marker for this region.  
In recent years, the effect of WUR on host response to PRRSV-infection has been 
validated across breeds, genetic sources, and following infection with two different North 
American PRRSV isolates (Boddicker et al., 2014a,b; Hess et al., 2016; Waide et al., 
2017). Other questions that have arisen as a result of these studies included: what is the 
effect of WUR following PRRS vaccination, and, what is the effect of WUR following 
co-infection with another pathogen? The first question is important because, although 
PRRS vaccines are limited in their ability to provide protection against infection with a 
heterologous strain, modified live virus (MLV) vaccines have risen in popularity. 
Therefore, it is vital to establish that the favorable (B) allele at WUR following infection 
with a field isolate of PRRSV is also favorable following PRRS MLV vaccination. The 
second question is important since it is well known that PRRS suppresses the immune 
response, making pigs more susceptible to secondary infections (Yin et al., 2013). As a 
result, co-infection with PRRSV and other pathogens is commonly observed in the field. 
The PHGC co-infection trials were designed to address both of these questions by 
estimating the effect of WUR following PRRS vaccination and co-infection with PRRSV 
and porcine circovirus type 2b (PCV2b), another common virus in swine herds.  
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Additional objectives of these co-infection trials were to identify regions of the 
genome other than WUR associated with host response to PRRS vaccination and 
PRRSV/PCV2b co-infection and to identify regions with a different effect on host 
response to co-infection, depending on previous vaccination for PRRS. Regions specific 
to host response to co-infection, depending on PRRS vaccination status, represent subsets 
of SNPs that can be used to select pigs for improved host response to PRRS, depending 
on prior vaccination, or not, for PRRS.   
These co-infection trials were also used to perform an additional study to assess 
whether a PRRSV-infected training population can be used to predict host response to 
PRRSV/PCV2b co-infection and whether response to PRRS vaccination can be used to 
predict host response to infection with a field isolate of PRRSV. These were important 
objectives since it is usually not feasible to collect disease phenotypes on breeding 
animals (or perhaps even their relatives) to select for improved host response to disease. 
A secondary objective was to evaluate the predictive ability of using only SNPs within 
the WUR region versus SNPs across the genome and SNPs outside of the WUR region to 
identify the training and validation scenario best able to predict host response to 
PRRSV/PCV2b co-infection or infection with a field isolate of PRRSV only.  
The first study in this thesis was designed to address the question of whether selection 
for increased feed efficiency results in increased susceptibility to infection. The objective 
of this study was to estimate the effect of divergent selection for feed efficiency on host 
response to experimental infection with PRRSV.  The rest of this thesis largely focused 
on evaluating and identifying regions of the genome associated with increased resistance 
or susceptibility to PRRSV-infection, whether by PRRS vaccination or co-infection with 
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PCV2b. Specific objectives were to estimate the effect of WUR on host response to 
PRRS vaccination and PRRSV/PCV2b co-infection, to identify regions of the genome 
other than WUR associated with host response to PRRS vaccination and PRRSV/PCV2b 
co-infection, to functionally annotate identified regions, and to assess the predictive 
ability of training on host response to PRRSV-infection using SNPs across the genome 
versus WUR only, or SNPs other than WUR, to predict host response to PRRSV/PCV2b 
co-infection or PRRSV-only infection. Lastly, prior to implementing selection based on 
WUR genotype into a routine breeding program, it must be established that the favorable 
allele for host response to PRRS is not unfavorably associated with traits of economic 
importance under non-challenged conditions. Therefore, the final objective of this thesis 
was to estimate the effect of WUR genotype on economic traits in commercial pig lines 
under normal, non-challenged conditions.  
 
Organization of the Thesis 
The second chapter of this thesis is a review of current literature related to the 
impact of PRRS on the industry, clinical signs and symptoms of infection and co-
infection with PCV2b, current PRRS control strategies, potential advantages and 
disadvantages of selecting for PRRS resistance, and various strategies for implementing 
genetic selection to breed pigs for improved host response to PRRS. The third chapter 
presents results for the effect of divergent selection for feed efficiency based on residual 
feed intake on response to infection with PRRSV; results presented in Chapter 4 show the 
effect of WUR genotype on host response to PRRS MLV vaccination and co-infection 
with PRRSV and PCV2b; Chapter 5 presents results from genome-wide association 
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studies to identify genomic regions associated with host response to PRRS vaccination 
and PRRSV/PCV2b co-infection; the study described in Chapter 6 was designed to 
explore the predictive ability of training and validating on different SNP subsets using a 
PRRSV-infected training population to predict host response to PRRSV/PCV2b co-
infection and a vaccinated population to predict response to infection with a field PRRSV 
isolate; and the study described in Chapter 7 was designed to investigate whether the 
favorable allele at WUR following PRRS challenge is unfavorably associated with 
growth or reproduction traits in commercial pig lines under normal, non-challenged 
conditions. Chapter 8 is a general discussion that further analyzes the results of these 
studies and discusses genetic selection strategies to breed pigs for improved host response 
to PRRS. 
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CHAPTER 2: LITERATURE REVIEW 
  
 
Porcine Reproductive and Respiratory Syndrome (PRRS) 
 
 
Economic impact 
Pork production is a major contributor to the U. S. economy. In addition to 
supplying the needs of its domestic market, the U. S. exports between 20 and 25% of the 
total pork produced per year. This is expected to be just over 5 billion pounds of carcass 
in 2017 (USDA, 2016). However, the emergence of new viruses and re-emergence of 
existing strains poses a constant threat to this industry. The most economically 
devastating disease to the industry is caused by the porcine reproductive and respiratory 
syndrome (PRRS) virus (Nieuwenhuis et al., 2012). It has been estimated that a PRRS 
outbreak results in an average loss of $75 per litter in U.S. herds for litters farrowed 
during an outbreak (Neumann et al., 2005). PRRS-related piglet death is the primary 
factor for economic loss, as well as economic losses in the nursery and finishing phases. 
Initial reports estimated that PRRS costs the U.S. swine industry $560 million per year 
(Neumann et al., 2005). This figure has since been up-dated and combined losses in the 
breeding and growing-pig herds are now estimated at $664 million per year (Holtkamp et 
al., 2013). The latter figure reflects production losses only, and does not include extra 
health care related costs. Follow-up analyses estimated that an additional $140 million is 
spent on diagnostic testing, treatment, or increased biosecurity related to PRRS each year 
(Holtkamp et al., 2013).   
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Clinical signs of PRRS virus infection 
PRRS is a particularly devastating disease because it affects pigs during all stages 
of production. As the name suggests, PRRS affects reproductive performance, by causing 
late term abortions, mummified and stillborn piglets, and delayed return to estrus. Live 
born piglets often exhibit weakness or failure to thrive (Wensvoort et al., 1991). Other 
clinical signs include coughing, sneezing, fever, blue discoloration of the ears (for about 
10% of PRRS cases) (Straub, 1993; Rossow, 1998), and slowed growth (Doeschl-Wilson 
et al., 2009; Boddicker et al., 2012). PRRS virus (PRRSV) can also be fatal to adult pigs, 
especially late-term gestating females (Zimmerman, 2009), as well as to nursery piglets. 
However, most PRRS-related deaths are the result of co-infection with other pathogens 
(Chung et al., 1997).  
 
Challenges of controlling PRRSV-infection 
One factor that has complicated the control of PRRS is the rapid transmission of 
the virus. PRRS was first identified in the U. S. in the late 1980’s (Keffaber, 1989), at 
which time it was referred to as “Mystery Swine Disease” (MSD) (Zimmerman, 2009). 
In 1990, the first European case of MSD was detected in Germany. A year later, 3,000 
additional cases were reported throughout Germany, followed by the first reported cases 
of PRRS in the Netherlands (Zimmerman, 2009). Soon after, a research group in 
Lelystad, the Netherlands identified the causative agent of PRRS by isolating the virus in 
alveolar macrophages and was initially referred to as the Lelystad virus (Wensvoort et al., 
1991). PRRS soon spread to other European countries, including Belgium, Spain, France, 
 10 
the United Kingdom, Denmark, and Poland (Zimmerman, 2009). By 1991, the disease 
was prevalent in all major pork producing countries, including Korea, Japan, and Taiwan, 
earning official recognition as a pandemic. It is believed that the rapid spread of the 
Lelystad virus (or PRRSV, as we now call it) during these years was a direct result of 
increased herd size (and thereby increased pig-to-pig contact), as well as increased 
movement of infected pigs and pig semen (Zimmerman, 2009). More recent studies 
suggest that PRRSV is capable of airborne transmission upwards of 4.7 kilometers 
(Otake et al., 2010), which could also have potentiated spread of the disease.  
Another factor that has complicated the control of PRRS is the high mutation rate 
of PRRSV. This characteristic has resulted in high genetic and antigenic variability of the 
virus and is also the reason that new strains of PRRSV are continually emerging (Meng, 
2000). For example, recent reports indicate the emergence of a new highly pathogenic 
PRRSV strain that appears to have resulted from a recombination event of a North 
American strain with a highly pathogenic strain from China, for which up to 80% 
mortality rate was observed in infected pigs (Liu et al., 2017). However, despite the high 
mutation rate of the virus, pigs are the only known natural host of PRRSV.  
PRRSV is a small, enveloped, positive-stranded RNA virus (Wensvoort et al., 
1991; Meulenberg et al., 1993) that is encoded by eight open reading frames (ORFs) 
(Meulenberg et al., 1993) and is a member of the virus family Arteriviridae of the order 
Nidoviridales (Rowland et al., 2012). Two types of PRRSV exist, type 1 and type 2, 
which refer to European and North American strains, respectively (Rowland et al., 2012). 
Since these types only share ~60% sequence identity at the nucleotide level (Calvert et 
al., 2007), it is not surprising that antigenic variability has been described between 
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PRRSV types  (Wensvoort et al., 1992). Genetic variability between PRRSV types is 
most extensive in the open reading frames (ORFs).  
Genetic and antigenic diversity also exists within each PRRSV type, most of 
which can be found in ORF5 (Wensvoort et al., 1992; Meng, 2000). Different strains 
within a PRRSV type are referred to as quasispecies, which are subject to undergoing 
positive and negative selection pressure (Rowland et al., 1999). It is believed that the 
existence of quasispecies plays a role in the persistence of PRRSV-infection, due to 
positive selection pressure on escaping cytotoxic T cell or neutralizing antibody 
responses, which has been observed for other viruses (Meng, 2000). Several studies have 
also shown that the antigenic and genetic variability among PRRSV strains contributes to 
differences in their virulence (Meng, 2000). This has been demonstrated experimentally, 
as significant differences in clinical respiratory disease, rectal temperature, and gross and 
microscopic lung lesion score for pigs infected with different PRRSV strains (Halbur et 
al., 1996).  
Vaccine development has been underway ever since the emergence of PRRS in 
the late 1980s. However, the high genetic and antigenic diversity of PRRSV has 
contributed greatly to the difficulty of developing an efficacious, cross-protective 
vaccine. Currently, two main forms of commercial PRRSV vaccines exist: killed and 
modified live virus (MLV) vaccines. MLV vaccines have shown to be more effective 
than killed vaccines, but are far from ideal (Meng, 2000). First, studies show that PRRS 
MLV vaccines provide some cross-protection against heterologous strains, but do not 
prevent re-infection (Hu and Zhang, 2014). For example, results presented by Nielsen et 
al. (1997) showed that pigs vaccinated with a MLV vaccine still became infected with a 
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field isolate of PRRSV, although reduced levels of PRRS viremia were observed upon re-
infection. Secondly, although the vaccine virus is modified so as not to result in clinical 
pathology, vaccination with a PRRS MLV vaccine still results in infection, as evidenced 
by the presence of vaccine virus in serum several weeks post-vaccination (Nielsen et al., 
1997). Finally, infection with live virus subjects the host to the possibility of the virus 
mutating into new, virulent PRRSV strains.  
 
Host immune response to PRRSV-infection 
The primary target cell of PRRSV is the alveolar macrophage (Calvert et al., 
2007). PRRSV enters the target cell by binding to heparin sulfate proteoglycans 
expressed on the surface of the host cell, followed by internalized of virus particles in 
vesicles. The internalization and uncoating procedure is facilitated by the cellular protein 
CD163, which is a known member of the scavenger receptor cysteine-rich superfamily 
(Calvert et al., 2007; Van Gorp et al., 2010; Niu et al., 2016). The acidic environment 
within the virus vesicles cause the virus particles to be released once internalized (Calvert 
et al., 2007).  
As evidence of the persistence of PRRSV-infection, research shows that PRRSV 
can be found in serum for 30 or more days post-infection (Xiao et al., 2004). The virus is 
also known to persist in tonsil tissue, the inguinal lymph node, and the sternal lymph 
node (Xiao et al., 2004). In farrow-to-finish herds, PRRSV persists longest in young pigs 
(i.e. 6 to 9 weeks of age) (Chung et al., 1997). Infected pigs eventually clear PRRSV 
around 6 weeks post-infection (Wesley et al., 2006), which is believed to be directly 
related to a lack of susceptible macrophages, the target cell of PRRSV (Xiao et al., 2004).  
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The persistence of PRRSV-infection is largely due to the ability of PRRSV to 
alter and evade host immune responses. For instance, PRRSV-infection alters cytokine 
production by increasing production of the anti-inflammatory cytokine interleukin (IL)-
10, and decreasing production of interferon (IFN)–α. Increasing IL-10 production down-
regulates the inflammatory response to infection (Thanawongnuwech and Thacker, 2003; 
Amadori and Razzuoli, 2014). There is also evidence that IFN-α is capable of delaying 
PRRSV replication (Ait-ali et al., 2007), but the level of IFN-α is suppressed in PRRSV-
infected pigs (Albina et al., 1998). IFN-γ, a second type of interferon, also plays a role in 
protective immunity against PRRSV-infection. Previous research indicates that IFN-γ 
production level varies depending on the isolate of PRRSV (Wesley et al., 2006). IFN-γ 
is most likely produced by activated natural killer cells and functions as a chemical 
messenger to activate anti-viral proteins. IFN-γ production peaks around 10 days post 
PRRSV-infection (Wesley et al., 2006; Zuckermann et al., 2007).  
In addition to modulating cytokine production, PRRSV also evades innate host 
defenses by down-regulating the expression of major histocompatibility complex (MHC) 
class I glycoproteins on the surface of virally-infected macrophages (Thacker et al., 
1997). PRRSV infects and then hijacks the machinery of the alveolar macrophage 
(Wensvoort et al., 1991), which functions by processing and presenting pathogen to B 
cells and T helper cells, or, in the case of viral infections, to cytotoxic T cells, via the 
MHC (Murphy, 2012). Once a cytotoxic T cell recognizes a viral peptide, it kills the 
virally-infected cell by releasing toxins that eventually destroy it (Murphy, 2012). 
PRRSV has been shown to down-regulate the expression of MHC proteins of PRRSV-
infected macrophages (Thacker et al., 1997), thereby enabling the persistence of infection 
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(Xiao et al., 2004). Down-regulation of MHC proteins results in reduced ability of 
cytotoxic T cells to recognize and destroy PRRSV-infected macrophages (Thacker et al., 
1997). Results from an experimental study, which showed that cytotoxic T cell activity 
was not detected until 49 days post PRRSV-infection, provides evidence for this 
phenomena (Costers et al., 2009).  
In addition to altering the innate response to infection, PRRSV-infection also 
compromises adaptive immune responses. There is evidence that antibodies are produced 
soon after PRRSV-infection, but these antibodies lack neutralizing activity, and therefore, 
are not protective (Yoon et al., 1994). Protective antibodies with effective neutralizing 
capabilities are not produced until 28 days post-infection (Lopez and Osorio, 2004). 
However, a large concentration of neutralizing antibodies is required to effectively 
protect against PRRSV-infection and the antibodies that are produced are typically strain-
specific. Therefore, neutralizing antibodies produced following infection with one strain 
of PRRSV generally offer no protection against PRRS challenge with a heterologous 
strain (Loving et al., 2015).  
 
Co-infection with PRRSV and porcine circovirus (PCV) 
The economic impact and clinical signs of PRRSV-infection are enhanced when 
pigs are co-infected with PRRSV and another pathogen, which is commonly observed in 
the field. Perhaps the most common example is the co-infection with PRRSV and porcine 
circovirus (PCV) (when pigs are not previously vaccinated against PCV), which occurs 
for two main reasons: PCV is ubiquitous in nature (Gillespie et al., 2009; Segalés, 2015) 
and pigs already infected with PRRSV are more susceptible to infection with other 
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diseases (Yin et al., 2013). Co-infection with PRRS and PCV is the cause of what was 
historically referred to as “atypical PRRSV-infection” (Allan and Ellis, 2000). Co-
infection of these viruses results in similar clinical signs and symptoms as PRRSV-
infection alone, but with increased severity of infection (Opriessnig et al., 2008; Tsai et 
al., 2012).  
PCV is a small, single-stranded DNA virus with a circular genome and is a 
member of the virus family Ciroviridae (Gillespie et al., 2009). Two types of PCV exist, 
type 1 (PCV1) and type 2 (PCV2) which are considered genetically and antigenically 
distinct viral types (Meehan et al., 1998). PCV1 is typically non-pathogenic, in contrast 
to PCV2. The type b strain of PCV2 has been identified as the causative agent of post-
weaning multisystematic wasting syndrome (PMWS), a wasting disease in piglets (Allan 
and Ellis, 2000). Cases of PCV2 have been reported in every major swine producing 
country in the world (Gillespie et al., 2009). 
In addition to the ubiquitous nature of PCV, co-infection with PRRSV and PCV is 
also commonly observed in the field because pigs already infected with PRRSV are more 
susceptible to secondary infections (Yin et al., 2013). In the case of PRRSV/PCV2b co-
infection, an increase in PCV2b replication is observed in cells already infected with 
PRRSV (Allan et al., 2000; Harms et al., 2001), suggesting that replication of PRRSV 
enhances the replication of PCV2b. One theory for this phenomena is that PRRSV-
infected cells are more permissive to infection with a second virus (Niederwerder et al., 
2015).  
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Current PRRS control strategies 
Clearly, a need for an effective PRRS control strategy is necessary. Over the 
years, various methods have been developed, but a single, effective control strategy is not 
yet available. Current PRRS control strategies are discussed below.  
PRRS vaccines have already been discussed in some detail, including an 
explanation of the difficulty of developing an effective, cross-protective vaccine. An 
alternate use of PRRS MLV vaccines is to vaccinate entire herds as a way of intentionally 
exposing all pigs to replicating PRRSV (Linhares et al., 2015). This strategy, referred to 
as “load-close-expose”, is utilized with the intention of boosting host immunity upon 
subsequent PRRSV exposure. Studies show that farms that were previously exposed to 
PRRSV recovered from PRRSV-infection sooner than farms that were not exposed to 
PRRSV (Linhares et al., 2015). Economic analyses from a recent study also indicated that 
exposure to PRRS MLV vaccine virus was financially advantageous compared to 
exposure using a field strain of PRRSV because, although pigs inoculated with a field 
strain returned to PRRSV-negative status faster, this approach resulted in greater 
production losses (Linhares et al., 2015). Before implementing preventative MLV 
vaccination, however, it is important to consider whether the reduction in production 
losses out-weighs the cost of the MLV vaccine, or the potential risk of the vaccine virus 
mutating into a virulent PRRSV strain.  
Other PRRS control strategies include the use of pig-flow strategies to prevent 
PRRS from entering a PRRSV-negative facility (Zimmerman, 2009). One such strategy, 
referred to as herd closure, has proven effective in eradicating PRRSV while maintaining, 
or even increasing the number of weaned pigs prior to closure (Schaefer and Morrison, 
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2007). According to this strategy, replacement animals are not allowed to enter the farm 
for a minimum of six months post-PRRSV exposure, with the aim of preventing PRRSV 
positive animals from entering the farm. Instead, current females are re-bred until the end 
of the closure period. A consequence is missing the opportunity to introduce genetically 
superior replacement animals during this period. At the end of the closure period, 
diagnostic testing is performed to ensure that outside replacement gilts and/or outside 
semen sources are negative for PRRSV. This diagnostic testing step is critical since pigs 
that do not display symptoms may still be infected with PRRSV (Wills et al., 1997).  
 “All-in/all-out” is an alternative pig flow strategy that has been an effective 
means of control for infection with other respiratory diseases in pigs, including 
Mycoplasma hyopneumoniae, and Actinobacillus pleuroneumoniae (Scheidt et al., 1995). 
However, all-in/all-out is more costly than herd closure (Schaefer and Morrison, 2007). 
For the all-in/all-out method, pigs are sectioned-off into clean, disinfected individual 
rooms in an attempt to control horizontal transmission of the virus from older, infected 
pigs to younger pigs upon entering the finishing facility (Zimmerman, 2009). Results 
show that, compared to a continuous flow set-up, pigs in an all-in/all-out management 
system had significantly greater growth rate and feed intake and significantly lower lung 
lesion scores when placed in a Mycoplasma hyopneumoniae-infected facility (Scheidt et 
al., 1995). Results of economic analyses indicated that remodeling facilities to switch 
from a continuous flow set-up to an all-in/all-out management system had a net economic 
advantage when pigs were exposed to Mycoplasma hyponeumoniae. A drawback of the 
all-in/all-out strategy is that breeding and farrowing schedules are complicated by the 
need to group pigs in individual rooms by age (Scheidt et al., 1995). 
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 De-population and re-population (depop-repop) is another commonly used pig-
flow strategy to control PRRSV-infection. For this strategy, all pigs on the farm are either 
euthanized or sent to slaughter and then re-populated with PRRSV-free pigs after the 
facility has been thoroughly cleaned and disinfected. Depop-repop is a fast, effective 
strategy for disease eradication and has the ability to eradicate multiple diseases 
simultaneously (Yeske, 2004), but is an even more expensive control strategy than herd 
closure or all-in/all-out. Depop-repop is considered most beneficial for isolated farms, 
rather than farms in pig-dense areas, since the latter are more likely to become re-
infected. Compared to herd closure and all-in/all-out, depop-repop presents more 
opportunities for economic loss, including financial losses at the slaughter plant when de-
populated pigs are below market weight, loss of euthanized pigs, downtime for 
cleaning/disinfection (approximately four weeks) during which no pig production occurs, 
and the cost of diagnostic testing of replacement animals (Yeske, 2004).  
Another PRRS control strategy that has been successful in reducing the incidence 
of PRRS is the use of regional control programs (RCPs). RCPs have successfully 
eradicated other diseases in the U. S., including classical swine fever and Aujeszky’s 
disease (Valdes-Donoso et al., 2016). PRRS RCPs, developed with the goal of 
eradicating PRRS in high hog-density areas, require the full cooperation of all farmers in 
the area. This is particularly important for PRRS because, since the disease is not 
zoonotic, farmers are not required to report a PRRS outbreak (Valdes-Donoso et al., 
2016). In the U. S., the first RCP for PRRS was established in Stevens County, 
Minnesota in 2004 (Corzo et al., 2015), which has been referred to as the N212 
Minnesota Voluntary Regional PRRS Elimination Project (RCP-N212). The first step in 
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establishing RCP-N212 was to test all farms for PRRSV using a PRRSV-specific 
enzyme-linked immunosorbent assay and polymerase chain reaction test. Based on these 
tests, only farms with 100% negative results were considered PRRS-free. All other farms 
were encouraged to begin a PRRS-elimination procedure. This step was successful in 
eliminating the disease from the region, but implementation of strict biosecurity 
protocols, continued veterinary surveillance, and regular communication between 
producers and veterinarians proved essential to maintaining a PRRSV-negative status 
(Corzo et al., 2015).  
As of 2014, the RCP-212 control program has expanded to include hog facilities 
in 39 counties in Minnesota (Valdes-Donoso et al., 2016). A recent study was conducted 
using data collected from 2012-2014 to analyze the success of this program. Results show 
that incidence of PRRS significantly decreased as the number of participating farms 
increased (Valdes-Donoso et al., 2016). The program was also successful at increasing 
producer awareness for the value of sharing disease status information as a means of 
effectively controlling disease within a region. As of the beginning of 2016, there were 
more than 30 RCPs located throughout the U. S. and Canada. These programs continue to 
focus on local eradication of PRRS, but have also attempted to eradicate porcine 
epidemic diarrhea virus, which has posed a major threat to the swine industry in recent 
years (Valdes-Donoso et al., 2016).  
 
Genetic Selection for Increased Disease Resistance 
 
Although each of the abovementioned disease control strategies is, at the very 
least, partially effective in reducing the incidence of disease, PRRS continues to threaten 
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the pork industry. Therefore, a single, effective PRRS control strategy has not yet been 
identified. An alternative control strategy that has received attention in recent years is the 
use of genetic selection to breed livestock for improved host response to disease.  The 
first indication that genetic selection may be a promising control strategy for PRRS was 
the observation that certain breeds appeared to be more naturally resistant to PRRS than 
other breeds (Ait-ali et al., 2007). Additional studies confirmed the existence of a host 
genetics component for PRRS resistance (Lewis et al., 2007; Lunney et al., 2011; 
Boddicker et al., 2012).  
 
PRRS Host Genetics Consortium (PHGC) 
The PRRS Host Genetics Consortium (PHGC) is a group of individuals from 
academia and industry that formed based on a shared interest in identifying a host 
genetics component for PRRS resistance. The long-term goal of this consortium is to use 
the identified genes/genomic regions to breed pigs for improved host response to 
PRRSV-infection. Multiple breeding companies have participated in the consortium by 
providing nursery-age commercial piglets to be used for these on-going experimental 
infection trials. For the original PHGC trials (i.e. 1-15), groups of approximately 200 pigs 
each were supplied by the breeding companies and shipped to Kansas State University at 
weaning age. Upon arrival at Kansas State, piglets were given several days to acclimate 
to their surroundings prior to inoculation with the NVSL 97-7985 (NVSL; trials 1-9 and 
15) or KS-2006-72109 (KS06; trials 10-14) PRRSV isolate. During the infection period, 
multiple weight and serum samples were collected from 0 to 42 days post-infection (dpi) 
(Lunney et al., 2011). Weights collected at the beginning and end of the trial were used to 
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calculate weight gain (WG) post-infection and repeated viremia measurements were used 
to quantify PRRS viral load (VL) as the area under the curve from 0 to 21 dpi. Ear tissue 
was also collected to obtain single nucleotide polymorphism (SNP) genotypes for each 
pig using a panel of over 60,000 SNPs located across the pig genome.  
The initial publication from the PHGC presents results of a genome-wide 
association study (GWAS) for PRRS VL and WG for the first three PHGC trials 
(Boddicker et al., 2012). These results indicated the presence of a major quantitative trait 
locus (QTL) for host response to PRRS located at 139 megabases (Mb) on Sus scrofa 
chromosome (SSC) 4 (Boddicker et al., 2012). Within this 1 Mb region, the SNP 
WUR1000125 (WUR) was selected as a tag SNP for this QTL. Results showed that 
WUR was associated with 15.7% of the total genetic variation in PRRS VL and 11.2% of 
the total genetic variation in WG from 0 to 42 dpi (Boddicker et al., 2012). At this SNP, 
the “B” allele is the favorable allele under PRRS challenge and was found to be dominant 
to the “A” allele (Boddicker et al., 2012). 
Identification of this major QTL on SSC4 prompted additional research, including 
a study to identify the causal mutation for the QTL. Results of a RNA-sequencing 
analysis showed that the guanylate binding protein (GBP5) gene was differentially 
expressed in blood for pigs with the AA versus AB WUR genotype (Koltes et al., 2015). 
A mutation was identified in GBP5 that introduces an illegitimate splice acceptor site for 
individuals with the AA genotype. Introduction of this splice acceptor site results in a 5-
basepair insertion, resulting in a shifted reading frame and ultimately, a truncated protein 
product. Consistent with the favorable effect of the “B” allele under PRRSV-infection, 
results showed that AB pigs produced more of the wild-type transcript than pigs with the 
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AA genotype for the WUR SNP. Another study identified an association of GBP5 with 
response to infection with live bacteria, particularly inflammasome assembly (Shenoy et 
al., 2012), but Koltes et al. (2015) was the first to detect an association of GBP5 with 
response to viral infection. Since then, recent research has shown that GBP5 also plays a 
role in the innate antiretroviral immune response following infection with human 
immunodeficiency virus (Krapp et al., 2016).  
 
Selection for resistance versus tolerance 
One application of the QTL associated with resistance to PRRSV-infection 
(Boddicker et al., 2012) is to select individuals based on WUR genotype to breed pigs for 
increased disease resistance. Disease resistance is defined as the ability of the host to 
exert some control over the parasite or pathogen life cycle (Bishop, 2014). The definition 
of resistance can be interpreted in several ways, such as a lower likelihood of becoming 
infected, reduced pathogen replication once inside the host, or reduced pathogen 
shedding (Bishop, 2014).  
There is evidence from multiple livestock species that genetic selection for 
increased resistance to disease is possible. For example, in cattle, genomic regions 
associated with susceptibility to clinical mastitis (Lund et al., 2008), Mycobacterium 
avium paratuberculosis (Kirkpatrick et al., 2011), bovine keratoconjunctivits (Kizilkaya 
et al., 2013), and bovine respiratory disease complex (Neibergs et al., 2014) have been 
identified. In chickens, researchers have identified genomic regions associated with 
specific diseases, such as Marek’s disease (Heifetz et al., 2007; Wolc et al., 2013), as 
well as general immune function (Zhou et al., 2003). In addition to the QTL for PRRS 
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(Boddicker et al., 2012), other studies have shown evidence of genomic regions 
associated with response to disease in pigs, including N-protein specific immunoglobulin 
G (IgG) response to PRRS (Hess et al., 2014), susceptibility to PCV2b (Engle et al., 
2014), susceptibility to pseudorabies virus infection (Reiner et al., 2002), and B and T 
cell development in response to PCV2b (Kreikemeier et al., 2015).  
Identification of genomic regions associated with response to disease not only has 
implications at the individual animal level, but also at the herd level because animals that 
experience reduced pathogen replication/shedding at the individual level are less 
infectious to pen mates. Therefore, selecting for increased disease resistance not only 
lessens the impact of disease on performance of the individual, but also reduces pathogen 
level at the herd/population level.  
One argument against selecting for increased disease resistance is that selection 
for resistance may result in increased pathogen virulence. There is evidence that 
increased selection pressure can cause pathogens to mutate into new forms as a way of 
evading host defenses (Roy and Kirchner, 2000). An alternative strategy is to select for 
increased disease tolerance. According to its original definition from the field of ecology, 
tolerance is the ability of the host to maintain fitness under stress (Simms, 2000). In the 
context of disease challenge, tolerance is defined as the change in performance as 
pathogen burden increases, or mathematically, as the slope of performance regressed on 
pathogen level (Doeschl-Wilson et al., 2012). In keeping with this definition, individuals 
with a slope of zero are considered completely tolerant since they are able to maintain the 
same level of performance upon pathogen exposure.    
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To date, selection for increased disease tolerance has received less attention than 
selection for increased disease resistance. This is largely due to the difficulty of 
identifying suitable phenotypes to quantify tolerance. Analysis of disease resistance 
requires repeated measurements of performance and pathogen burden recorded on the 
same individual (Doeschl-Wilson et al., 2012). However, tolerance phenotypes are 
typically measured at the group level, meaning that ultimately, groups of individuals, 
rather than individuals themselves, will be selected for increased disease tolerance 
(Doeschl-Wilson et al., 2012). Another disadvantage of selecting for disease tolerance is 
that, unlike selecting for disease resistance, tolerance does not allow eradication of the 
disease. Selecting for increased disease resistance will reduce pathogen level over time, 
whereas pathogens will continue to replicate and be transmitted when selecting for 
increased disease tolerance (Roy and Kirchner, 2000).  
 
Genetic selection methods  
Marker assisted selection (MAS) 
Two methods of selection for increased disease resistance or disease tolerance 
include: marker assisted selection (MAS) and genomic selection. MAS is an indirect 
method of selection, where superior animals are selected based on genotype at a SNP that 
is in linkage disequilibrium (LD) with a QTL (Wakchaure et al., 2015). When a SNP and 
QTL are in LD it means that the allele at the SNP and the allele at the QTL will be 
inherited as a set. Therefore, the allele at the SNP can be used to predict the allele at the 
QTL and visa versa. For MAS to be effective, knowledge of the causative gene/mutation 
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for the QTL is not needed. Rather, genotype for a SNP linked to a QTL is sufficient for 
making selection decisions.  
A statistical association between a SNP and trait of interest can be detected using 
a GWAS. The two main GWAS methods used include fitting SNP effects one at a time to 
analyze a trait of interest using a linear model (single-SNP GWAS), or fitting all SNP 
effects simultaneously using Bayesian statistics. For the single-SNP approach, the effect 
of each SNP is fitted one at a time using the following linear model: 
𝐲 =   𝐗𝐛 + 𝐖i𝐩i + 𝐙𝛂 +  𝐞 
where y = vector of phenotypes; X = design matrix of fixed effects and b = 
corresponding vector of solutions; 𝐖i= matrix of fixed genotype effects for the i
th SNP 
and pi = corresponding vector of solutions; Z = design matrix of random effects and α = 
corresponding vector of solutions; and e is the vector of random environmental effects 
where the effects are assumed ~N(0,σe2). For single-SNP GWAS, the number of models 
fitted is equal to the number of SNPs genotyped. This is a good approach for determining 
the effect of each SNP irrespective of the other SNPs in the genome.     
As an alternative to single-SNP GWAS, Bayesian methods, including BayesA, B, 
C, and Cπ, which were developed to perform genomic prediction, can also be used to 
perform GWAS (Zou and Zeng, 2008). The Bayesian methods fit the effects of all SNPs 
in the model simultaneously. The effect of each SNP is fitted as a random effect with a 
mean of zero and the parameter π equal to the proportion of SNPs expected to have no 
effect on the phenotype (Meuwissen et al., 2001). The Bayesian methods that have been 
developed differ in their assumption regarding the distribution of SNP effects and the use 
 26 
of locus-specific variances versus a single variance across all SNPs. The general model 
equation for Bayesian GWAS is: 
𝐲 = 𝐗𝐛 + ∑𝐳i𝛂i𝛅i
k
i=1
+ 𝐞 
where y = vector of phenotypes; X = design matrix of fixed effects and b = 
corresponding vector of solutions; 𝐳i = vector of genotype effects for the i
th SNP; 𝛂i = 
vector of allele substitution effects for the ith SNP; 𝛅i = vector indicating whether (𝛅i = 1) 
or not (𝛅i = 0) the effect of the i
th SNP is included in the model for a given iteration; and 
e = vector of random environmental effects.  
The BayesA method assumes an infinitesimal model (i.e. that all SNPs have a 
small effect on the phenotype (π = 0)), that SNP effects follow a univariate t-distribution, 
and allows for locus-specific variances (Meuwissen et al., 2001). One downfall of 
BayesA is that this method over-regresses the large QTL effects back to zero (Meuwissen 
et al., 2001).  
BayesB, like BayesA, was also developed by Meuwissen et al. (2001) and is 
considered a variable selection method of BayesA. This means that some SNPs are 
assumed to have no effect on the phenotype for a given iteration. These SNP effects are 
set to zero and are not fitted in the model for that iteration (Meuwissen et al., 2001). 
Iterations are performed using a sampling method, such as the Metropolis-Hastings 
method (Hastings, 1970), to construct a Monte Carlo Markov Chain. The effect of each 
parameter is estimated from the joint posterior distribution for each iteration and these 
estimates are then used to up-date the Markov Chain for the following iteration. The 
BayesB method gives more weight to SNPs with larger effects, which makes it the 
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preferred method when major QTL are suspected. For BayesC, like BayesB, SNP effects 
are sampled from a mixture distribution. Unlike BayesA and BayesB, BayesC and 
BayesCπ assume the same variance for each locus that has a non-zero effect (Habier et 
al., 2011). Unlike the other Bayesian methods, for BayesCπ, π is treated as an unknown 
parameter and is estimated from the data (Habier et al., 2011).  
Once an association between a SNP and the trait of interest is identified using 
GWAS, selection candidates are genotyped for the SNP to facilitate selection decisions. 
Proper implementation of MAS requires re-estimation of the SNP effect after several 
generations to ensure that the SNP and QTL are still in LD. Results from a simulation 
study for a commercial pig population indicated that MAS is most profitable when 
linkage between SNP and QTL is population-wide, as opposed to breed or line specific 
(Hayes and Goddard, 2003). In fact, MAS becomes more difficult, or perhaps even 
impractical, if the linkage phase of the SNP and QTL differs between commercial lines 
within a company.   
Studies show that implementation of MAS in a breeding program can increase 
response to selection anywhere from 8 to 64% (Hayes and Goddard, 2003). For 
populations in which performance testing is conducted, perhaps the most prominent 
advantage is the opportunity to reduce generation interval. Generation interval can be 
reduced as long as the allele for the QTL is known, meaning that selection decisions can 
be made without waiting to record phenotypic information on selection candidates. A 
reduction in generation interval or increase in: intensity of selection, accuracy of 
selection, or genetic variability for the trait, all translate to an increase in genetic gain. 
MAS is also useful for selecting animals for improved performance for traits that are 
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difficult or expensive to measure, traits that can only be measured later in life, or traits 
that are not possible to record on the breeding animals (Meuwissen and Goddard, 1996; 
Wakchaure et al., 2015).  
There are, however, some disadvantages of MAS. First, markers linked to QTL 
must be identified. This requires phenotypes and genotypes recorded on a large number 
of individuals. When conducting single-SNP GWAS, an appropriate significance 
threshold must be selected. A threshold that is too stringent may mean that some QTL 
will not be detected, whereas setting a threshold that is too liberal increases the number of 
false positive associations, thereby reducing the accuracy of the identified marker (Hayes 
and Goddard, 2003). It is also important to note that a certain degree of bias exists when 
attempting to identify QTL using family data. Since individuals within a family are 
related, a certain degree of LD always exists within families. Therefore, the effect of a 
QTL identified within a family may be over-estimated, compared to the effect on the 
larger population (Goddard and Hayes, 2009).  
There are also several practical problems associated with MAS. One is the cost of 
genotyping. Although costs continue to decrease, this may be a limiting factor for some 
populations. Secondly, different sets of SNPs are present on different versions of SNP 
panels. Therefore, it is possible that a genetic marker for MAS identified using one SNP 
panel will not be present on a newer version. In addition, identification of a suitable 
marker for MAS is limited to the markers on the panel. Therefore, unless an association 
can be detected between a QTL and a SNP existing on the panel, no candidate for MAS 
will be identified. Even if a QTL is detected, the magnitude of the QTL effect should also 
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be taken into consideration. For example, it may not be worth implementing MAS for a 
QTL that explains a small proportion of the total genetic variance for the trait of interest.  
Additional points to consider prior to implementing MAS are: a large sample size 
should be used to obtain the most accurate estimate of the QTL effect as possible, the 
marker should be expressed in both sexes (i.e. marker should not be located on the Y 
chromosome), if selection is performed across lines the marker should also segregate 
across lines, and the allele or genotype being selected should not be unfavorably 
associated with other economically important traits. When implementing MAS to breed 
for increased disease resistance, it is also important to keep in mind that this selection 
strategy is only practical when major QTL affect the trait of interest. However, since 
most disease traits are polygenic, identifying major QTL for MAS is not expected to be 
an effective control strategy for all diseases. For example, in humans, QTL typically 
explain less than 4% of the total genetic variation for complex traits, which are defined as 
traits controlled by many loci with small effects. A similar figure is expected for 
livestock species (Goddard and Hayes, 2009). For such traits, genomic selection is 
considered the preferred genetic selection strategy.  
 
Genomic prediction and genomic selection 
Genomic selection, proposed by Meuwissen, Hayes, and Goddard in 2001, is a 
method used to select individuals based on SNP genotype using all SNPs on the SNP 
panel (Meuwissen et al., 2001). Genomic selection is applied under the assumption that a 
SNP panel is dense enough so that all QTL are expected to be in LD with at least one 
SNP (Goddard and Hayes, 2009). To perform genomic selection, so-called training and 
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validation populations are required. A training population is used to simultaneously 
estimate the effect of each SNP for all SNPs included on the SNP panel. The estimated 
SNP effects are then used to estimate the genomic breeding value of the individuals 
included in the validation population using genomic prediction.  
Different genomic prediction methods exist, which use the marker information in 
different ways. One genomic prediction strategy is to replace the pedigree-based 
relationship matrix with the genomic relationship matrix (GRM) (VanRaden, 2008). The 
GRM is constructed using SNPs genotypes for each individual to estimate genomic 
relationships between all individuals in the dataset. Another strategy is to use one of the 
previously described Bayesian methods to estimate individual SNP effects, keeping in 
mind that some methods shrink the effects of SNPs with small effects on the trait.  
An advantage of genomic selection, compared to MAS, is that genomic prediction 
makes use of all of the QTL affecting a trait, even those with small effects (Meuwissen et 
al., 2001). In addition, no prior knowledge of individual QTL effects is necessary. With 
genomic prediction, it is also possible to estimate genomic breeding values for 
individuals in the validation population that lack phenotypic information. Therefore, as 
with MAS, selection decisions can be made at an early age, which ultimately reduces the 
generation interval and increases genetic gain.  
Accurate SNP effects are crucial to the success of genomic prediction. Obtaining 
accurate SNP effects requires a large training population (since most QTL effects are 
small) and that SNP effects be re-estimated as the population changes. Because breeding 
values of the validation population are estimated from the training population, the 
accuracy of estimated breeding values (EBV) in the training population is also important 
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for the success of genomic selection. This also means that the accuracy of EBV for the 
validation population is only as good as the accuracy of EBV for the training generation. 
A final consideration is that the process of training and validating on SNPs across the 
genome also includes SNPs with little to no effect on the phenotype, which can introduce 
noise and decrease accuracy of predicting genetic merit (Goddard and Hayes, 2009). 
 
Conclusions 
 
In conclusion, PRRS is considered the most economically devastating disease to 
the swine industry, in part because PRRS affects pigs during all stages of production, 
PRRSV persists within a herd, and no single, effective PRRS control strategy is yet in 
use. Commercial PRRSV vaccines are used, but have limited efficacy following infection 
with a heterologous PRRSV strain, due to the high mutation rate of PRRSV.    
The PHGC was formed to explore a different approach: to identify genes and 
genomic regions associated with resistance to PRRSV-infection. Regions associated with 
disease response have been identified in other livestock species and have the potential to 
be used to breed animals for improved host response to infection using MAS or genomic 
selection strategies. The identification of a major QTL for host response to PRRS on 
SSC4 indicates the possibility of using genetic selection as a PRRS control strategy.  
Prior to the research presented in this thesis, the effect of WUR, a genetic marker 
for the QTL on SSC4, had been validated across breeds, breeding companies, and 
following infection with two different isolates of PRRSV. However, the research 
presented in this thesis sought to address several unanswered questions including: what is 
the effect of WUR on host response to PRRS vaccination or co-infection with PRRSV 
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and other pathogens, and, what is the effect of WUR on economically important traits 
under non-challenged conditions? Other questions included: are regions other than WUR 
associated with host response to PRRS vaccination or co-infection with PRRSV and other 
pathogens, and finally, which genomic regions should be used to predict genetic merit for 
host response to PRRS vaccination or co-infection with other pathogens?  
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Abstract 
 
Feed efficiency is of great importance to the swine industry, yet few studies have 
evaluated the robustness of pigs selected for increased feed efficiency based on residual 
feed intake (RFI) when challenged with disease. RFI is calculated as the difference 
between the observed and expected feed intake. The objective of this study was to assess 
the effect of porcine reproductive and respiratory syndrome (PRRS) virus (PRRSV) 
infection on lines of pigs divergently selected for RFI. Hypothesizing that the more feed 
efficient low RFI (LRFI) pigs would be more affected by PRRSV-infection, 97 piglets 
from LRFI and 99 piglets from high RFI (HRFI) selection lines were experimentally 
infected with the NVSL 97-7985 PRRSV isolate 1 to 3 weeks post-weaning. Pig body 
weight was recorded weekly and used to calculate average daily gain (ADG). For 
comparison, ADG was also evaluated on 489 non-challenged LRFI and HRFI pigs 
housed in a separate facility. Viral load (VL) was quantified as area under the curve for 
0-21 days post-infection (dpi) of the log of PCR-based serum viremia. Antibody level 
was analyzed from serum samples collected at 4, 7, and 11 dpi by PRRS ELISA and 
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MAGPIX assays to quantify PRRSV-specific IgG antibody and total antibody, 
respectively, during the early stages of PRRSV-infection. There was a tendency for pigs 
from the LRFI line to have lower VL (P = 0.09), greater ADG (P = 0.10), and be more 
likely to survive the PRRSV-challenge (P = 0.06) than pigs from the HRFI line. 
However, joint analysis of challenged and non-challenged pigs showed a significant 
interaction between RFI line and challenge status (P = 0.04), which demonstrated that 
growth of the LRFI line was less affected by PRRSV-challenge than growth of the HRFI 
line. In addition, a significant interaction between RFI line and dpi for the ELISA (P < 
0.001) and MAGPIX (P = 0.007) assays indicated that the increase in antibody levels 
from 7 to 11 dpi was greater for the LRFI line than for the HRFI line. In conclusion, the 
line selected for increased feed efficiency based on RFI (LRFI line) had greater growth 
under challenge and was therefore less affected by the PRRSV-challenge than the line 
selected for reduced efficiency (HRFI line). This suggests that the pigs selected for 
reduced RFI were more robust to the viral challenge. 
 
Introduction 
 
Residual feed intake (RFI) is defined as the difference between expected and 
actual feed intake for a given amount of growth and maintenance (Koch et al., 1963). 
Therefore, pigs that are more efficient eat less than expected per unit of growth, resulting 
in lower RFI than less efficient (high RFI) animals. In pigs, increased feed efficiency can 
be achieved by selecting for lower RFI, with reported heritability estimates of 0.20 ± 0.06 
(Young and Dekkers, 2012), 0.29 ± 0.07 (Cai et al., 2008), and 0.24 ± 0.03 (Gilbert et al., 
2007).  
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Although feed efficient animals are desirable because they are more economical 
for farmers, there are concerns that selection for increased feed efficiency could lead to 
increased susceptibility to stressors and diseases as a correlated response. More 
specifically, the theory of resource allocation proposes that energy-demanding processes, 
such as mounting an immune response, may be compromised in animals that have been 
selected for high production efficiency (Rauw, 2012; Rauw et al., 1998), suggesting that 
such animals may be more susceptible to disease (Knap and Bishop, 2000). Selection for 
increased feed efficiency based on RFI has indeed been shown to negatively impact 
immune response in chickens and beef cattle (Rauw, 2007). Based on this research, it is 
hypothesized that pigs selected for low RFI would be immuno-compromised in 
comparison to high RFI pigs, based on assessment of growth performance and levels of 
serum viremia and antibodies following infection with the porcine reproductive and 
respiratory syndrome virus (PRRSV). PRRS is an economically devastating disease 
(Holtkamp et al., 2013) and it is of particular interest to the swine industry to evaluate the 
robustness of feed efficient pigs to this disease and their ability to mount an effective 
immune response. Thus, the objective of the current study was to determine the effect of 
PRRSV-infection on lines of pigs that were divergently selected for RFI.  
 
Materials & Methods 
 
This project was approved by the Kansas State University and Iowa State University 
Institutional Animal Care and Use Committees. 
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Animals 
Pigs used in this study were from generation 8 of the Iowa State University (ISU) 
RFI lines with divergent selection for low and high RFI during the growing period (Cai et 
al., 2008; Young and Dekkers, 2012). Compared to the line selected for high RFI (HRFI), 
the line selected for low RFI (LRFI) had 376 g/d lower feed intake (LRFI mean = 1,989 
g/d), 79 g/d slower growth (LRFI mean = 768 g/d), 2.5 mm less backfat (LRFI mean = 
15.88 mm), and 1.5 cm2 larger loin muscle area (LRFI mean = 45.02 cm2), resulting in 
the LRFI line having 241 g/d lower RFI from approximately 35 to 110 kg body weight, 
and 0.22 g lower feed to gain ratio (LRFI mean = 2.58 g/g) (Cai et al., 2008; Young and 
Dekkers, 2012).  
Pigs used for this experiment were born at the ISU Lauren Christian Swine 
Research Farm, which was negative for PRRS and other major diseases, such as 
influenza and porcine epidemic diarrhea virus. In total, 196 pigs (97 LRFI and 99 HRFI 
pigs) from 16 sires and 51 first parity litters were used for the PRRSV-challenge 
experiment. Pigs were shipped to a bio-secure facility at Kansas State University at 
weaning (between 14 and 32 days of age) in 2 groups of 100 pigs, separated by 
approximately 2 weeks. The average weaning ages were 22.9 and 24.5 days for groups 1 
and 2, respectively. Average weaning weights were 5.42 Kg for group 1 and 5.70 Kg for 
group 2.  Upon arrival, the 2 groups were housed in separate rooms in the same facility 
and randomly placed into pens measuring 3.66 m by 3.66 m, with 16-18 pigs per pen. 
Roughly equal numbers of LRFI and HRFI pigs were sorted into each pen. Pigs from the 
two lines have been housed in mixed pens since the beginning of the selection experiment 
and no unusual behavioral differences between lines were noted outside of the typical 
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establishment of hierarchy upon initial placement in pens. Behavior was assessed on an 
observational basis and monitored daily.  
Both groups were given approximately 1 week to acclimate to their new 
environment before receiving an intranasal and intramuscular dose of 105 tissue culture of 
the NVSL 97-7985 PRRSV isolate, following the standard procedure for PRRSV 
inoculation implemented for the PRRS Host Genetics Consortium (PHGC) trials (Lunney 
et al., 2011). All pigs within a group were inoculated on the same day, but group 2 pigs 
were inoculated approximately 2 weeks after group 1. Body weights (BW) were recorded 
weekly and serum samples were collected at 0, 4, 7, 11, 14, 21, 28, 35, and 39 days post-
infection (dpi). Group 1 pigs were necropsied at 40 dpi, but due to limits on availability 
of the facility, pigs from group 2 were necropsied at 28 dpi. Viremia was measured on 
each serum sample using the Taq-man quantitative PCR method, as described by 
Boddicker et al. (2012). 
Comparative growth data was also collected without a PRRSV-challenge on pigs 
that were either full or half-siblings of the PRRSV-challenged pigs (Table 3.1). These 
pigs were from the second parity of generation 8 of the ISU RFI lines from 17 sires and 
58 litters. These non-challenged pigs were housed in the nursery facility of the ISU 
Lauren Christian Swine Research Farm, also negative for major diseases such as 
influenza and porcine epidemic diarrhea virus, with 8 to 12 pigs per pen. Pen dimensions 
and arrangement of the facility are described in Sadler et al. (2011). Anywhere from 2 to 
4 BW records were collected on each pig in the nursery, with an average of 20 days 
between weights. Ages of these non-challenged pigs at first BW measurement were 
similar to those of the PRRSV-challenged pigs at inoculation, 32.0 ± 3.0 and 39.5 ± 5.5 
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days old, respectively. All pigs in the challenged and non-challenged experiments 
received a standard nursery diet throughout the duration of the study.  
 
Traits 
Traits analyzed included mortality, average daily gain (ADG), viral load (VL), 
viremia, and antibody levels. Since the 2 PRRSV-challenged groups were necropsied on 
different days (group 1 at 40 dpi and group 2 at 28 dpi), mortality was analyzed as a 
binary variable as the number of pigs dead by the end of the trial (40 dpi for group 1 and 
28 dpi for group 2), and as the number of pigs dead by 28 dpi. For the PRRSV-
challenged pigs, ADG was calculated as the slope of BW regressed on days, from 0 to 28 
dpi for both groups. ADG was also calculated as the regression of BW data from 0 to 39 
dpi for group 1. For the non-challenged pigs, all available weights collected in the 
nursery were used to calculate ADG as the regression of BW on age.  
Viral load was calculated as area under the curve using log10-transformed viremia, 
as described by Boddicker et al. (2012). Only viremia data up to 21 dpi were used for 
calculation of VL since some pigs entered a rebound phase after 21 dpi, which was 
determined not to have a host genetics component in other PHGC trials (Boddicker et al., 
2012; Islam et al., 2013).  
The 196 total pigs used in the challenge study did not include 2 pigs from group 2 
that died prior to inoculation and 2 pigs from group 1 that died after inoculation as a 
result of severe combined immunodeficiency disease (SCID; Ozuna et al., 2012). The 
occurrence of SCID was unrelated to the PRRSV-challenge since SCID is a genetic 
disorder. Therefore, data for these 4 pigs were excluded from all analyses. The early 
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death of these 4 pigs and their associated lack of PRRSV antibodies following challenge 
prompted the assessment of antibody data from serum samples from all pigs collected at 
4, 7, and 11 dpi, and these provided the basis of the antibody data used in this study. 
Antibody specific to PRRSV and total antibody were measured by ELISA (IDEXX 
PRRS X3, IDEXX Laboratories Inc.; Westbrook, Maine, USA) and MAGPIX 
(MAGPIX, Lumminex Laboratories; Billerica, Massachusetts, USA) assays, respectively. 
For the ELISA assay, antibody levels were expressed as the sample-to-positive (S/P) 
ratio, a semi-quantitative measurement of the amount of PRRSV IgG within a sample. 
Results of the MAGPIX assay were reported as mean fluorescence intensity (MFI) 
values.  
 
Statistical analyses 
Normality of residuals was tested for each trait.  Some outlying data points were 
detected, but no outliers were removed since values were confirmed by the laboratory 
staff and the number of data points was limited.   
For the PRRSV-challenged pigs, ADG, day viremia, VL, mortality, and antibody 
response were analyzed. A joint analysis of ADG of the challenged and non-challenged 
pigs was also conducted. All phenotypic analyses were performed using the MIXED 
procedure in SAS 9.3 (Statistical Analysis System Institute Inc., Cary, North Carolina, 
USA), with the exception of the mortality analysis, for which the GLIMMIX procedure 
of SAS was used. A threshold of P = 0.05 was used to determine significance for main 
effects. Although the biological hypothesis for this study was one-sided (i.e. the LRFI 
pigs were expected to be more affected by the PRRSV-challenge than the HRFI pigs), all 
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statistical analyses were performed using 2-sided tests (i.e. using the null hypothesis of 
no difference between the means of the LRFI and HRFI lines for a particular trait).   
 
Average daily gain, viremia, viral load, and mortality  
Using a single record per individual, ADG, viremia on each day, and VL were 
analyzed for the PRRSV-challenged pigs using a mixed model with group (1 or 2), line 
(LRFI or HRFI), group*line, sex (gilt or barrow), and the covariate of age at inoculation 
fitted as fixed effects. Sire, litter, and pen were included as random effects to account for 
genetic, maternal, and common environmental effects, respectively. The effect of “litter” 
also accounted for any differences in weaning age, since all pigs from a litter were 
weaned on the same day. Mortality was analyzed as a binary variable using the same 
model.  
The model for the joint ADG analysis of the challenged and non-challenged pigs 
included the fixed effects of PRRS status (challenged or non-challenged), line, PRRS 
status*line, group within PRRS status (2 groups for the PRRSV-challenged pigs and 1 
group for the non-challenged pigs), sex, sex*PRRS status, and covariates for age (at 
inoculation for the challenged pigs and age at first weight for the non-challenged pigs), 
age*PRRS status, age at last weight, and age at last weight*PRRS status. Sire, dam, litter, 
and pen were fitted as random effects. For the PRRSV-challenged pigs, ADG was 
calculated as the slope from 0 to 28 dpi. 
 
 
 
 49 
Antibody response 
Statistical analyses of S/P ratio for 4 dpi and a joint analysis of S/P ratio for 7 and 
11 dpi were performed for the ELISA data. A separate analysis was conducted for 4 dpi 
because negative S/P values were observed, meaning that the background values were 
greater than the sample values. The model used to analyze 4 dpi was identical to the 
model used for analysis of VL and viremia, except for the additional fixed effect of assay 
date, the day on which the PRRS ELISA assay was run (day 1, 2, or 3). No plate 
information was available for these assays. The ELISA data for 7 and 11 dpi was 
analyzed jointly using a repeated measures model. This model was identical to the model 
described above, except for the inclusion of the main effect of dpi and the following 
additional interactions: group*dpi, line*dpi, and group*line*dpi. The effect of assay date 
was not included since it was confounded with group for these days. An unstructured 
(co)variance structure for the residuals was used to account for repeated measurements 
with “animal” specified as the repeated subject.  
A similar approach was used to analyze MFI for the MAGPIX assay. As with the 
ELISA data, MFI at 4 dpi was analyzed separately from the data for 7 and 11 dpi. 
Negative control (covariate), positive control (covariate), assay date (random, 8 levels), 
and plate within assay date (random, 13 levels) were included as additional effects in the 
model described for analysis of the ELISA data for 4 dpi. This same model was also used 
to analyze the MFI data for 7 and 11 dpi jointly, but with additional interactions for day, 
as described for the repeated measures model of the PRRS ELISA data. Similar to the 
analysis of the ELISA data, an unstructured (co)variance structure for the residuals was 
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included to account for repeated measurements with “animal” specified as the repeated 
subject.  
 
Heritabilities  
Although the size of data set was limited for genetic parameter estimation, 
heritabilities of ADG and VL were also estimated for comparison to results from other 
PHGC trials (Boddicker et al., 2014). Genetic parameters were estimated using ASReml 
3.0 (Gilmour et al., 2009). Heritabilities for ADG and VL were estimated using a single-
trait animal model, using the PRRSV-challenged data, with the fixed effects of group, 
line, group*line, age (at inoculation), and sex. Random effects included animal, litter, and 
pen. A 9-generation pedigree with 16,406 animals was used for these analyses. 
  
Results 
Average daily gain 
Raw weight data for the PRRSV-challenged and non-challenged pigs showed a 
consistent, upward trend in BW with age (Fig. 3.S1). The non-challenged pigs, on 
average, had 173 g/d greater ADG than the challenged pigs, suggesting that the 
challenged pigs experienced reduced growth, although there were many confounding 
factors due to differences in housing and timing of weight collection of the challenged 
and non-challenged pigs. Average daily gain was not found to be heritable for the 
PRRSV-challenged pigs but litter explained 13 ± 8 % of the phenotypic variation in 
ADG. 
The joint analysis of ADG of the challenged and non-challenged pigs resulted in a 
significant interaction of line by PRRS status (P = 0.04), which is illustrated in Fig. 3.1. 
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This interaction shows that the decrease in growth performance when pigs were 
challenged with PRRSV was lower for the LRFI line (-148.3 ± 77.2 g/d) than for the 
HRFI line (-197.7 ± 71.6 g/d). Without challenge, LRFI pigs had numerically (21.9 g/d) 
slower growth than the HRFI pigs (P = 0.20). Following the PRRSV-infection, the LRFI 
pigs tended to grow slightly (27.6 g/d) faster than HRFI pigs (P = 0.10; Table 3.2). Thus, 
although the line effects were not significant for these separate analyses of ADG by 
challenge status, the significant interaction of line by challenge status for the joint 
analysis demonstrates that ADG of LRFI pigs was less affected by PRRSV-infection than 
ADG of the HRFI pigs. For these analyses, ADG was calculated using 0 to 28 dpi for the 
PRRSV-challenged pigs, but similar results were obtained when calculating ADG from 0 
to 39 dpi for group 1, for which LRFI pigs had numerically greater ADG (20.0 g/d) than 
HRFI pigs (P = 0.33).  
 
Viremia and viral load 
Preceding any statistical analyses of the viremia data, it was noted that 28 pigs 
from group 2 had detectable viremia on day 0 (viremia > 0) (Fig. 3.S2). This indicates 
that group 2 pigs were exposed to PRRSV prior to inoculation, likely from the already-
infected group 1 pigs, which were housed in a separate room in the same facility. 
Although these non-zero viremia values on 0 dpi are not desirable for the purposes of this 
experiment, there was no evidence that the data from these pigs biased our results. For 
instance, these 28 pigs were roughly equally divided between the 2 lines (16 LRFI and 12 
HRFI) and statistical analysis of the group 2 pigs did not indicate a line difference for 
viremia at 0 dpi (P = 0.47) or VL (P = 0.45). Also, excluding these 28 pigs from the 
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statistical analyses of ADG, VL, and viremia did not significantly change line differences 
or interpretations. Thus, in all analyses presented, data from all pigs were included.  
Analysis of VL indicated suggestive evidence (P = 0.09) that LRFI pigs had 
lower VL than HRFI pigs (Fig. 3.2). When viremia was analyzed separately for each dpi, 
no evidence of a line difference was detected for any of the time points, except at 21 dpi, 
for which LRFI pigs tended to have lower (P = 0.06) viremia than HRFI pigs (Fig. 3.3). 
The heritability estimate for VL was 0.33 ± 0.33 and litter explained 7 ± 13 % of the 
phenotypic variation in VL. 
 
Antibody response analyses 
Nearly all PRRS ELISA S/P ratio values (170/175) at 4 dpi were negative 
(background value > sample value). Analysis of S/P ratio at 4 dpi did not indicate a 
difference between lines (P = 0.34) or groups (P = 0.19). Similarly, no difference in MFI 
was detected at 4 dpi between lines (P = 0.32) or groups (P = 0.82) for the MAGPIX 
assay. 
Most importantly, the interaction of line*dpi was significant for both S/P ratio (P 
< 0.001) and MFI (P = 0.007). The increase in S/P ratio from 7 dpi to 11 dpi was 
significantly greater (P < 0.001) for the LRFI line (1.72 ± 0.05) than for the HRFI line 
(1.44 ± 0.06), as depicted in Fig. 3.4. This result was replicated for the MAGPIX assay 
(Fig. 3.5), for which the increase in MFI from 7 dpi to 11 dpi was significantly greater (P 
= 0.007) for the LRFI line (9,915 ± 588) than the HRFI line (7,622 ± 608).  
Other effects for these analyses are presented in Table 3.3. For both assays, 
antibody levels were significantly greater (P < 0.001) at 11 dpi than at 7 dpi. The 
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interaction of group by dpi was also significant for both S/P ratio (P < 0.001) and MFI (P 
= 0.04). However, no differences (P > 0.05) between RFI lines or groups were detected 
for S/P ratio or MFI.  
 
Mortality 
Four LRFI and 11 HRFI pigs died before the end of the PRRSV-challenge trial 
(40 dpi), not including the 4 pigs that died from SCID (Table 3.4). When mortality was 
analyzed as the number of pigs dead by the end of the trial (40 dpi for group 1 and 28 dpi 
for group 2), LRFI pigs from group 1 were 8.7 times (94% confidence interval: 1.00, 
75.56) more likely to survive the PRRSV-challenge than HRFI pigs (P = 0.06), but no 
line difference was detected within group 2 (P = 0.87). The main effect of line (P = 0.18) 
was also not significant. When mortality was analyzed as the number of pigs that died 
before 28 dpi, no evidence of line (P = 0.30), group (P = 0.54), or group*line (P = 0.22) 
effects were detected.  
Discussion 
 
Contrary to our initial biological hypothesis, multiple lines of evidence from this 
study indicate that pigs selected for increased feed efficiency based on RFI (LRFI pigs) 
were not more affected by PRRSV-infection than HRFI pigs. Firstly, results of the joint 
analysis of ADG indicated that the LRFI pigs were actually less affected by the PRRSV-
challenge than the HRFI pigs, but it must be noted that many confounding factors exist 
between the environments of the challenged and non-challenged pigs. Therefore, it is 
impossible to determine whether the significant line*PRRS status interaction was driven 
entirely by the PRRSV-infection, or in combination with other factors that distinguished 
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the two environments. Analyses of antibody data indicated that LRFI pigs had a greater 
increase in production of PRRSV-specific and total antibody than HRFI pigs, suggesting 
that the early immune response of LRFI pigs was greater than that of the HRFI pigs. In 
addition, although results of the day viremia analyses indicated that viremia of LRFI pigs 
was not different from HRFI pigs for any particular day throughout the course of 
infection, when VL was analyzed to summarize these viremia data, there was suggestive 
evidence that, overall, the LRFI line had lower PRRS viremia than the HRFI line. Lastly, 
there was suggestive evidence that LRFI pigs were more likely to survive the PRRSV-
challenge than HRFI pigs.  
Analyses of ADG, VL, and day viremia were also performed by including BW at 
0 dpi as an additional covariate, to determine the significance of an animal’s weight at the 
beginning of the trial on these traits (Fig. 3.2). Doing so did not change results for any of 
the traits analyzed, except for the joint analysis of ADG; when BW at 0 dpi and its 
interaction with PRRS status were fitted as fixed effects, the interaction of line*PRRS 
status was no longer significant (P = 0.28). However, numerically, the decrease in ADG 
when pigs were challenged with PRRSV was still lower for the LRFI line (-183.3 ± 72.8 
g/d) than for the HRFI line (-207.3 ± 67.3 g/d). When BW at 0 dpi was analyzed as the 
response variable, LRFI pigs (8.03 ± 0.62 Kg) were not significantly different (P = 0.66) 
from HRFI pigs (8.16 ± 0.57 Kg). Although BW at 0 dpi was not significantly different 
between lines, including BW at 0 dpi as a covariate numerically adjusted the lines to the 
same starting weight, which reduced the magnitude and significance of the line*PRRS 
status effect. 
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Although several studies have evaluated the impact of PRRSV on growth 
(Boddicker et al., 2012; Doeschl-Wilson et al., 2009; Petry et al., 2007), this study is 
novel in analyzing the effect of PRRSV-infection on lines of pigs that were divergently 
selected for feed efficiency based on RFI. It is important to note that selection within the 
lines used for this study was performed under conditions without exposure to major 
diseases, including PRRS. Results of our study confirm previous findings that, in general, 
pigs experienced reduced growth under PRRSV-challenge (Boddicker et al., 2012; 
Doeschl-Wilson et al., 2009; Petry et al., 2007). During the selection experiment, pigs 
from the LRFI and HRFI lines were mixed within pens to enable more direct 
comparisons across lines within a pen.  For this same reason, LRFI and HRFI pigs were 
also mixed for the PRRSV-challenge experiment.  
Although ADG under PRRSV-challenge did not appear to be heritable based on 
our analyses, in contrast to the moderate estimate of heritability obtained in the PHGC 
trials of commercial crossbred pigs (Boddicker et al., 2014), standard errors of the 
estimates were large due to the small sample size and confounding of genetic with 
maternal effects. Our estimate of the litter effect for ADG was similar to that reported by 
Boddicker et al. (2014). Boddicker et al. (2012) also reported the presence of a major 
gene on chromosome 4 for VL and ADG following challenge, but this region was not 
segregating in the RFI lines since both lines were fixed for the unfavorable allele in this 
region. 
A complication in this study was that 28 pigs from group 2 had non-zero viremia 
values at 0 dpi. However, removing these animals had no effect on conclusions for any of 
the traits analyzed, and they were therefore retained for all analyses. More than likely, 
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these values indicate that the group 2 pigs became infected with PRRSV from the 
already-infected group 1 pigs. This is plausible since group 2 arrived at Kansas State 
University approximately 1 week after group 1 was inoculated with PRRSV.  Although 
pigs were placed in different rooms of the same facility, the virus may have been 
transmitted from room to room, due to the highly virulent nature of the NVSL 97-7985 
PRRSV isolate (Alonso et al., 2013). More importantly, all pigs in the PRRSV-
challenged experiment demonstrated non-zero viremia values at 4 dpi, which indicated 
that every pig was successfully challenged with PRRSV. Our reported estimate of 
heritability for VL was consistent with results reported by Boddicker et al. (2014). 
Likewise, our estimate of the litter effect for VL was similar to that obtained by 
Boddicker et al. (2014). 
Collection of the antibody data was not part of the original experimental design, 
but was performed to determine the cause of death of the SCID pigs and these data were 
analyzed here to capitalize on the opportunity to evaluate early immune response. 
Because our hypothesis was that LRFI pigs are immuno-compromised compared to HRFI 
pigs, we expected that the LRFI pigs would produce fewer antibodies than the HRFI pigs, 
even during the early stage of infection. At 4 dpi, antibody was detected using the 
MAGPIX assay but not with the ELISA assay. This was as expected since these assays 
were designed to detect very different types of antibodies: the MAGPIX assay detected 
all antibodies present within a sample, whereas the PRRS ELISA assay detected PRRSV-
specific IgG antibodies only (Stanisic, S., IDEXX, personal communication, 2014). 
Therefore, the antibodies detected by the MAGPIX assay may have included IgM 
antibodies produced in response to PRRSV-infection (as class-switching would not have 
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occurred by this time point; Lopez and Osorio, 2004), as well as antibodies produced in 
response to other pathogens. It was not surprising that no PRRSV-specific IgG antibodies 
were detected at 4 dpi, since pigs do not start to produce PRRSV-specific antibodies until 
7 dpi (Lopez and Osorio, 2004). A potential drawback of the MAGPIX data analyzed 
here is that the MAGPIX assay was still in the early stages of validation in the laboratory 
at the time and some unusually high, high-positive values were obtained. Nevertheless, 
some significant line differences were observed for the data obtained.  
Our finding that the increase in S/P ratio and MFI from 7 to 11 dpi was greater for 
the LRFI line than for the HRFI line indicates that the early immune response of the 
LRFI pigs was greater than that of the HRFI pigs upon primary exposure to PRRSV. 
With data for such early time points, it is not possible to draw conclusions regarding the 
adaptive immune response of the LRFI versus HRFI line since anti-PRRSV total 
antibody and neutralizing antibody do not plateau until 1-2 months after infection (Lopez 
and Osorio, 2004). Using samples collected on sows from a natural PRRS outbreak, 
approximately 46 days after the outbreak, Serão et al. (2014) found that sows with a 
genetic pre-disposition for higher S/P ratio levels also had increased reproductive 
performance. Additional studies must be performed to determine whether LRFI pigs have 
greater S/P ratio levels under PRRSV-infection during this same timeframe and if so, 
whether such levels are also associated with increased performance.  
Taken together, the findings presented in this paper, especially the significant 
results of the joint analysis of ADG and the antibody assays, were unexpected since they 
appear to contradict the resource allocation theory proposed by Rauw et al. (1998), which 
suggests that animals selected for increased feed efficiency based on RFI do not allocate 
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as much energy to an immune response as less feed efficient animals (Rauw, 2007). 
Therefore, a feed efficient animal, which expends a greater proportion of energy intake 
on growth, is proposed to have less available energy for other processes, such as the 
ability to combat infection, and may be immuno-compromised as a result (Knap and 
Bishop, 2000; Rauw, 2012). Previous research has indicated that chickens selected for 
reduced RFI were less able to cope with high temperatures and had lower levels of non-
specific antibody when injected with adrenocorticotropic hormone than their HRFI 
counterparts (Rauw, 2007). In terms of immune response, previous research suggests that 
pigs selected for lean growth capacity tend to be immuno-compromised (Knap and 
Bishop, 2000). Results from our study appear to contradict these previous findings, as do 
results of a recent study with another set of lines of pigs divergently selected for RFI; 
Renaudeau et al. (2013), which indicated no evidence of a difference in heat tolerance 
between RFI lines.   
A recent, comparative study of the ISU RFI lines identified that the circulating 
blood cell profile (based on a complete blood count) of LRFI pigs differed from that of 
HRFI pigs (Mpetile et al., 2014). Results showed that LRFI pigs had lower numbers of 
white blood cells (WBC), including eosinophils, monocytes, and basophils than HRFI 
pigs. The authors argued that these line differences were due to the fact that the LRFI 
pigs are not only more efficient in converting feed to gain, but also more efficient in 
terms of WBC production. Contrary to this finding, results of a similar study in Large 
White pigs by Clapperton et al. (2006) indicated that pigs selected for lean growth and 
feed intake had higher numbers of WBCs. Although it is beyond the scope of this paper 
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to speculate about the nature of this contradiction, there were many differences between 
these 2 studies, including breed, age when samples were collected, and disease pressure.  
Other studies of RFI lines of pigs divergently selected for RFI during the grow-
finish phase have also identified that LRFI pigs are better than HRFI pigs at directing 
resources where needed. For example, previous research at ISU and the French National 
Institute for Agricultural Research (INRA), described by Young et al. (2010), identified 
that sows from the LRFI line have larger litters and are better able to utilize body reserves 
to support lactation, resulting in increased piglet performance prior to weaning. Other 
research has identified that LRFI pigs have a protein profile that is better equipped to deal 
with physiological stressors (Grubbs et al., 2014) and that LRFI pigs have less behavioral 
reactivity to novel stimuli (Colpoys et al., 2014). The fact that these results appear to 
challenge the generally accepted resource allocation theory clearly indicates that there are 
many biological processes of the LRFI pigs that we do not yet understand. A working 
hypothesis for the results from our study is that LRFI pigs were not more affected by 
PRRSV-infection than HRFI pigs, and may even have responded better, because they 
were better able to direct resources towards combating the viral infection.  
It is however, important to note a few limitations of this study. The first is that 
this selection experiment for RFI was not replicated and does not have a true control line. 
However, the parallel divergent selection experiment for RFI at INRA provides some 
form of replication and recent work with these lines provides an additional piece of 
evidence in support of our working hypothesis: growth of the LRFI line was shown to be 
less affected by environmental variation than the HRFI line (Gilbert et al., 2014). 
Although we may conclude that the line differences identified in our study were a direct 
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result of selection, excluding drift, we cannot quantify how much of the observed line 
differences are due to selection for low RFI versus selection for high RFI because 
correlated response to selection may have been asymmetrical. 
Another potential limitation of this study is the small sample size for a genetics 
study, although 196 animals is a large sample size compared to other disease challenge 
studies. Nevertheless, the fact that significant results were obtained for the joint analysis 
of ADG and for the antibody analyses indicate that the study had sufficient power to 
detect line differences for these traits. 
 
Conclusions 
 
This is one of the first studies to directly address how selection for increased feed 
efficiency based on RFI affects the ability of pigs to respond to a disease challenge. 
Despite the fact that the study lacked a true control, the selection experiment at INRA 
provides a suitable form of replication and recent research at this institution is congruent 
with the general conclusion presented here: pigs selected for increased feed efficiency 
based on RFI were not more affected by PRRSV-infection than inefficient pigs, and may 
even have responded better to PRRSV-infection. Specifically, results of the joint ADG 
analysis identified that growth rate of the more efficient (LRFI) pigs was less affected by 
PRRSV-infection than that of the inefficient (HRFI) line. It is important to note, however, 
that there were many confounding factors between the challenged and non-challenged 
environments. In addition, antibody analyses showed that the LRFI pigs had a greater 
increase in production of PRRSV-specific IgG antibodies and total antibody from 7 to 11 
dpi, indicating that the early immune response of the LRFI pigs was greater than that of 
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the HRFI pigs. LRFI pigs tended to have lower VL than HRFI pigs and results of the 
mortality analyses provide suggestive evidence that LRFI pigs were more likely to 
survive the PRRSV-challenge than HRFI pigs.  
Based on these findings, we can reject the initial biological hypothesis that LRFI 
pigs demonstrate poorer performance than HRFI pigs upon infection with PRRSV and 
conclude that pigs selected for increased feed efficiency based on RFI (LRFI pigs) were 
not more affected by PRRSV-infection than the less feed efficient (HRFI) pigs. In fact, 
LRFI pigs may have responded better to PRRSV-infection, although additional research 
is needed to validate this proposition. Taken together, accumulating lines of evidence 
suggest that LRFI pigs are able to favorably adapt to environmental and infectious 
disease stressors and are more robust than HRFI pigs, possibly because of their superior 
ability to direct resources where needed.  
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Table 3.1. Descriptive statistics by challenge status, group, and line: low residual feed 
intake (LRFI) and high residual feed intake (HRFI) line. 
 
 
      Raw Mean 
Challenge 
Statusa 
Groupb Line 
Number of 
Litters 
Sex Count 
ADG, 
g/dc 
VLd 
Challenged 
1 
LRFI 14 
Barrows 24 205 103.0 
Gilts 25 240 101.8 
HRFI 14 
Barrows 22 185 104.2 
Gilts 27 206 105.8 
2 
LRFI 10 
Barrows 23 289 100.5 
Gilts 25 305 94.8 
HRFI 13 
Barrows 25 260 101.3 
Gilts 25 275 102.6 
Non-
Challenged 
 
LRFI 27 
Barrows 124 490 - 
 Gilts 103 467 - 
 
HRFI 31 
Barrows 159 505 - 
 Gilts 103 479 - 
 
 
aChallenged pigs were experimentally infected with porcine reproductive and respiratory 
syndrome (PRRS) virus. 
bGroup: group 1 versus group 2. Group 2 was experimentally infected with PRRS virus 
18 days after group 1.  
cADG, Average Daily Gain: grams of weight gain per day.  
dVL, Viral Load: calculated as area under the curve of log-transformed viremia between 0 
and 21 days post-infection. 
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Table 3.2. P-valuesa of fixed effects in the analysis of viral load (VL) and average daily 
gain (ADG) of the porcine reproductive and respiratory syndrome (PRRS) virus 
(PRRSV)-challenged pigs and the joint analysis of ADG of the challenged and non-
challenged pigs.  
 
 
 PRRSV-challenged only  Joint analysis 
Effects VLb ADG, g/d  ADG, g/d 
Group 0.53 0.06  - 
Line 0.09 0.10  0.87 
Group*Line 0.86 0.95  - 
Sex 0.28 0.12  0.75 
Age <0.01 0.08  0.10 
PRRS Statusc - -  0.28 
PRRS Status*Line - -  0.04 
Group(PRRS Status) - -  0.62 
PRRS Status*Sex - -  0.07 
PRRS Status*Age - -  0.28 
Age at Last Weight - -  0.02 
PRRS Status*Age at Last Weight - -  0.88 
 
 
aEffects not included in the model are indicated by dashes (-). 
bVL, Viral Load: calculated as area under the curve of log-transformed viremia between 0 
and 21 days post-infection. 
cPRRS Status: PRRSV-challenged versus non-challenged pigs. 
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Table 3.3. P-values of fixed effects for the analysis of antibody data. 
 
 Assaya 
Effect PRRS ELISA MAGPIX 
Groupb 0.68 0.23 
Linec 0.79 0.35 
Group*Line 0.44 0.39 
Dayd < 0.001 < 0.001 
Group*Day < 0.001 0.04 
Line*Day < 0.001 0.007 
Group*Line*Day 0.49 0.19 
 
aThe porcine reproductive and respiratory syndrome (PRRS) ELISA assay (IDEXX 
PRRS X3, IDEXX Laboratories Inc.; Westbrook, Maine, USA) measured the level of 
PRRS virus-specific IgG within a serum sample. The MAGPIX assay (MAGPIX, 
Lumminex Laboratories; Billerica, Massachusetts, USA) measured the level of total 
antibody present within a serum sample. 
bGroup: group 1 versus group 2. Group 2 was experimentally infected with PRRS virus 
18 days after group 1. 
cLine: low residual feed intake versus high residual feed intake line. 
dDay post-infection.  
 
Table 3.4. Mortality in the porcine reproductive and respiratory syndrome (PRRS) virus-
challenged pigs by group and residual feed intake (RFI) line: low (LRFI) or high (HRFI). 
Each entry represents the number of pigs that died/total number of pigs. Note that 
numbers are not cumulative.  
 
 Groupa   
 1  2   
Line 0-28 dpi 28-40 dpi  0-28 dpi  Total 
LRFI 1/49 0/49  3/48  4/97 
HRFI 5/49 3/49  3/50  11/99 
Total 6/98 3/98  6/98  15/196 
 
aGroup 2 was experimentally infected with PRRS virus 18 days after group 1. Groups 1 
and 2 were necropsied at 40 and 28 days post-infection (dpi), respectively. The number of 
pigs that died before day 28 of the experiment and the number of pigs that died between 
28 and 40 days are listed separately for group 1. 
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Figure 3.1. Least square means of average daily gain (ADG) for the joint analysis of 
porcine reproductive and respiratory syndrome (PRRS) virus-challenged and non-
challenged pigs.  
 
Results showed a significant interaction (P = 0.04) between residual feed intake (RFI) 
line [low RFI (LRFI) and high RFI (HRFI)] and challenge status. Columns with different 
letter assignments significantly differ at P < 0.05. 
 
 
 
Figure 3.2. Least square means of viral load by residual feed intake (RFI) line [low RFI 
(LRFI) and high RFI (HRFI)] with and without inclusion of weight on day of 
experimental infection (Wt0) with porcine reproductive and respiratory syndrome 
(PRRS) virus in the model as a covariate.  
 
Results include pigs from group 1 and group 2 (infected with PRRS virus 18 days after 
group 1). The P-values of the main effect of RFI line were 0.12 and 0.09 when Wt0 was 
included and not included in the model, respectively.   
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Figure 3.3. Least square means of log viremia of the porcine reproductive and respiratory 
syndrome (PRRS) virus-challenged pigs.  
 
P-values for each day post-infection (dpi) indicate the effect of residual feed intake (RFI) 
line [low RFI (LRFI) versus high RFI (HRFI)] on viremia. Up to 28 dpi, data included 
records for both group 1 and group 2 (infected with PRRS virus 18 days after group 1). 
Results for 35 dpi and 39 dpi were calculated based on group 1 data only since group 2 
was necropsied on 28 dpi.  
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Figure 3.4. Least square means of porcine reproductive and respiratory syndrome 
(PRRS) ELISA sample-to-positive (S/P) ratio from the joint analysis of data for 7 and 11 
days post-infection (dpi).  
 
Results are shown by group, dpi, and residual feed intake (RFI) line: low (LRFI) and high 
(HRFI). Columns with different letter assignments significantly differ at P < 0.05. 
 
 
 
 
 
 
 
 
 
Figure 3.5. Least square means of MAGPIX mean fluorescence intensity (MFI) from the 
joint analysis of data for 7 and 11 days-post infection (dpi).  
 
Results are shown by group, dpi, and residual feed intake (RFI) line: low (LRFI) and high 
(HRFI). Columns with different letter assignments significantly differ at P < 0.05. 
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Abstract 
 
A major QTL for host response to Porcine Reproductive and Respiratory 
Syndrome (PRRS) virus (PRRSV) infection was identified in a previous study. SNP 
WUR10000125 (WUR), which is in complete linkage disequilibrium with the putative 
causative mutation, can be used as a tag SNP for the QTL. However, the effect of WUR 
following PRRS vaccination and/or co-infection with other pathogens is not known. 
Therefore, objectives of this study were to estimate the effect of WUR on host response 
following PRRS vaccination and co-infection with PRRSV and porcine circovirus type 
2b (PCV2b), to estimate genetic parameters for host response to vaccination and co-
infection, and to estimate the effect of previously identified candidate SNPs under 
PRRSV-only or PCV2b-only infection on host response to co-infection. Data from 2 
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trials, comprising a total of 396 commercial crossbred nursery pigs from a single genetic 
source, were used for all analyses. Pigs were pre-selected based on WUR genotype: 
approximately half AA and half AB, where B is the favorable and dominant allele. At 
weaning, pigs were shipped to Kansas State University where half of the pigs were 
vaccinated with a PRRS modified live virus vaccine. Four weeks later, all pigs were co-
infected with field strains of PRRSV and PCV2b and followed for 42 days. Body weight 
and serum viremia measurements were collected following vaccination and co-infection 
to calculate ADG and viral load (VL), respectively. Average heritability estimates for 
PRRS VL, PCV2b VL, and ADG were 0.29, 0.09, and 0.40, respectively. Post-
vaccination, AB pigs had lower vaccination VL (P = 0.03) and faster gain (P = 0.004) 
than AA pigs, as expected. Post co-infection, AB pigs had lower PRRSV VL (P < 
0.001), but did not significantly differ from AA pigs in growth rate (P = 0.86). For 
PCV2b VL, suggestive evidence of an interaction between vaccination and WUR 
genotype (P = 0.11) was detected, where AB pigs had significantly lower PCV2b VL 
when vaccinated (P = 0.007) but not when they were not vaccinated (P = 0.87). In 
addition to WUR, several PRRS-associated SNPs and a PCV2b-associated SNP had 
significant effects on host response to co-infection. In conclusion, marker assisted 
selection based on WUR genotype alone, or along with other candidate SNPs for PRRSV 
and PCV2b infection, is a promising strategy to select for improved host response to not 
just PRRS, but also co-infection with PRRSV and PCV2b, and perhaps other pathogens.  
 
Introduction 
 
Porcine reproductive and respiratory syndrome (PRRS) is an economically 
devastating disease that has afflicted the U.S. pork industry since the late 1980s 
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(Keffaber, 1989). Vaccine development has been underway nearly as long, but with 
limited success. In recent years, the use of PRRS modified live virus (MLV) vaccines has 
risen in popularity, but remain limited in their ability to protect against heterologous 
strains (Hu and Zhang, 2014). PRRS virus (PRRSV) weakens the immune system, 
making pigs more susceptible to co-infection with other pathogens (Yin et al., 2013). Co-
infection with PRRSV and porcine circovirus type 2b (PCV2b) is common worldwide 
and can increase morbidity and mortality compared to infection with PRRSV alone. 
Previously, a major QTL on chromosome 4 was found to be associated with host 
response to PRRSV-infection (Boddicker et al., 2012). The WUR10000125 (WUR) SNP 
was selected as a tag SNP for this region. However, the effect of this region on host 
response following PRRS vaccination or co-infection with other pathogens is not known 
and is important for predicting the effect of selecting on WUR genotype in the field. 
Therefore, the first objective of this study was to estimate the effect of WUR genotype 
following PRRS vaccination and co-infection with PRRSV and PCV2b. A second 
objective was to estimate genetic parameters for ADG and PRRS viral load (VL) 
following PRRS vaccination, and for ADG, PRRS VL, and PCV2b VL following co-
infection. The final objective was to estimate the effect of candidate SNPs that were 
previously identified under PRRSV-only or PCV2b-only infection on ADG, PRRS VL, 
and PCV2b VL following vaccination and co-infection.  
 
Materials & Methods 
 
This project was approved by the Kansas State University and Iowa State University 
Institutional Animal Care and Use Committees. 
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Animals 
 
Data from 2 experimental co-infection trials of commercial Large White x Landrace 
crossbred pigs from the same genetic source (trial 1 [n = 199 barrows] and 2 [n = 197 
barrows]) were used for this study. Pigs were the same cross and also from the same 
genetic source as pigs from PRRS Host Genetics Consortium (PHGC) trials 1-3 and 11, 
used for analyses conducted by Boddicker et al. (2012, 2014) and Hess et al. (2016), 
although separated by several generations. This study adds to results presented by 
Niederwerder et al. (2015), which were based on the first of the 2 trials analyzed here by 
estimating genetic parameters, analyzing additional phenotypes, and conducting in-depth 
analyses of the effect of genotype at WUR and other candidate SNPs.  
Trial 1 pigs were from 12 sires and 48 litters and trial 2 pigs were from 10 sires and 
79 litters, with sires and dams unique to each trial. Pigs originated from the same, high 
health multiplier farm, where sows were vaccinated for PCV2 but not for PRRS. Pigs 
were pre-selected based on WUR genotype at the source: approximately half for the AA 
and half for the AB genotype. The B allele, corresponding to the “G” nucleotide, is 
favorable under PRRSV-infection and has shown to be dominant to A, which 
corresponds to the “A” nucleotide, but occurs at a low frequency in commercial 
populations (Boddicker et al., 2012). At weaning (between 18 and 28 days of age), pigs 
were shipped to a biosafety level 2 (BSL-2) facility at Kansas State University (K-State). 
Upon their arrival, pigs were randomly sorted into one of 2 rooms and placed into 10 
pens per room, balanced by WUR genotype, with 11-12 pigs per pen. Pigs from trial 1 
were allowed to acclimate to their new surroundings for 4 days and pigs from trial 2 for 3 
days, after which all pigs in one of the rooms received a 2-mL dose of a commercial 
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PRRS MLV vaccine (Ingelvac PRRS®, Boehringer Ingelheim Vetmedica Inc., St. 
Joseph, MO) according to the label instructions. Average age and weight at vaccination 
were 26.9 ± 4.0 days and 6.2 ± 1.4 kg, respectively. Four weeks post-vaccination (Post 
Vx), all pigs were co-infected with field strains of PRRSV and PCV2b that were isolated 
from a pig with postweaning multisystemic wasting syndrome, a porcine circovirus 
associated disease (PCVAD). The inoculum was prepared according to Niederwerder et 
al. (2015). Forty-two days post co-infection (Post Co-X), all surviving pigs were 
euthanized using pentobarbital sodium and tissue was collected for genotyping using the 
GeneSeek-Neogen PorcineSNP80 BeadChip (GeneSeek, Igenity; Lincoln, NE). Body 
weights were recorded weekly throughout the vaccination period (-28 to 0 days post-
infection [dpi]) and throughout the co-infection period (0 to 42 dpi) on both vaccinated 
(Vx) and non-vaccinated (Non-Vx) pigs. Serum samples were collected on Vx pigs at -
28, -24, -21, -17, -14, and -7 and on all pigs at 0, 4, 7, 11, 14, 21, 28, 35, and 42 dpi 
during the co-infection period. Serum samples were used to quantify PRRS and PCV2b 
viremia using Real Time PCR analysis according to Niederwerder et al. (2015).  
 
Traits 
Descriptive statistics for all traits are presented in Table 4.1. Pigs that died prior 
to co-infection (0 for trial 1 and 10 for trial 2) were excluded from all analyses because 
causes of death were unrelated to co-infection with PRRSV and PCV2b. Across the 2 
trials, 89 Non-Vx AA, 106 Non-Vx AB, 95 Vx AA, and 106 Vx AB pigs were used for 
analyses. ADG was calculated as the slope of body weight regressed on dpi Post Vx and 
Post Co-X using all body weight data collected from -28 to 0 and 0 to 42 dpi, respectively 
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(Fig. 4.S1). Body weight measurements at both -28 and 0 dpi were required to calculate 
ADG Post Vx and at 0 and 35 or 0 and 42 dpi to calculate ADG Post Co-X. Body weight 
measurements at 35 dpi were utilized if weight at 42 dpi was not available and was 
justified by the high correlation (0.97) between ADG calculated using either 35 or 42 dpi 
(data not shown). PRRS and PCV2b VL were calculated for each individual as the area 
under the curve of log10-transformed viremia values according to Boddicker et al. (2012). 
Viremia data from -28 to 0 dpi were used to calculate vaccination VL (Fig. 4.S2) and 
data from 0 to 21 dpi were used to calculate PRRS VL Post Co-X (Fig. 4.S2), consistent 
with analyses of 3 PRRSV-only infection trials described by Boddicker et al. (2012). 
PRRS viremia data after 21 dpi were not used since a portion of individuals enter a 
rebound phase after 21 dpi. Virus rebound was previously determined to be a property of 
the virus, rather than host genetics (Islam et al., 2013). Since viremia data for PCV2b was 
much noisier and there was no clear evidence of rebound, all available data from 0 to 42 
dpi were used to calculate PCV2b VL Post Co-X (Fig. 4.S3). For calculation of PRRS 
and PCV2b VL, at least 4 viremia measurements were required per pig to have sufficient 
data for estimating area under the curve, including measurements at 0 and 21 dpi for 
PRRS VL and at 0 and 42 dpi for PCV2b VL.  
Clinical signs of co-infection were also recorded from 0 to 42 dpi. Pigs were 
monitored daily by a veterinarian or trained personnel and clinical symptoms were 
recorded, including cyanotic or blue discoloration of the ears, requirement of veterinary 
treatment, and mortality. Antimicrobial and anti-inflammatory medications were 
administered under the direction of a veterinarian for moderate to severe clinical disease 
as previously described (Niederwerder et al., 2015). These clinical traits were analyzed as 
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binary variables: whether a pig did/did not die, did/did not display clinical signs of blue 
ear for at least one day during the indicated period, and did/did not require veterinary 
treatment for at least one day during the indicated period. 
 
Genotype data 
For all analyses presented, a genomic relationship matrix (GRM) was used to 
account for genetic relationships among the 396 individuals. Genotypes across 61,729 
SNPs (remaining after quality control) were available on 376 genotyped pigs. Sire-dam 
pedigree information was also available for these genotyped pigs, as well as 20 non-
genotyped pigs, which was combined to construct a H matrix (Fernando et al., 2014) 
using the JWAS software (Cheng et al., 2016). Quality control of SNP genotypes was 
performed in 3 steps: 1) fixed SNPs were removed, 2) genotypes with a gene call score 
lower than 0.3 were set to missing, and 3) SNPs with at least 15% missing genotypes 
were removed. Missing genotypes were replaced with the average genotype (on a 0/1/2 
scale) by SNP. Final genotyping rate was 99.43%. 
Genotypes for 10 candidate SNPs that were identified in previous studies to have 
associations with host response to PRRSV-only or PCV2b-only infection were extracted 
for further analyses. Candidate SNP names and references are presented in Table 4.2. For 
these analyses, SNP genotypes of the 10 candidate SNPs were simultaneously fitted as 
fixed effects to estimate the effect of SNP genotype on PRRS VL, PCV2b VL, and ADG. 
Linkage disequilibrium, calculated as the squared correlation, was less than 0.3 for all 
pairs of candidate SNPs. Multiple test correction was not performed since all SNPs had 
previously identified associations with host response to infection.  
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Statistical analyses 
All analyses were performed using ASReml 4.0 (Gilmour et al., 2015).  
 
 
Candidate SNP analyses 
The following univariate animal model was used to estimate the effect of 
genotype for each of the 10 candidate SNPs (Table 4.2) previously identified under 
PRRSV-only or PCV2b-only infection on PRRS VL, PCV2b VL, and ADG, separately 
by vaccination group (Vx or Non-Vx) and co-infection period (Post Vx or Post Co-X): 
 
Model [1]  Yijklmno = Trialj + WURk + ∑ SNPlm
10
l=1 + 
 β1 ∗ WtVxi + β2 ∗ VxAgei + β3 ∗ PCV2_0i + 
 Animali + Littern + Peno(j) + eijklmno 
where Yijklmno = is the observed phenotype; Trialj = fixed effect of the j
th trial (trial 1 or 
2); WURk = fixed effect of the WUR SNP genotype (AA or AB); SNP = fixed effect of 
the mth genotype (AA, AB, or BB) of the lth candidate SNP (SNP 1 through 10); β1 = 
partial regression coefficient for the covariate weight at -28 dpi (WtVx); β2 = partial 
regression coefficient for the covariate age at -28 dpi (VxAge); β3 = partial regression 
coefficient for the covariate level of PCV2b viremia at 0 dpi; Animal = random animal 
genetic effect with a variance-covariance structure proportional to the genomic 
relationship matrix based on SNP genotypes with the assumption ~ N(0, 𝐆σα
2); Litter = 
random litter effect (127 levels); and Pen = random effect of pen nested within trial (40 
levels). For this model, interaction effects of trial with each fixed effect were also fitted 
and removed if not significant (P > 0.10). Animal, litter, and pen(trial) were fitted as 
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random effects to account for genetic, common environmental, and random 
environmental effects, respectively.  
The level of PCV2b viremia at 0 dpi was fitted as a covariate because 24 Non-Vx 
and 13 Vx pigs had non-zero PCV2b viremia values at 0 dpi. This suggests that some 
pigs were exposed to PCV2b prior to entry into the facility, likely from their mothers; 
although sows were vaccinated against PCV2, it is well known that vaccination reduces 
PCV2 virus replication but may not eliminate it (Gerber et al., 2011). To account for this, 
PCV2b viremia level on day of co-infection (PCV2_0) was fitted as an additional 
covariate and all phenotypes were adjusted to PCV2_0 = 0 for all pigs, rather than to the 
mean, as pigs should have been negative for PCV2b prior to co-infection. The genetic 
variance explained by significant SNPs was computed as the difference between the sum 
of genetic and litter variance when fitting all 10 candidate SNPs versus fitting all 
candidate SNPs except for the SNP in question.  
Although PCV2b VL, PRRS VL, and ADG were analyzed separately for Vx and 
Non-Vx pigs for the candidate SNP analyses, Vx and Non-Vx pigs were analyzed jointly 
for analyses of the binary traits (mortality, blue ear, and treatment) to aid with 
convergence for this more complex type of analysis. The model for these analyses was 
the same as Model [1] but with the addition of VxStatus (Vx or Non-Vx for PRRS) and 
WUR*VxStatus as additional fixed effects. A probit model, which assumes a residual 
variance of one, was used for these analyses. 
 
 
 
  
80 
Multivariate model  
Multivariate animal models were used to analyze PCV2b VL, PRRS VL, and 
ADG by VxStatus and time period (Post Vx or Post Co-X), when applicable, to estimate 
the effect of WUR and the interaction of WUR by VxStatus by specifying contrasts and 
to estimate genetic parameters. PCV2b VL of Non-Vx pigs and PCV2b VL of Vx pigs 
were analyzed as 2 separate traits based on the following 2-variate model: 
 
Model [2] 
 
where yN(yV) is a vector of phenotypes for PCV2b VL for Non-Vx(Vx) pigs; XN(XV) is 
the design matrix of fixed effects and bN(bV) the corresponding vector of solutions; 
𝐙αN(𝐙αV) is the design matrix of random genetic effects and αN(αV) the corresponding 
vector of solutions; 𝐙lN(𝐙lV) is the design matrix of random litter effects and lN(lV) the 
corresponding vector of solutions; 𝐙pN(𝐙pV) is the design matrix of random pen effects 
and pN(pV) the corresponding vector of solutions. Fixed effects were the same as those 
fitted for Model [1], except that genotypes of the 10 candidate SNPs were not included in 
the model. For the 3 PRRS VL traits (vaccination VL Post Vx, PRRS VL of the Non-Vx 
group Post Co-X, and PRRS VL of the Vx group Post Co-X) and the 4 ADG traits (ADG 
of the Non-Vx group Post Vx, ADG of the Vx group Post Vx, ADG of the Non-Vx group 
Post Co-X, and ADG of the Vx group Post Co-X), similar 3-variate and 4-variate models 
were fitted, respectively. 
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The covariance matrix of random animal genetic, litter, pen, and residual effects 
for Model [2] was specified as follows:  
 
where G represents the GRM for the Non-Vx(N) and Vx(V) individuals and I represents 
the identity matrix. For all analyses, covariances were allowed between traits for the 
animal genetic effect and for the litter effect. Covariances between traits were also fitted 
for pen effects and for residuals for traits that were defined for the same vaccination 
group, but were constrained to 0 for traits that were defined for different vaccination 
groups. This is because Vx and Non-Vx pigs were allocated to different rooms.  When 
the estimate of litter and/or pen(trial) variance was 0 or near 0 for a trait, that effect was 
removed from the model for that trait to aid with convergence.  
Initially, a 9-variate model was fitted to estimate genetic parameters across the 3 
PRRS VL, 2 PCV2b VL, and 4 ADG traits but this model did not converge, due to a 
limited amount of data. Therefore, genetic correlations between PRRS VL/PCV2b VL, 
PRRS VL/ADG, and PCV2b VL/ADG were obtained by fitting a series of 2-variate 
models for each pair of traits according to Model [2]. 
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An additional question that arose throughout the course of this study was whether 
the effect of WUR genotype on response to PRRSV challenge was different upon initial 
versus secondary PRRSV exposure. To address this question, a contrast was fitted to test 
the average effect of WUR genotype across the 2 primary PRRSV exposure traits (Vx 
pigs Post Vx and Non-Vx pigs Post Co-X) versus the secondary exposure trait (Vx pigs 
Post Vx).  To obtain an accurate estimate for this contrast, a set of orthogonal contrasts 
that test these contrasts, as well as other interesting effects of WUR genotype and PRRS 
vaccination status, were fitted based on Model [2] and are listed in Table 4.S1.  
 
Genetic parameters 
Heritability estimates and genetic correlations among the 2 PCV2b VL, 3 PRRS 
VL, and 4 ADG traits were obtained using the corresponding 2-variate, 3-variate, and 4-
variate models resembling Model [2]. These same models were used to estimate genetic 
correlations among the 2 PCV2b VL, 3 PRRS VL, and 4 ADG traits and genetic 
correlations between each pair of PRRS VL/PCV2b VL, PRRS VL/ADG, and PCV2b 
VL/ADG traits were estimated using bivariate models. Heritability estimates for the 
binary traits (mortality, blue ear, and treatment) were obtained based on Model [1] but 
with the addition of VxStatus (Vx or Non-Vx for PRRS) and WUR*VxStatus as 
additional fixed effects in the model. All genetic parameters were calculated excluding 
the effect of WUR from the model to allow WUR genotype to contribute to the observed 
genetic variation.  
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Results 
 
Effect of WUR genotype and vaccination status 
Average daily gain 
During the vaccination period, a significant interaction of VxStatus by WUR 
genotype was detected (P = 0.003), where AB pigs grew numerically (2.7%) faster than 
AA pigs within the Non-Vx group (P = 0.27), and significantly (8.1%) faster than AA 
pigs within the Vx group (P = 0.004) (Fig. 4.S1).  
During the co-infection period, no significant main effects or interaction effect of 
WUR genotype by VxStatus (P = 0.75) were detected, but Vx pigs grew numerically 
(2.7%) faster than Non-Vx pigs (P = 0.52) and AA pigs grew numerically (0.1%) faster 
than AB pigs (P = 0.86) (Fig. 4.S1). Pigs grew significantly faster Post Co-X than Post 
Vx (P < 0.001), which was expected since pigs were older Post Co-X than Post Vx (Fig. 
4.1).  
 
PRRS viral load 
During the vaccination period, AB pigs had significantly (8.7%) lower 
vaccination VL than AA pigs, as expected (P = 0.03).  The same relationship was 
observed Post Co-X, for which AB pigs had (6.7%) lower PRRS VL than AA pigs (P < 
0.001). In addition, Vx pigs had (28.5%) lower PRRS VL than Non-Vx pigs (P < 0.001), 
suggesting at least a partially protective effect of the vaccine (Fig. 4.S2). No significant 
interaction of WUR genotype by VxStatus was detected (P = 0.50) (Fig. 4.1).  
Results of the PRRS VL analysis suggested that the magnitude of the WUR effect 
on PRRS VL was numerically greater following primary exposure, whether by 
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vaccination (6.6 VL units) or co-infection (6.1 VL units), than following secondary 
exposure (3.7 VL units). To test this, additional contrasts were fitted, which indicated 
that, although not significant (P = 0.39), the average effect of WUR genotype for the 2 
primary exposure traits was 72.0% greater than for the secondary exposure trait, and that 
the effect of WUR genotype did not significantly differ between the 2 primary exposure 
traits (P = 0.70) (Fig. 4.1) (Table 4.S1). 
Additional contrasts showed that PRRS VL of Vx pigs during the vaccination 
period was significantly (P < 0.001) greater than PRRS VL of Vx pigs during the co-
infection period and that AB pigs had significantly (P < 0.001) lower PRRS VL than AA 
pigs, when averaged over time period and VxStatus (Table 4.S1). 
 
PCV2b viral load 
Results indicated a tendency towards a significant (P = 0.11) interaction effect of 
WUR genotype by VxStatus during the co-infection period, for which AB pigs had 
significantly (P = 0.007) (10.6%) lower PCV2b VL than AA pigs within the Vx group, 
but not within the Non-Vx group (0.8%) (P = 0.87) (Fig. 4.S3). In contrast to results for 
PRRS VL, Vx pigs had significantly (P = 0.001) (10.9%) greater VL than Non-Vx pigs 
(Fig. 4.1).  
 
Blue ear, treatment, and mortality  
No evidence of a WUR genotype by VxStatus effect or WUR genotype effect was 
detected for analyses of mortality, blue ear, or treatment, but the effect of VxStatus was 
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significant for every trait except for treatment from 0 to 21 and 0 to 42 dpi (Table 4.3). 
Analysis of mortality from 0 to 21 dpi and blue ear from 22 to 42 dpi did not converge.  
For the significant VxStatus effects, a greater proportion of Vx pigs died from 22 
to 42 (10%, P = 0.01) and from 0 to 42 dpi (11%, P = 0.04) and a greater proportion of 
Vx pigs required treatment from 22 to 42 dpi (23%, P = 0.01), than Non-Vx pigs. 
However, a smaller proportion of Vx pigs displayed clinical signs of blue ear from 0 to 
21 (10%, P = 0.001) and from 0 to 42 dpi (13%, P = 0.006) than Non-Vx pigs.  
 
Genetic parameters 
Within traits 
Heritability estimates (Table 4.4) and genetic correlations by time period and 
VxStatus are presented for ADG, PRRS VL, and PCV2b VL in Table 4.5. For ADG and 
PRRS VL, which were defined both Post Vx and Post Co-X, heritability estimates were 
higher for traits measured Post Co-X than Post Vx. ADG Post Co-X was moderately 
heritable at 0.41 ± 0.23 and 0.68 ± 0.22 for Vx and Non-Vx pigs, respectively. PRRS VL 
Post Co-X was also moderately heritable for Non-Vx pigs, at 0.61 ± 0.23, but less so for 
Vx pigs, at 0.13 ± 0.19. PCV2b VL Post Co-X was less heritable than either ADG or 
PRRS VL, at 0.09 ± 0.15 and 0.09 ± 0.19 for Non-Vx and Vx pigs, respectively. 
Heritability of ADG Post Vx was lower for Vx pigs (0.18 ± 0.24) than Non-Vx pigs (0.33 
± 0.21).  
Litter explained 13% or less of the total phenotypic variation for each PRRS VL 
trait and l9% or less for each ADG trait, except for ADG of Vx pigs Post Vx, for which 
litter explained 40% of the phenotypic variation (Table 4.4). Substantial litter variances 
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were observed for both PCV2b traits, where litter explained 54 and 49% of the total 
phenotypic variation for PCV2b VL of Vx and Non-Vx pigs, respectively. 
Estimates of genetic correlations are presented in Table 4.5. All estimates had 
large standard errors (SEs) because of the small sample sizes but these are the only 
estimates available for these hard-to-measure traits and they will, therefore, be presented 
with some detail. A strong, positive genetic correlation was detected between vaccination 
VL and PRRS VL of Non-Vx pigs Post Co-X, at 0.94 ± 0.84, which are both related to 
primary PRRSV exposure; however, these primary exposure groups had the weakest 
genetic correlation for ADG, at 0.10 ± 0.56. The phenotypic correlation for PRRS VL of 
Vx pigs Post Vx and Post Co-X was low, at -0.05 ± 0.12 but these 2 traits showed a 
moderate and positive genetic correlation (0.57 ± 1.12). A strong, positive genetic 
correlation was also detected between PCV2b VL of Vx and Non-Vx pigs at 0.99 ± 0.94. 
For ADG, estimates of genetic and phenotypic correlations indicated a positive 
relationship between ADG traits for the Non-Vx group, while a negative genetic 
relationship but a positive phenotypic relationship was noted between ADG traits of the 
Vx group (Table 4.5). Genetic correlations were highest for ADG for the Vx and Non-Vx 
groups within a time period (i.e. among Non-Vx and Vx pigs Post Vx and among Non-
Vx and Vx pigs Post Co-X), rather than among ADG across time periods for the same 
vaccination group. For example, the genetic correlation among ADG for Vx and Non-Vx 
pigs was 0.92 ± 0.92 Post Vx and 0.75 ± 0.37 Post Co-X. The lowest genetic correlation 
was detected among ADG for groups exposed to PRRSV for the first time at 0.10 ± 0.56, 
as previously mentioned.  
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Heritability estimates for mortality, blue ear, and treatment are presented in Table 
4.4. Results indicate that mortality and blue ear were low to moderately heritable for all 
phases of the co-infection period, with similar heritability estimates, ranging from 0.18 to 
0.27. Litter did not explain any of the phenotypic variation for mortality or blue ear. 
Treatment was not heritable, although a sizeable litter component was detected for 
treatment from 22 to 42 and 0 to 42 dpi, suggesting that pigs from some litters received 
treatment longer than pigs from other litters during the second half of the co-infection 
period.  
 
Across traits 
Phenotypic and genetic correlations between the 9 ADG, PRRS VL, and PCV2b 
VL traits analyzed by time period and VxStatus are presented in Table 4.5. Overall, 
phenotypic correlations were lower than genetic correlations and had lower SEs. In 
general, phenotypic correlations of PRRS VL with ADG and PCV2b VL were weak, 
ranging from 0.04 ± 0.09 to 0.27 ± 0.08. Phenotypic correlations between PCV2b VL and 
ADG prior to Co-X were low, at 0.05 ± 0.09 for Non-Vx pigs and -0.18 ± 0.09 for Vx 
pigs. In contrast, Post Co-X, phenotypic correlations between PCV2b VL and ADG were 
negative and moderately high, at -0.54 ± 0.07 for Non-Vx pigs and -0.58 ± 0.06 for Vx 
pigs.  
For the correlations with PRRS VL, a negative phenotypic correlation was 
detected between ADG prior to Co-X with PRRS VL Post Co-X for both Non-Vx (-0.09 
± 0.09) and Vx (-0.25 ± 0.08) pigs (Table 4.5), as expected. However, corresponding 
genetic correlations were in the opposite direction, at 0.63 ± 0.51 and 0.55 ± 1.18, 
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respectively. The phenotypic correlation between PRRS VL and ADG of the Vx group 
Post Co-X also indicated a negative relationship (-0.25 ± 0.08), as did the genetic 
correlation at -0.16 ± 0.79. Strong, positive genetic correlations were detected for PCV2b 
VL of Vx pigs with vaccination VL, PRRS VL of Non-Vx pigs Post Co-X, and PRRS VL 
of Vx pigs Post Co-X, at 0.92 ± 1.71, 0.97 ± 1.68, and 0.99 ± 1.83, respectively.  
Similar to results for PRRS VL, ADG prior to Co-X had a negative phenotypic 
relationship (-0.18 ± 0.09) with PCV2b VL Post Co-X for Vx pigs (Table 4.5) but the 
corresponding genetic correlation was in the opposite direction, at 0.55 ± 1.47. The 
strongest genetic correlations for PCV2b VL with ADG were observed for PCV2b VL 
and ADG Post Co-X for Non-Vx pigs at -0.87 ± 0.40 and for PCV2b VL and ADG Post 
Co-X of Vx pigs at -0.90 ± 0.67, with corresponding phenotypic correlations in the same 
direction. 
 
Candidate SNP analyses 
When SNP genotypes of the 10 candidate SNPs were simultaneously fitted in the 
model, several significant (P < 0.05) associations were detected (Table 4.6) for PRRS 
VL and ADG, but not for PCV2b VL (Table 4.S2). All but one of the significant 
associations were detected for traits analyzed Post Co-X, with the greatest number of 
associations (3) for ADG of Non-Vx pigs (Table 4.6). Of candidate SNPs with 
significant effects, SNP DIAS0000349 explained the greatest proportion of phenotypic 
variance for a trait (Table 4.6). SNPs ALGA0039771 and ASGA0032151 were 
associated with both ADG and PRRS VL. For ALGA0039771, the B allele was 
associated with increased ADG for Non-Vx pigs Post Vx (P = 0.02), representative of 
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growth rate under normal, non-challenged conditions, but with higher PRRS VL in Vx 
pigs Post Co-X (P = 0.02). For SNP ASGA0032151, the BB genotype was associated 
with increased ADG (P < 0.001) and lower PRRS VL (P = 0.02) for Vx pigs Post Co-X.  
SNPs DIAS0000349, H3GA0020425, MARC0058875, and SNP1 were all 
associated with a single trait (Table 4.6). For DIAS0000349 and H3GA0020425, the BB 
genotype was associated with increased ADG Post Co-X for both Non-Vx (P < 0.001) 
and Vx pigs (P = 0.01), respectively. Pigs with the AA genotype for MARC0058875 (P = 
0.03) and SNP1 (P = 0.02) had greater ADG during the co-infection period for Non-Vx 
pigs. SNPs MARC0056777, ASGA0031860, MARC0037274, and SNP2 were not 
significantly (P > 0.05) associated with any trait.  
  
Discussion 
 
This is the first study to assess the effect of WUR genotype, previously associated 
with PRRSV-only infection (Boddicker et al., 2012, 2013), on host response to PRRS 
vaccination and co-infection with PRRSV and PCV2b. Results from this study not only 
validate the effect of WUR genotype in a separate population of commercial crossbred 
pigs with another isolate of PRRSV, but indicate that the favorable (B) allele under 
PRRSV-only infection is also favorable following vaccination for PRRS with a 
commercial MLV vaccine and during co-infection with PCV2b. The AB genotype was 
associated with significantly reduced vaccination VL and significantly faster growth Post 
Vx, as well as significantly lower PRRS VL and PCV2b VL (within the Vx group) Post 
Co-X. For practical reasons, only barrows were used in this study. Thus, the effect of 
  
90 
WUR on host response to vaccination and co-infection with PRRSV and PCV2b 
observed here must be validated for gilts in future studies.   
Co-infection with PRRSV and PCV2b was identified as an ideal model to study 
the effect of WUR upon co-infection, given the extensive literature documenting 
increased clinical signs in PRRSV/PCV2b co-infected pigs (Van Reeth et al., 1999; 
Shibata et al., 2000). The ubiquitous nature of PCV2b in swine populations was an 
additional motivating factor in selecting this virus to be used for the co-infection model. 
However, this very characteristic of PCV2b also added an extra layer of complexity to 
the study since complete elimination of exposure to the virus prior to co-infection proved 
difficult. Thirty-seven of the 396 pigs were found to have non-zero PCV2b titers at 0 dpi 
and were likely exposed to PCV2b from their mothers prior to arrival at K-State. 
Although sows were vaccinated against PCV2, vaccination does not guarantee 
elimination of replicating PCV2. To account for the positive PCV2b titers of these 37 
pigs prior to co-infection, the effect of PCV2b viremia at 0 dpi (PCV2_0) was fitted as a 
covariate for the analysis of each trait and all traits were adjusted to PCV2_0 = 0, to 
model the situation that all pigs were negative for PCV2b at the time of co-infection.  
 
Effect of WUR genotype on host response to PRRS vaccination and co-infection 
with PRRSV and PCV2b  
It was of interest to estimate the effect of WUR genotype on host response 
following PRRS vaccination and co-infection with PCV2b for several reasons. First, 
PRRS vaccines are becoming more widely used and MLV vaccines are currently 
considered the most effective (Hu and Zhang, 2014). However, PRRS MLV vaccines, 
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albeit less virulent than field strains, still result in PRRSV-infection, and thus it was 
important to confirm that the favorable (AB) WUR genotype under infection with a field 
isolate of PRRS was also favorable following MLV vaccination. Furthermore, 
information regarding the effect of WUR genotype on host response following infection 
with diseases other than PRRS is limited. This is another important point to consider 
because we must establish that selecting for improved response to PRRS based on WUR 
genotype does not have a negative impact on response to other common diseases.  
Previous studies have shown that AB pigs had significantly reduced PRRS VL 
following experimental infection with PRRSV (Boddicker et al., 2012; Hess et al., 2016), 
forming the basis for the hypothesis that AB pigs would have significantly lower PRRS 
VL than AA pigs following PRRS vaccination and co-infection with PRRSV and PCV2b.  
Our results supported this hypothesis. In a recent study conducted by Abella et al. (2016), 
no significant effect of WUR genotype on PRRS VL was detected. However, pigs from 
the Abella et al. study were older, only 80 pigs were used for analyses, and pigs were 
experimentally infected with a European PRRSV strain, rather than a North American 
strain.  
Our results for the analysis of PRRS VL also showed that PCV2_0 had a 
significant, positive effect on PRRS VL Post Co-X of Non-Vx pigs. The trend was the 
same for Vx pigs Post Co-X, although not significant. Although not a major point, the 
result is worth discussing because, to date, there is no evidence that PCV2b increases the 
replication of PRRSV, as this result suggests. However, there is evidence that PRRSV 
increases PCV2 replication (Allan et al., 2000; Harms et al., 2001).  Although the exact 
mechanism is not clear, it is suspected that PRRSV increases PCV2 replication by 
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stimulating immune cells, thereby increasing the number of cells which support PCV2b 
replication (Yin et al., 2013; Niederwerder et al., 2015).  
For this reason, we hypothesized that AB pigs would not only have lower PRRS 
VL than AA pigs Post Co-X but also lower PCV2b VL. Our results support this 
hypothesis since AB pigs had significantly lower PCV2b VL within the Vx group and 
numerically lower PCV2b VL within the Non-Vx group. Thus, because AB pigs had 
significantly lower vaccination VL, they also had significantly lower PCV2b VL 
following co-infection. Little is known about the effect of WUR genotype on host 
response to PCV2b infection, except for a recent PCV2b experimental infection trial in 
which the effect of WUR genotype on PCV2b VL was not significant (Ciobanu et al., 
University of Nebraska-Lincoln, personal communication). However, pigs in the Ciobanu 
et al. study were neither vaccinated for nor co-infected with PRRSV. 
The effect of WUR genotype on ADG following PRRSV-infection has been 
investigated in previous studies, but its effect was not consistent. For example, AB pigs 
infected with the NVSL PRRSV isolate (GenBank accession number AY545985) had 
significantly greater ADG under infection (Boddicker et al., 2012). The same trend was 
observed for pigs infected with the KS06 PRRSV isolate (Hess et al., 2016), but the 
effect was not significant. It was concluded that this observed inconsistency was a result 
of differences in virulence between the NVSL and KS06 isolates (Hess et al., 2016). 
Because MLV vaccines are less virulent than field strains (Hu and Zhang, 2014), we 
hypothesized that AB pigs may not have significantly greater ADG than AA pigs Post Vx 
but that the effect would be greater Post Co-X. However, the opposite result was 
obtained. It may be that the vaccine virus, although modified, was still virulent enough to 
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result in a significant WUR effect and that WUR genotype does not have a significant 
effect on ADG upon co-infection with PCV2b. However, the opposite would be expected 
since WUR affected both PRRS VL and PCV2b VL Post Co-X. Results from Abella et 
al. (2016), in which pigs were vaccinated with a PRRS MLV vaccine, support the finding 
that AB pigs had significantly greater ADG following PRRS vaccination.  
Results indicate no evidence of a significant effect of WUR on blue ear, 
treatment, or mortality. Of these 3 traits, only mortality was analyzed for previous 
PRRSV-only infection trials, and, consistent with results from the current study, no 
significant effect of WUR on mortality was detected (Boddicker, 2013). There was, 
however, a significant Trial*WUR effect for blue ear from 0 to 21 and 0 to 42 dpi, which 
was driven by the fact that more AB pigs had clinical signs of blue ear in trial 1 but more 
AA pigs had clinical signs of blue ear in trial 2. Each trait was analyzed separately for 0 
to 21, 22 to 42, and 0 to 42 dpi, since a previous study of trial 1 showed evidence of more 
severe clinical signs during the latter half  (22 to 42 dpi) of the co-infection period 
(Niederwerder et al., 2015). 
  In general, the findings that Non-Vx pigs were more likely to develop blue ear 
Post Co-X, that a greater proportion of Vx pigs required treatment, and a greater 
proportion of Vx pigs died during the co-infection period, are consistent with results 
reported by Niederwerder et al. (2015) based on trial 1 of this study. Results from the 
current study show that increased clinical signs in Vx pigs are likely driven by 
significantly higher PCV2b VL for Vx AA pigs Post Co-X. Therefore, our results support 
the conclusion presented by Niederwerder et al. (2015) that the early protective effect of 
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the vaccine was outweighed by an increased incidence of clinical signs consistent with 
PCVAD during the later phase of the co-infection period. 
 
Effect of WUR genotype, depending on previous vaccination, or not, for PRRS 
The second objective of this study was to determine whether the effect of WUR 
genotype was consistent for PRRS VL, PCV2b VL, and ADG, regardless of whether or 
not pigs were previously vaccinated against PRRS. Since Niederwerder et al. (2015) 
identified a protective effect of the vaccine upon re-exposure to PRRSV, we 
hypothesized that the level of PRRS viremia would be greater for Non-Vx than Vx pigs 
Post Co-X, which could result in a greater magnitude of WUR effect for the Non-Vx than 
Vx pigs. 
While Non-Vx pigs did indeed have significantly greater PRRS VL than Vx pigs 
Post Co-X, the effect of WUR genotype by VxStatus Post Co-X was not significant. 
However, based on results of fitting a contrast for the average effect of WUR genotype 
following primary versus secondary PRRSV exposure, the direction of the 
WUR*VxStatus effect Post Co-X was in the expected direction. Results indicated that, 
numerically, the effect of WUR was greater upon primary PRRSV exposure, whether by 
vaccination or co-infection, than upon secondary exposure. Likewise, the magnitude of 
the WUR effect was greater within the Non-Vx group than the Vx group for the effect of 
WUR*VxStatus Post Co-X.  
These findings are consistent with the biological role of the putative causative 
gene for WUR, Guanylate Binding Protein 5 (GBP5)(Koltes et al., 2015), which has a 
known role in innate response to infection (Shenoy et al., 2012). It is reasonable that an 
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innate immune response gene has a larger effect upon primary than secondary exposure 
because innate, rather than adaptive immunity, is predominantly responsible for 
controlling the initial response to infection. 
The effect of WUR*VxStatus for PCV2b VL tended towards significance, with 
PCV2b VL significantly lower for AB pigs than AA pigs within the Vx group but not 
within the Non-Vx group. This result was likely because Vx pigs were positive for 
PRRSV upon co-infection. Possibly, vaccination suppressed innate immune responses, 
allowing propagation of PCV2b, thereby increasing the magnitude of the WUR effect for 
this group. However, this difference between WUR genotypes for Vx pigs did not 
translate to differences in growth rate during the co-infection period. Results for ADG 
indicated that AB pigs grew numerically faster within the Non-Vx group and AA pigs 
grew numerically faster within the Vx group, but the effect of WUR genotype by 
VxStatus was not significant. Since AA pigs had significantly greater PRRS VL and 
PCV2b VL than AB pigs within the Vx group, we expected AA pigs to have lower ADG 
as a result.   
 
Genetic parameters provide novel insight regarding genetic relationships among 
host response traits 
The third objective of this study was to estimate genetic parameters for host 
response following PRRS vaccination and co-infection. Except for days on treatment, 
low to moderate heritability estimates were obtained for all traits, indicating that selecting 
for improved response to vaccination and/or co-infection based on these traits is possible. 
Heritability estimates for vaccination VL, ADG of Vx pigs Post Vx, and PRRS VL of Vx 
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pigs Post Co-X, were lower than reported by Boddicker et al. (2014) based on analyses of 
8 trials in which pigs were experimentally infected with the NVSL PRRSV isolate, or 
Hess et al. (2016), based on analyses of these same 8 trials plus one additional trial and 4 
trials in which pigs were experimentally infected with the KS06 PRRSV isolate. There 
are many possible explanations for this, including differences in experimental design, 
such as challenge with the PRRS MLV vaccine versus the NVSL or KS06 PRRSV 
isolate. Pigs used in the current study had a shorter acclimation period compared to those 
in the trials described by Boddicker et al. (2012, 2014) and Hess et al. (2016), which may 
also have contributed to the especially large phenotypic variance for vaccination VL (i.e. 
474 VL units2, versus 93 VL units2 and 155 VL units2 for PRRS VL of Non-Vx pigs and 
PRRS VL of Vx pigs Post Co-X, respectively). The large phenotypic variance may also 
reflect the many stressors that pigs endured prior to vaccination, including post-weaning 
stress, transportation stress, and the stress of being placed into new social groups upon 
new pen assignments.  
 Several interesting genetic and phenotypic correlations were observed across and 
within traits. Standard errors were generally high, which was to be expected, given the 
limited number of animals for this type of genetic analysis, although 396 individuals is 
considered to be a large data set for an experimental challenge study of this nature. Since 
genetic parameters for host response traits following PRRS vaccination and PRRSV and 
PCV2b co-infection have not been previously reported, these estimates provide novel 
insight into the genetic relationships among these traits  
Perhaps the most interesting genetic correlation identified was that between the 2 
primary exposure traits: vaccination VL and PRRS VL of Non-Vx pigs Post Co-X. The 
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high, positive estimate for the genetic correlation (0.94), albeit with a large SE (0.84) 
suggests that the same genes that control response to vaccination also control response to 
primary infection with a field isolate. This suggests that response to vaccination could be 
used as an indicator trait for response to infection with a field isolate of PRRSV. The 
moderate, positive genetic correlation for PRRS VL between Vx pigs prior to and after 
co-infection (0.57 ± 1.12) suggests that some of the genes that control response to PRRS 
VL upon primary PRRSV exposure also control response to secondary PRRSV exposure. 
However, the SE is large for both of these estimates and thus, additional research is 
needed before stronger conclusions can be drawn. For PCV2b VL, a high, positive 
genetic correlation (0.99 ± 0.94) was detected between the Vx and Non-Vx groups, 
suggesting that the same genes that control response to PCV2b infection in pigs 
previously vaccinated for PRRS also control host response in pigs not previously 
vaccinated for PRRS. Again, the SE of this estimate was large. 
  Results for ADG indicated a low genetic correlation between groups exposed to 
PRRS for the first time (0.10 ± 0.56), suggesting that ADG following vaccination is not a 
good indicator of ADG upon primary exposure to PRRSV. Likewise, a moderate, 
negative genetic correlation (-0.48 ± 0.62) was detected between Vx pigs before and after 
co-infection, suggesting that different genes control growth upon vaccination versus re-
exposure. Among all ADG traits, the strongest genetic correlations were detected 
between Non-Vx and Vx groups prior to co-infection (0.92 ± 0.92) and between Non-Vx 
and Vx groups Post Co-X (0.75 ± 0.37), suggesting that growth of Vx pigs Post Vx is a 
better indicator of growth of Non-Vx pigs Post Vx than growth of Vx pigs Post Co-X. 
The same for Vx and Non-Vx pigs Post Co-X.  
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Between traits, the strong positive genetic correlations of PCV2b VL of Vx pigs 
with vaccination VL, PRRS VL of Non-Vx pigs Post Co-X, and PRRS VL of Vx pigs 
Post Co-X suggest that the same genes that control response to vaccination VL and PRRS 
VL also control immune response to PCV2b VL for pigs previously exposed to PRRS. 
This is plausible, given what we know about the immunological interactions of these 
viruses, as previously mentioned (Allan et al., 2000). Although small, a negative 
phenotypic (-0.04 ± 0.08) correlation was observed between vaccination VL and ADG 
Post Vx, which agrees with Boddicker et al. (2014), who reported negative genetic (-0.46 
± 0.35) and phenotypic (-0.25 ± 0.04) correlations between PRRS VL and weight gain 
upon PRRSV-only infection. The direction of these correlations is also consistent with 
genetic (-0.74 ± 0.10, -0.52 ± 0.17) and phenotypic (-0.33 ± 0.03, -0.23 ± 0.05) 
correlations reported by Hess et al. (2016) following experimental infection with the 
NVSL and KS06 PRRSV isolates, respectively. Genetic and phenotypic correlations 
between ADG and PRRS VL Post Co-X were consistent with this observation for Vx 
pigs but not for Non-Vx pigs. However, SEs were large. Negative genetic and phenotypic 
correlations were also observed between PCV2b VL and ADG Post Co-X, which are 
consistent with results reported by Engle et al. (2014) following experimental infection 
with PCV2b.  
 
Effect of other candidate SNPs on host response to PRRS vaccination and co-
infection with PRRSV and PCV2b 
The final objective of this paper was to validate the effects of candidate SNPs that 
were identified following PRRSV-only or PCV2b-only infection in pigs co-infected with 
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PRRSV and PCV2b, with the hypothesis that the effect of SNPs previously associated 
with either virus would also be significant for co-infected pigs. For these analyses, WUR 
genotype was fitted as a fixed effect because WUR genotype was part of the experimental 
design of the study and to allow the candidate SNPs to explain variation due to regions 
other than the QTL on chromosome 4. 
Results indicate that several SNPs that were previously associated with host 
response to PRRSV-only infection also had an effect on host response to co-infection 
with PRRSV and PCV2b. However, for some SNPs, the direction of the effect was not 
consistent with previously reported results. For SNP1, AA pigs within the Non-Vx group 
had numerically lower PCV2b VL and significantly greater ADG Post Co-X than AB or 
BB pigs. The direction of the effect of SNP1 genotype on PCV2b VL is consistent with 
results reported by Engle et al. (2014) from a study in which pigs were experimentally 
infected with PCV2b. However, Engle et al. (2014) did not identify a significant effect of 
SNP1 on ADG.  
Significant associations of candidate SNP genotype with PRRS VL and/or ADG 
were also detected for SNPs ASGA0032151, H3GA0020425, ALGA0039771, 
MARC0058875, and DIAS0000349. It was not possible to compare the direction of these 
effects to those reported in the literature because previous associations were with PRRS 
antibody (Serão et al., 2014; Hess, 2016), which was not available for this study. 
However, results for SNPs ASGA0032151, H3GA0020425, and ALGA0039771 were in 
the expected direction, based on the assumption that increased ADG and decreased VL 
are correlated with increased PRRS antibody production. Results for SNP 
MARC0058875 were also in the expected direction based on analyses of PRRSV-
  
100 
infected commercial nursery pigs (Hess, 2016), but not based on analyses of gestating 
multiplier females following a PRRS outbreak (Serão et al., 2014). Results for SNP 
DIAS0000349 were not in the expected direction. 
For the current study, pigs with the BB genotype for SNP ASGA0032151 had 
significantly greater ADG and lower PRRS VL Post Co-X. These findings agree with 
results reported by Serão et al. (2014) where the B allele was associated with increased 
PRRS antibody level. Similarly, BB pigs for SNP H3GA0020425 had significantly 
greater ADG Post Co-X than AB or AA pigs, which is consistant with numerically 
greater PRRS antibody production reported by Serão et al. (2014). For SNP 
ALGA0039771, the AA genotype was associated with significantly lower PRRS VL Post 
Co-X for Vx pigs. This finding is consistent with results from analyses of PRRSV-only 
infected commercial nursery pigs where AA pigs had significantly greater PRRS antibody 
production than AB or BB pigs (Hess, 2016). The opposite direction of effect was 
observed for Non-Vx pigs prior to co-infection, representative of growth under non-
challenged conditions, where AB pigs had significantly greater ADG than AA pigs. 
For SNP MARC0058875, pigs with the AA genotype had significantly greater 
ADG Post Co-X for Non-Vx pigs. This finding agrees with results presented by Hess 
(2016) where pigs with the AA genotype had significantly increased PRRS antibody 
production, but conflicts with results by Serão et al. (2014) where the B allele was 
associated with increased PRRS antibody level. For SNP DIAS0000349, pigs with the 
BB genotype had the highest ADG Post Co-X. This conflicts with results reported by 
Hess (2016) where the AA genotype was associated with greater PRRS antibody 
production following PRRSV-only infection.  
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Conclusions 
 
Results from this study not only validate the effect of WUR genotype, a major 
QTL for PRRS-resistance, in a separate population of commercial crossbred pigs with 
another isolate of PRRSV, but also indicate that the favorable allele following PRRSV-
only infection is favorable upon vaccination for PRRS with a commercial MLV vaccine 
and after co-infection with PRRSV and PCV2b. Results from this study provide novel 
insight regarding the role of this QTL on response to infection, including the finding that 
the WUR effect was numerically greater for PRRS VL upon primary PRRSV exposure 
(whether by vaccination or co-infection) than secondary exposure and that the effect of 
WUR on PCV2b VL depends on whether or not pigs were previously vaccinated for 
PRRS. Our results also support the conclusion drawn by Niederwerder et al. (2015) that 
the early protective effect of the MLV vaccine was outweighed by increased mortality 
and days on treatment during the latter half of the co-infection period.  
Heritability estimates indicate that ADG, PRRS VL, and PCV2b VL were lowly 
to moderately heritable, suggesting that genetic improvement of these traits is possible. 
Several interesting genetic correlations were detected, providing a first look at the genetic 
and phenotypic relationships among these traits. However, because the size of the dataset 
was limited and, thus, SEs were large, care must be taken in drawing conclusions based 
on these estimates. Several candidate SNPs associated with PRRSV-only or PCV2b-only 
infection from previous studies were also associated with host response to co-infection 
with PRRSV and PCV2b.  
Taken together, these findings suggest that marker assisted selection for WUR 
genotype alone, or alongside other candidate SNPs for PRRSV or PCV2b-only infection, 
  
102 
is a promising strategy to select for improved response to not just PRRSV-infection but 
also co-infection with PRRSV and PCV2b, and perhaps other pathogens. The genetic 
correlation between the 2 primary PRRSV exposure traits also suggests that response to 
vaccination can be used as an indicator for response to PRRSV-infection with a field 
isolate, but because the SE of this correlation was large, further investigation is needed to 
solidify this conclusion.  
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Table 4.1. Descriptive statistics by trial (1, 2), vaccination status (Vx and Non-Vx), and genotype for the WUR SNP (AA and AB) for 
host response prior to (-28 to 0 days post-infection [dpi]) or after (0 to 21, 22 to 42, or 0 to 42 dpi) co-infection with PRRS virus and 
PCV2b.  
 
Trait 
 Count by Trial
1
  
Count Non-Vx2 
 
Count Vx3 
 
Trial 1 Trial 2 
 1 2 
 
AA AB 
 
AA AB 
 
Mean SD  Mean SD 
PRRS VL4               
-28 to 0 dpi  98 88 
 
-- -- 
 
87 99 
 
55.0 26.2 88.6 12.1 
0 to 21 dpi  193 175 
 
85 96 
 
86 101 
 
77.6 15.5 63.1 17.6 
ADG (kg/d)               
-28 to 0 dpi  199 187 
 
87 104 
 
92 103 
 
0.35 0.08 0.52 0.15 
0 to 42 dpi  185 172 
 
85 96 
 
82 94 
 
0.84 0.16 0.84 0.23 
PCV2b VL               
0 to 42 dpi  173 163  82 91  79 84  160.1 41.5 94.4 52.5 
Mortality
5
               
0 to 21 dpi  199 183  86 101  92 103 
 
0.01 0.10 0.03 0.16 
22 to 42 dpi  199 183  86 101  92 103  0.10 0.30 0.08 0.28 
0 to 42 dpi  199 183  86 101  92 103  0.11 0.31 0.11 0.31 
Blue Ear
6 
              
0 to 21 dpi  199 183  86 101  92 103 
 
0.28 0.45 0.10 0.31 
22 to 42 dpi  199 183  86 101  92 103  0.02 0.14 0.04 0.21 
0 to 42 dpi  199 183  86 101  92 103  0.28 0.45 0.14 0.35 
Treatment
7 
              
0 to 21 dpi  199 183  86 101  92 103 
 
0.08 0.27 0.15 0.36 
22 to 42 dpi  199 183  86 101  92 103  0.21 0.41 0.18 0.38 
0 to 42 dpi  199 183  86 101  92 103  0.24 0.43 0.24 0.43 
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1Trial: All analyses were conducted using 2 trials of 199 (trial 1) and 197 (trial 2) 
commercial crossbred nursery piglets.  
2Non-Vx, Non-Vaccinated: Pigs were not vaccinated against porcine reproductive and 
respiratory syndrome (PRRS) virus prior to co-infection with PRRS and porcine 
circovirus type 2b (PCV2b) 28 days later.  
3Vx, Vaccinated: Pigs were vaccinated against PRRS virus prior to co-infection with 
PRRS virus and PCV2b 28 days later.  
4VL, Viral Load: Calculated as the area under the curve of log-transformed viremia 
between the indicated dpi. 
5Mortality: A pig died (=1) or survived (=0) during the co-infection period.  
6Blue Ear: A pig did (=1) or did not (=0) display clinical signs of blue ear for at least one 
day during the co-infection period.  
7Treatment: A pig did (=1) or did not (=0) receive veterinary treatment for at least one 
day during the co-infection period. 
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Table 4.2. SNPs used for the candidate SNP analyses.  
 
 
SNP Name 
Minor 
Allele 
Major 
Allele 
MAF1 Position2 
Prior 
Association 
Reference 
MARC0056777 B/G A/A 0.36 1, 294 
Mortality after 
PRRSV3-
infection 
Boddicker, 2013 
DIAS0000349 A/A B/G 0.06 7, 26.9 PRRSV N-
protein specific 
IgG in serum at 
42 dpi
4
 
Hess, 2016 MARC0058875 B/G A/A 0.37 7, 29.08 
ALGA0039771 B/G A/C 0.34 7, 29.24 
ASGA0031860 A/A B/G 0.25 7, 24 
PRRS S/P ratio5 
Serão et al., 
2014 
H3GA0020425 A/A B/G 0.37 7, 27 
MARC0058875 B/G A/A 0.37 7, 29.08 
ASGA0032151 A/A B/G 0.47 7, 30.4 
MARC0037274 A/A B/G 0.31 7, 128 
SNP16 B/C A/A 0.38 7, 28.8 
PCV2b7 viremia Engle et al., 2014 
SNP26 A/A B/G 0.30 12, 3.7 
 
 
1MAF, minor allele frequency. 
2Chromosome, megabase. 
3PRRSV, porcine reproductive and respiratory syndrome virus. 
4dpi, days post-infection. 
5S/P, sample-to-positive ratio based on a PRRSV-specific ELISA. 
6SNP1, SNP2: Candidate SNPs (names not yet published; personal communication).  
7PCV2b, porcine circovirus type 2b.  
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Table 4.3. Estimated proportion of affected individuals [95% confidence intervals] by VxStatus and WUR genotype (AA and AB).  
 
 
 
Within each row, estimates with different letter assignments significantly differ at P < 0.05. 
 
Trait 
 Non-Vaccinated1  Vaccinated2 P-value 
 AA AB  AA AB VxStatus3 WUR4 VxStatus*WUR5 
Mortality6          
0 to 21 dpi  -- --  -- -- NC7 NC NC 
22 to 42 dpi  0.02b [0.00, 0.08] 0.04ab [0.01, 0.10]  0.10ab [0.05, 0.18] 0.11a [0.06, 0.19] 0.01 0.55 0.69 
0 to 42 dpi  0.03b [0.01, 0.10] 0.07ab [0.03, 0.14]  0.11a [0.06, 0.20] 0.11ab [0.06, 0.19] 0.04 0.55 0.36 
Blue Ear8          
0 to 21 dpi  0.24a [0.15, 0.35] 0.22ab [0.14, 0.33]  0.12bc [0.06, 0.20] 0.09c [0.04, 0.17] 0.001 0.94 0.80 
22 to 42 dpi  -- --  -- -- NC NC NC 
0 to 42 dpi  0.26a [0.17, 0.37] 0.23a [0.15, 0.34]  0.17ab [0.10, 0.26] 0.09b [0.04, 0.17] 0.006 0.50 0.36 
Treatment9          
0 to 21 dpi  0.07a [0.03, 0.14] 0.09a [0.04, 0.16]  0.16a [0.10, 0.25] 0.12a [0.07, 0.20] 0.07 0.73 0.35 
22 to 42 dpi  0.09b [0.04, 0.17] 0.16ab [0.09, 0.26]  0.24a [0.16, 0.35] 0.22a [0.14, 0.32] 0.01 0.52 0.18 
0 to 42 dpi  0.14b [0.07, 0.24] 0.24ab [0.16, 0.35]  0.28a [0.19, 0.39] 0.25ab [0.17, 0.36] 0.11 0.44 0.13 
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1Non-Vaccinated: Pigs were not vaccinated against porcine reproductive and respiratory 
syndrome (PRRS) virus prior to co-infection with PRRS and porcine circovirus type 2b 
(PCV2b) 28 days later.  
2Vaccinated: Pigs were vaccinated against PRRS virus prior to co-infection with PRRS 
virus and PCV2b 28 days later.  
3VxStatus: P-value for the effect of vaccination status. 
4WUR: P-value for the effect of WUR SNP genotype.  
5VxStatus*WUR: P-value for the effect of vaccination status by WUR SNP genotype.  
6Mortality: A pig died (=1) or survived (=0) during the indicated days post-infection 
(dpi).  
7NC, No Convergence: Analysis did not converge. 
8Blue Ear: A pig did (=1)/did not (=0) display clinical signs of blue ear for at least one 
day during the indicated dpi. 
9Treatment: A pig did (=1)/did not (=0) receive veterinary treatment for at least one day 
during the indicated dpi. 
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Table 4.4. Estimates of heritability (±SE) and litter components (±SE) for traits post 
PRRS vaccination and post co-infection with PRRS virus and PCV2b.   
 
 
Trait Heritability Litter Component1 
ADG    
(Non-Vx2) -28 to 0 dpi3 0.33 ± 0.21 0.13 ± 0.15 
(Vx4) -28 to 0 dpi 0.18 ± 0.24 0.40 ± 0.15 
(Non-Vx) 0 to 42 dpi 0.68 ± 0.22 0.13 ± 0.13 
(Vx) 0 to 42 dpi 0.41 ± 0.23 0.19 ± 0.16 
PRRS VL5   
(Vx) -28 to 0 dpi 0.13 ± 0.22 0.13 ± 0.13 
(Non-Vx) 0 to 21 dpi 0.61 ± 0.23 0.08 ± 0.14 
(Vx) 0 to 21 dpi 0.13 ± 0.19 0.12 ± 0.14 
PCV2b VL   
(Non-Vx) 0 to 42 dpi 0.09 ± 0.15 0.49 ± 0.11 
(Vx) 0 to 42 dpi 0.09 ± 0.19 0.54 ± 0.13 
Mortality6   
 0 to 21 dpi NC7 NC 
22 to 42 dpi 0.27 ± 0.11 0 ± 0 
 0 to 42 dpi 0.24 ± 0.10 0 ± 0 
Blue Ear8   
 0 to 21 dpi 0.18 ± 0.10 0 ± 0 
22 to 42 dpi NC NC 
0 to 42 dpi 0.20 ± 0.10 0 ± 0 
Treatment9   
 
0 to 21 dpi 0.02 ± 0.15 0 ± 0 
 22 to 42 dpi 0 ± 0 0.19 ± 0.08 
 
0 to 42 dpi 0.02 ± 0.15 0.16 ± 0.12 
 
1Litter Component: Expressed as a proportion of the total phenotypic variance.   
2Non-Vx, Non-Vaccinated: Pigs were not vaccinated against porcine reproductive and 
respiratory syndrome (PRRS) virus prior to co-infection with PRRS and porcine 
circovirus type 2b (PCV2b) 28 days later.  
3dpi, days post-infection.  
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4Vx, Vaccinated: Pigs were vaccinated against PRRS virus prior to co-infection with 
PRRS virus and PCV2b 28 days later.  
5VL, Viral Load: Calculated as the area under the curve of log-transformed viremia 
between the indicated dpi. 
6Mortality: A pig died (=1)/survived (=0) during the indicated dpi.  
7NC, No Convergence: Analysis did not converge.  
8Blue Ear: A pig did (=1)/did not (=0) display clinical signs of blue ear for at least one 
day during the indicated dpi.  
9Treatment: A pig did (=1)/did not (=0) receive veterinary treatment for at least one day 
during the indicated dpi.  
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Table 4.5. Estimates of phenotypic (±SE) (above the diagonal) and genetic correlations (±SE) (below the diagonal) for host response 
of pigs vaccinated (Vx) or not (Non-Vx) for PRRS prior to (-28 to 0 dpi [days post-infection]) or after (0 to 21 or 0 to 42 dpi) co-
infection with PRRS virus and PCV2b.  
 
 
 
 PRRS1 VL2 
 
PCV2b3 VL 
 
ADG 
 
 
Vx 
(-28 to 0 dpi) 
Non-Vx 
(0 to 21 dpi) 
Vx 
(0 to 21 dpi) 
 Non-Vx 
(0 to 42 dpi) 
Vx 
(0 to 42 dpi) 
 Non-Vx 
(-28 to 0 dpi) 
Vx 
(-28 to 0 dpi) 
Non-Vx 
(0 to 42 dpi) 
Vx 
(0 to 42 dpi) 
PRRS VL 
Vx 
(-28 to 0 dpi) 
-- -- -0.05 ± 0.12  -- 0.14 ± 0.09  -- -0.04 ± 0.08 -- 0.14 ± 0.08 
Non-Vx 
(0 to 21 dpi) 
0.94 ± 0.84 -- --  0.04 ± 0.09 --  -0.09 ± 0.09 -- 0.09 ± 0.09 -- 
Vx 
(0 to 21 dpi) 
0.57 ± 1.12 0.26 ± 0.57 --  -- 0.27 ± 0.08  -- -0.25 ± 0.08 -- -0.25 ± 0.08 
PCV2b VL 
Non-Vx 
(0 to 42 dpi) 
-1.48 ± 2.15 -0.13 ± 0.72 0.30 ± 0.90  -- --  0.05 ± 0.09 -- -0.54 ± 0.07 -- 
Vx 
(0 to 42 dpi) 
0.92 ± 1.71 0.97 ± 1.68 0.99 ± 1.83  0.99 ± 0.94 --  -- -0.18 ± 0.09 -- -0.58 ± 0.06 
ADG 
Non-Vx 
(-28 to 0 dpi) 
0.61 ± 0.66 0.63 ± 0.51 0.47 ± 0.77  -0.77 ± 1.92 0.77 ± 1.10  -- -- 0.36 ± 0.09 -- 
Vx 
(-28 to 0 dpi) 
0.44 ± 1.12 -0.40 ± 0.63 0.55 ± 1.18  -0.80 ± 1.11 0.55 ± 1.47  0.92 ± 0.92 -- -- 0.14 ± 0.10 
Non-Vx 
(0 to 42 dpi) 
0.67 ± 0.42 0.70 ± 0.36 -0.63 ± 0.40  -0.87 ± 0.40 -0.70 ± 0.58  0.30 ± 0.28 0.10 ± 0.56 -- -- 
Vx 
(0 to 42 dpi) 
-0.37 ± 0.61 -0.04 ± 0.47 -0.16 ± 0.79  -0.04 ± 1.16 -0.90 ± 0.67  -0.20 ± 0.48 -0.48 ± 0.62 0.75 ± 0.37 -- 
 
1PRRS, porcine reproductive and respiratory syndrome.  
2VL, Viral Load: Calculated as the area under the curve of log-transformed viremia between the indicated dpi. 
3PCV2b, porcine circovirus type 2b. 
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Table 4.6. Least square (LS) means (±SE) and P-values for significant associations with host response for the candidate SNP analyses.  
 
    SNP Genotype1  SNP 
Variance4 Time Period2 VxStatus3 Trait SNP Name AA AB BB P-value 
Post Vaccination Non-Vx ADG ALGA0039771 0.44b ± 0.02 0.48a ± 0.03 0.44ab ± 0.03 0.02 0.03 
Post Co-Infection 
Non-Vx ADG 
DIAS0000349 -- 0.61b ± 0.06 0.86 a ± 0.04 <0.001 0.21 
MARC0058875 0.85a ± 0.06 0.74b ± 0.05 0.62b ± 0.08 0.03 0.02 
SNP15 0.83a ± 0.05 0.71b ± 0.05 0.65b ± 0.08 0.02 0.02 
Vx 
ADG 
H3GA0020425 0.63c ± 0.09 0.82b ± 0.05 0.98a ± 0.09 0.01 0.05 
ASGA0032151 0.57c ± 0.09 0.78b ± 0.08 1.09a ± 0.09 <0.001 0.05 
PRRS VL6 
ASGA0032151 65.93ab ± 5.15 67.69a ± 4.55 51.29b ± 5.59 0.02 0.03 
ALGA0039771 56.08b ± 3.69 62.83a ± 4.12 66.02a ± 4.93 0.02 0.01 
 
LS means with different letter assignments significantly differ at P < 0.05. 
1SNP Genotype: LS mean (±SE) for each candidate SNP genotype.  
2Time Period: Post vaccination against porcine reproductive and respiratory syndrome (PRRS) or post co-infection with PRRS virus 
and porcine circovirus type 2b (PCV2b). 
3VxStatus: Pigs were either vaccinated (Vx) or not (Non-Vx) against PRRS prior to co-infection with PRRS virus and PCV2b 28 days 
later. 
4SNP Variance: Proportion of phenotypic variance explained by the SNP.  
5SNP1: Candidate SNP (name not yet published) located on chromosome 7 at 28.8 megabases (Engle et al., 2014). 
6VL, Viral Load: Calculated as the area under the curve of log-transformed PRRS viremia between 0 and 21 days post-infection. 
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LS means with different letter assignments significantly differ at P < 0.05. 
 
Figure 4.1. Least square (LS) means of ADG (A), porcine reproductive and respiratory 
syndrome (PRRS) viral load (VL) (B), and porcine circovirus type 2b (PCV2b) VL (C). 
 
Results are presented following PRRS vaccination or PRRS virus and PCV2b co-
infection by WUR SNP genotype (AA and AB).  
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Table 4.S1. P-values for contrasts from multivariate analyses of PRRS viral load (VL) and ADG.   
 
Trait 
WUR1 effect for 
primary versus 
secondary exposure 
Interaction effect of 
WUR for primary 
exposure traits 
Effect of 
vaccination 
versus non-
vaccination2 
Average effect 
of vaccination 
versus average 
of 
co-infection 
Effect of WUR 
averaged across 
vaccination status 
and time period3 
Average effect of 
WUR pre versus 
post co-infection 
PRRS VL 0.39 0.70 <0.001 0.50 <0.001 -- 
ADG -- -- -- -- -- <0.001 
 
Significant associations (based on a p-value cut-off of P < 0.05) are bolded. 
 
1WUR: Pigs were pre-selected based on the AA or AB WUR SNP genotype. 
2Pigs were either vaccinated, or not, against porcine reproductive and respiratory syndrome (PRRS) virus prior to co-infection with 
PRRS and porcine circovirus type 2b (PCV2b) 28 days later.  
3Time Period: Post PRRS vaccination or post co-infection with PRRS virus and PCV2b.  
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Table 4.S2. P-values for associations of SNPs previously associated with PRRS or PCV2b infection with host response post PRRS 
vaccination and post co-infection with PRRS virus and PCV2b.   
 
 Vaccination Period1  Co-Infection Period2 
SNP Name 
ADG 
(Non-Vx3) 
ADG 
(Vx4) 
PRRS VL5 
(Vx)  
ADG 
(Non-Vx) 
ADG 
(Vx) 
PRRS VL 
(Non-Vx) 
PRRS VL 
(Vx) 
PCV2b VL 
(Non-Vx) 
PCV2b VL 
(Vx) 
MARC0056777 0.31 0.92 0.95  0.13 0.52 0.91 0.57 0.15 0.62 
ALGA0039771 0.02 0.35 0.37  0.31 0.29 0.99 0.02 0.83 0.91 
DIAS0000349 0.89 0.78 0.96  <0.001 0.14 0.95 0.61 0.66 0.64 
ASGA0031860 0.63 0.91 0.80  0.79 0.74 0.77 0.31 0.65 0.24 
H3GA0020425 0.71 0.19 0.15  0.20 0.01 0.87 0.93 0.44 0.19 
MARC0058875 0.29 0.57 0.27  0.03 0.14 0.33 0.79 0.50 0.14 
ASGA0032151 0.09 0.78 0.97  0.09 <0.001 0.71 0.02 0.68 0.90 
MARC0037274 0.51 0.52 0.34  0.87 0.38 0.15 0.38 0.87 0.55 
SNP16 0.84 0.15 0.22  0.02 0.49 0.86 0.31 0.22 0.17 
SNP27 0.83 0.33 0.67   0.14 0.65 0.92 0.13 0.38 0.41 
 
Significant associations (based on a p-value cut-off of P < 0.05) are bolded. 
1Vaccination Period: Analysis conducted using data collected post vaccination against porcine reproductive and respiratory syndrome 
(PRRS). 
2Co-Infection Period: Analysis conducted using data collected post co-infection with PRRS and porcine circovirus type 2b (PCV2b).  
3Non-Vx, Non-Vaccinated: Pigs not vaccinated against PRRS prior to experimental co-infection with PRRS virus and PCV2b 28 days 
later. 
4Vx, Vaccinated: Pigs vaccinated against PRRS prior to experimental co-infection with PRRS virus and PCV2b 28 days later. 
5VL, Viral Load: Calculated as the area under the curve of log-transformed viremia between the indicated days post-infection. 
6SNP1: Candidate SNP (name not yet published) located on chromosome 7 at 28.8 megabases (Engle et al., 2014).  
7SNP2: Candidate SNP (name not yet published) located on chromosome 12 at 3.7 megabases (Engle et al., 2014).  
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Figure 4.S1. Raw body weight data of pigs vaccinated (Vx) or not (Non-Vx) against 
porcine reproductive and respiratory syndrome (PRRS) selected for the favorable (AB) or 
unfavorable (AA) WUR SNP genotype. 
 
 
A modified live PRRS vaccine was administered at -28 days post-infection (dpi) and all 
pigs were co-infected with PRRS and porcine circovirus type 2b (PCV2b) at 0 dpi. 
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Figure 4.S2. Raw porcine reproductive and respiratory syndrome (PRRS) viremia data of 
pigs vaccinated (Vx) or not (Non-Vx) against PRRS selected for the favorable (AB) or 
unfavorable (AA) WUR SNP genotype.  
 
 
A modified live PRRS vaccine was administered at -28 days post-infection (dpi) and all 
pigs were co-infected with PRRS and porcine circovirus type 2b (PCV2b) at 0 dpi. 
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Figure 4.S3. Raw porcine circovirus type 2b (PCV2b) viremia data of pigs vaccinated 
(Vx) or not (Non-Vx) against porcine reproductive and respiratory syndrome (PRRS) 
selected for the favorable (AB) or unfavorable (AA) WUR SNP genotype.  
 
 
A modified live PRRS vaccine was administered at -28 days post-infection (dpi) and all 
pigs were co-infected with PRRS virus and PCV2b at 0 dpi. 
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CHAPTER 5. GENOMIC REGIONS ASSOCIATED WITH HOST RESPONSE 
TO PORCINE REPRODUCTIVE AND RESPIRATORY SYNDROME (PRRS) 
VACCINATION AND CO-INFECTION IN NURSERY PIGS1 
 
Abstract 
 
Background 
The WUR1000125 (WUR) single nucleotide polymorphism (SNP) can be used as 
a genetic marker for host response to porcine reproductive and respiratory syndrome 
(PRRS), PRRS vaccination, and co-infection with porcine circovirus type 2b (PCV2b). 
Objectives of this study were to identify genomic regions other than WUR associated 
with host response to PRRS vaccination and PRRSV/PCV2b co-infection and regions 
with a different effect on host response to co-infection, depending on previous 
vaccination for PRRS.  
 
Methods 
Commercial crossbred nursery pigs were pre-selected for WUR (n = 171 AA and 
198 AB pigs) where B is the dominant and favorable allele. Half of the pigs were then 
vaccinated for PRRS and four weeks later, all pigs were co-infected with PRRS virus and 
                                                        
1Co-authors: N V L Serão,a Z Weng,a,b E H Waide,a,c M C Niederwerder,d M A 
Kerrigan,d J K Lunney,e R R R Rowland,d and J C M Dekkersa 
aDepartment of Animal Science, Iowa State University, Ames, IA, 50011 
bABS Global Inc., DeForest, WI, 53532 
cThe Seeing Eye Inc., Morristown, NJ, 07960 
dDepartment of Diagnostic Medicine/Pathobiology, College of Veterinary Medicine, 
Kansas State University, Manhattan, KS, 66506 
eUSDA, ARS, BARC, APDL, Beltsville, MD, 20705 
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PCV2b. Average daily gain (ADG) and viral load (VL) were quantified post vaccination 
(Post Vx) and post co-infection (Post Co-X). Single-SNP genome-wide association 
analyses were then conducted to identify genomic regions associated with response to 
vaccination and co-infection. 
 
Results 
Multiple SNPs near the major histocompatibility complex were significantly 
associated with PCV2b VL (-log10P  ≥  5.5), regardless of prior vaccination for PRRS. 
Several SNPs were also significantly associated with ADG Post Vx and Post Co-X. SNPs 
with a different effect on ADG, depending on prior vaccination for PRRS, were identified 
Post Vx (-log10P = 5.6) and Post Co-X (-log10P = 5.5). No SNPs were significantly 
associated with vaccination VL (-log10P ≤  4.7) or PRRS VL (-log10P ≤ 4.3). Genes near 
SNPs associated with vaccination VL, PRRS VL, and PCV2b VL were enriched (P ≤ 
0.01) for immune-related pathways and genes near SNPs associated with ADG were 
enriched for metabolism pathways (P ≤ 0.04). SNPs associated with vaccination VL, 
PRRS VL, and PCV2b VL showed overrepresentation of health QTL identified in 
previous studies and SNPs associated with ADG Post Vx of Non-Vx pigs showed 
overrepresentation of growth QTL. 
 
Conclusions 
Multiple genomic regions were associated with PCV2b VL and ADG Post Vx and 
Post Co-X. Different SNPs were associated with ADG, depending on previous 
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vaccination for PRRS. Results of functional annotation analyses and novel approaches of 
using previously-reported QTL support the identified regions.  
 
Background 
 
Guanylate binding protein 5 (GBP5), located on Sus scrofa chromosome (SSC) 4, 
was identified as a major gene for host response to porcine reproductive and respiratory 
syndrome (PRRS) [1,2]. Since the causative mutation for GBP5 does not appear on 
commercial genotyping platforms, the single nucleotide polymorphism (SNP) 
WUR10000125 (WUR), which is in complete linkage disequilibrium with the causative 
mutation [2–4] can be used as a genetic marker for this mutation.  
Since the identification of this quantitative trait locus (QTL), the effect of WUR 
has been associated with host response to PRRS virus (PRRSV)-infection following 
infection with two different PRRSV isolates [3–6], PRRS vaccination [7], and co-
infection with PRRS and porcine circovirus type 2b (PCV2b) [7]. In addition, WUR was 
associated with PCV2b viral load (VL) following PRRSV/PCV2b co-infection for pigs 
previously vaccinated for PRRS, but not for non-vaccinated pigs [7]. Other genomic 
regions, including regions on SSC7 and SSC12 have been associated with PCV2b VL 
following experimental infection with PCV2b only [8].  
The first objective of this study was to identify genomic regions other than WUR 
that are associated with host response to PRRS vaccination and co-infection with PRRSV 
and PCV2b. A second objective was to identify regions with a different effect on host 
response to PRRSV/PCV2b-infection, depending on whether pigs were previously 
vaccinated for PRRS. The final objective was to assess the biological relevance of 
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genomic regions associated with each trait to provide support for, and assign biological 
function, to these statistically-associated regions.  
 
Materials & Methods 
 
This project was approved by the Kansas State University and Iowa State University 
Institutional Animal Care and Use Committees. 
 
Animals 
A detailed description of the animals used for this study is in Dunkelberger et al. 
[7]. Briefly, commercial Large White x Landrace crossbred barrows from two 
experimental co-infection trials (trial 1 n = 199; trial 2 n = 197) were used. Pigs 
originated from the same, high health multiplier farm and were pre-selected based on 
WUR marker genotype: approximately half for the AA genotype (n = 184) and the other 
half for the AB genotype (n = 212), where the B allele is the favorable and dominant 
allele [1]. Pigs were shipped to Kansas State University at weaning (between 18 and 28 
days of age) and sorted into one of 2 rooms upon arrival. Within each room, pens were 
balanced according to WUR genotype and pigs were given 3-4 days to acclimate to their 
new surroundings before all pigs within one room were vaccinated with a 2-mL dose of a 
commercial PRRS MLV vaccine (Ingelvac PRRS®, Boehringer Ingelheim Vetmedica 
Inc., St. Joseph, MO). Four weeks later, all pigs were co-infected with field strains of 
PRRSV and PCV2b [9]. Pigs were followed for the next 42 days, after which all 
surviving pigs were euthanized, and tissue was collected for genotyping. Body weights 
were recorded weekly throughout the vaccination (-28 to 0 days post-infection [dpi]) and 
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co-infection (0 to 42 dpi) periods on both vaccinated (Vx) and non-vaccinated (Non-Vx) 
pigs. Serum samples were collected on Vx pigs post vaccination (Post Vx) at -28, -24, -
21, -17, -14, and -7 dpi and on all pigs post co-infection (Post Co-X) at 0, 4, 7, 11, 14, 
21, 28, 35, and 42 dpi. Serum samples were used to quantify PRRS and PCV2b viremia 
using Real Time polymerase chain reaction (PCR) analysis according to Niederwerder et 
al. [9].  
 
Traits 
 
A detailed description of the traits analyzed for this study, including descriptive 
statistics for all traits analyzed, is in Dunkelberger et al. [7]. Briefly, 89 Non-Vx AA, 106 
Non-Vx AB, 95 Vx AA, and 106 Vx AB pigs were used for all analyses. ADG was 
calculated as the regression of body weight on dpi using body weight data from -28 to 0 
and 0 to 42 dpi for ADG Post Vx and Post Co-X, respectively. Vaccination VL, PRRS 
VL, and PCV2b VL were calculated for each individual as the area under the curve of 
log10-transformed viremia from -28 to 0, 0 to 21, and 0 to 42 dpi, respectively.  
  
Genotype data 
Ear tissue was used to genotype pigs from trials 1 and 2 using the GeneSeek-
Neogen PorcineSNP80 BeadChip (GeneSeek, Igenity; Lincoln, NE). Quality control of 
genotype data was performed in the following steps: 1) fixed SNPs were removed, 2) 
genotypes with a gene call score lower than 0.3 were set to missing, and 3) SNPs missing 
more than 15% of genotypes were removed. Final genotyping rate, calculated as the 
percent of genotypes called out of the total number of genotypes, was 99.43%. 
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For all analyses presented, a genomic relationship matrix (GRM) was used to 
account for relationships among the 369 individuals with both genotypes and phenotypes 
and was constructed according to VanRaden [10] by centering and scaling genotypes for 
all individuals across the 61,729 SNPs that remained after quality control.  
 
Genome-wide association analyses (GWAS) 
 
All GWAS were performed using single-SNP analyses with ASReml 4.0 [13].  
 
Univariate GWAS 
The following univariate animal model was used to test the effect of SNP 
genotype on vaccination VL by fitting the effect of one SNP at a time, with animal, litter, 
and pen(trial) fitted as random effects to account for genetic, common environmental, and 
random environmental effects, respectively: 
 
Model [1] 
 Yijklmn = μ + Trialj 
+ WURk + SNPl  + 
β1 ∗ WtVxi + β2 ∗ VxAgei + β3 ∗ PCV2_0i  
+ Animali + Litterm + Penn(j) + eijklmn  
where Yijklm = is the observed phenotype; Trialj = fixed effect of the j
th trial (1 or 2); 
WURk = fixed effect of WUR SNP genotype (AA or AB); SNP = fixed effect of the l
th 
genotype (AA, AB, or BB); βp = partial regression coefficient for the covariate weight at 
-28 dpi (WtVx) (P = 1), age at -28 dpi (VxAge) (P = 2), and PCV2b viremia at 0 dpi (P 
= 3); Animali = random animal genetic effect of the i
th individual, with a variance-
covariance structure proportional to the GRM with the assumption ~ N(0, 𝐆σα
2); Litter = 
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random litter effect (123 levels), assumed to be ~ N(0, 𝐈σl
2); and Pen = random effect of 
pen nested within trial (40 levels), assumed to be ~ N(0, 𝐈σp
2). Interaction effects of trial 
with each fixed effect were fitted but removed since they were not significant (P > 0.10).  
Including WUR genotype in the model as a fixed effect allowed for the 
identification of regions other than WUR associated with host response to PRRS 
vaccination, while simultaneously accounting for the effect of this marker. Level of 
PCV2b viremia at 0 dpi was fitted as a covariate because 37 (24 Non-Vx and 13 Vx) pigs 
had non-zero PCV2b viremia titers at 0 dpi, suggesting that they were exposed to PCV2b 
prior to entering the facility, likely from their mothers; all phenotypes were adjusted to 
PCV2_0 = 0 to model the situation that all pigs were negative for PCV2b at 0 dpi.   
 
Bivariate GWAS 
To identify the effect of vaccination on the effect of genomic regions for host 
response to co-infection, bivariate animal models were used to analyze ADG Post Vx, 
PRRS VL, PCV2b VL, and ADG Post Co-X of Vx versus Non-Vx groups as two 
separate traits, as described in Dunkelberger et al. [7]. For each bivariate GWAS, the 
following model was used to test the effect of each SNP averaged across vaccination 
status (main effect) and the interaction of SNP genotype with vaccination status 
(interaction effect): 
 
Model [2] 
 
[
𝐲N
𝐲V
] = [
𝐗N 0
0 𝐗V
] [
𝐛N
𝐛V
] +  [
𝐖𝐢N 0
0 𝐖𝐢V
] [
𝐠𝐢N
𝐠𝐢V
]  + [
𝐙αN 0
0 𝐙αV
] [
𝛂N
𝛂V
] + [
𝐙lN 0
0 𝐙lV
] [
𝐥N
𝐥V
] + [
𝐙pN 0
0 𝐙pV
] [
𝐩N
𝐩V
] + [
𝐞N
𝐞V
] 
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where subscripts N and V represent a trait recorded on Non-Vx and Vx pigs, 
respectively; yN(yV) =  vector of phenotypes; XN(XV) = design matrix of fixed effects 
(same as for Model [1]); bN(bV) = vector of solutions for fixed effects; WiN(WiV) = 
matrix of fixed genotype effects for the ith SNP genotype and giN(giV) = corresponding 
vector of solutions; 𝐙αN(𝐙αV) = design matrix of random genetic effects and N(V) = 
corresponding vector of solutions; 𝐙lN(𝐙lV) = design matrix of random litter effects and 
lN(lV) = corresponding vector of solutions; 𝐙pN(𝐙pV) = design matrix of random pen 
effects and pN(pV) = corresponding vector of solutions. The covariance matrix of random 
animal genetic, litter, pen, and residual effects was specified as follows:  
Var
[
 
 
 
 
 
 
 
𝛂N
𝛂V
𝐥N
𝐥V
𝐩N
𝐩V
𝐞N
𝐞V ]
 
 
 
 
 
 
 
=
[
 
 
 
 
 
 
 
 
 
𝐆Nσα N
2 𝐆NVσα N,V 0 0 0 0 0 0
𝐆NVσα N,V 𝐆Vσα V
2 0 0 0 0 0 0
0 0 𝐈σl N
2 𝐈σl N,V 0 0 0 0
0 0 𝐈σl N,V 𝐈σl V
2 0 0 0 0
0 0 0 0 𝐈σp N
2 0 0 0
0 0 0 0 0 𝐈σp V
2 0 0
0 0 0 0 0 0 𝐈σe N
2 0
0 0 0 0 0 0 0 𝐈σe V
2 ]
 
 
 
 
 
 
 
 
 
 
 
where G represents the GRM for the Non-Vx(N) and Vx(V) individuals and I represents 
the identity matrix. For all analyses, covariances were allowed between traits for the 
animal genetic effect and litter effect. However, covariances were constrained to 0 for 
pen effects and residuals since Vx and Non-Vx pigs were allocated to different rooms and 
no pig had records for both traits.  
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Correction for multiple testing 
Multiple test correction was performed to determine the appropriate significance 
threshold to interpret GWAS results. First, principal component analysis was used to 
determine the number of independent tests (i.e. SNPs) per chromosome as the number of 
principal components required to capture 99.5% of the variation [6,11] using the 
princomp function of R software [12]. Results are presented in Table 5.S1. Since the 
number of individuals used for analyses serves as an upper bound for the number of 
principal components that can be identified, chromosomes were divided into segments so 
that for each segment, the number of SNPs was fewer than the total number of 
individuals (i.e. n<369). The number of independent tests per chromosome segment was 
then summed to calculate the total number of independent tests across the genome. 
Unmapped SNPs were not included in this calculation. Bonferroni correction was then 
applied using the following equation:  
𝑝 − 𝑣𝑎𝑙𝑢𝑒 =  
𝛼
𝑛𝑢𝑚𝑏𝑒𝑟 𝑜𝑓 𝑖𝑛𝑑𝑒𝑝𝑒𝑛𝑑𝑒𝑛𝑡 𝑡𝑒𝑠𝑡𝑠 𝑎𝑐𝑟𝑜𝑠𝑠 𝑡ℎ𝑒 𝑔𝑒𝑛𝑜𝑚𝑒
 
where α = 0.10 and the number of independent tests for the whole genome = 26, 272. The 
resulting genome-wise significance –log10 p-value threshold was 5.4.  
 
Pathway analyses 
Pathway analyses were conducted to identify protein pathways that were enriched 
for genes near SNPs associated with each trait according to the procedure described by 
Waide et al. [6]. First, lists of SNPs at three –log10 p-value thresholds (2, 2.5, and 3, 
referred to as SNP lists T2, T2.5, and T3, respectively) for the combined additive and 
dominance effect (2-df test) of each SNP were generated for each trait. Next, 1-megabase 
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(Mb) windows were constructed for each SNP, which spanned 0.5 Mb on either side of 
each SNP. Then, for each SNP, ENSEMBL IDs (http://www.ensembl.org) were obtained 
for all genes contained within or flanking either side of the 1-Mb SNP window. These 
ENSEMBL IDs were then used to perform a statistical overrepresentation analysis using 
the GO Slim feature of the PANTHER software [14]. Compared to using the entire GO 
term database, GO Slim uses a limited set of gene ontology (GO) terms (550 versus 
45,237 total annotations) to provide a more general list of protein pathways that map to 
gene IDs (http://www.pantherdb.org). A custom background gene list was used, which 
consisted of all genes that mapped to 0.5 Mb on either side of each of the 61,729 SNPs 
used for GWAS. P-values for statistical overrepresentation of protein pathways were 
corrected by PANTHER software using the Bonferroni multiple testing correction 
method. The number of SNPs and genes corresponding to each SNP list for each trait are 
shown in Tables 5.S2 and 5.S3. 
 
QTL test  
A second type of analysis, hereafter referred to as the QTL Test, was also used to 
provide evidence for regions associated with each trait in this study.  A master list of 
previously reported QTL for all traits in the pig genome was downloaded from the QTL 
database for pigs at animalgenome.org. In the database, each QTL entry is assigned to 
one of the following trait categories: exterior, health, meat and carcass, production, and 
reproduction. In total, 16,032 QTL entries were downloaded. Filtering of the master list 
was then performed according to the following steps: duplicate QTL entries (i.e. entries 
for the same trait, location, and publication) were removed, QTL for the same trait from 
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the same study with overlapping positions were concatenated, QTL spanning more than 5 
Mb were removed, and all ADG, body weight, and growth-related QTL, which belong to 
the “production” category, were re-assigned to a new category entitled “growth”. After 
filtering, 9,892 unique QTL entries remained.   
 The filtered master QTL list was then used to construct a list of all QTL that 
mapped to each SNP. A QTL was mapped to a SNP if the QTL was either entirely 
contained within or entirely overlapped the 1-Mb SNP window. This list was used to 
determine the number of health and growth QTL that mapped to SNPs associated with 
VL and ADG traits, respectively. These lists were then used to assess overrepresentation 
of health or growth QTL mapping to SNPs for each list.  
 Using QTLI as the trait QTL (i.e. QTL for health or growth) mapped to one of the 
three SNP lists for a trait (i.e. T2, T2.5 or T3), QTLT as the list of all QTL (of all QTL 
types) mapped to one of the three SNP lists, and QTLG as the list of all QTL (for all QTL 
types) throughout the genome, the null hypothesis (H0) for this test was that the ratio P1 = 
QTLI:QTLT was equal to the ratio P2 = QTLI:QTLG. The alternative hypothesis (Ha) was 
that P1 > P2. 
P-values for the QTL Test were calculated as the probability of identifying QTLI 
or more trait QTL for a given SNP list under H0 using the binomial distribution, as 
follows:  
p − value =  ∑ (
K
x
) Px(1 − P)K−x
K
x= k
 
 
where k = QTLI; K = QTLT; and P = P2. Analyses were performed separately for health 
and growth QTL for each SNP list. 
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SNP test 
A third test, hereafter referred to as the SNP Test, was also performed to assess 
overrepresentation of health or growth QTL, but using slightly different information than 
the QTL Test. Using SNPI as the number of unique SNPs within a health or growth QTL 
(i.e. QTLI), SNPT as the number of SNPs in each SNP list (i.e. T2, T2.5, or T3), and 
SNPG the number of SNPs across the genome (i.e. 61,729), the H0 for this test was that P3 
= SNPI:SNPT was equal to P4 = SNPI:SNPG (H0: P3 = P4). The alternative hypothesis (Ha) 
was that P3 > P4. P-values for the SNP Test were also calculated using the above binomial 
distribution but using k = SNPI, K = SNPT, and P = P4.  
 
Results 
 
GWAS post vaccination  
Vaccination viral load 
No SNPs were significantly associated with MLV vaccination VL (maximum -
log10P = 4.65)(Fig. 5.1a). 
 
Average daily gain 
Five total SNPs, located on SSC9 at 52 Mb (i.e. 9_52), 11_53, and from 12_5 to 
12_6  (Fig. 5.1b) were significantly (-log10P ≥ 5.6) associated with ADG Post Vx for Vx 
pigs (Table 5.1). A different set of SNPs, including SNPs located at 15_129 and 5_5 
(Fig. 5.1b) were significantly (-log10P ≥ 5.4) associated with ADG Post Vx of Non-Vx 
pigs (Table 5.1).  
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Seven SNPs had a significant (-log10P ≥ 5.6) main effect on ADG Post Vx (Table 
5.2). These SNPs were located at 6_108, 7_81 to 7_82, 17_32, and 18_4 (Fig. 5.2). One 
of the only two SNPs with a significant interaction effect identified in this study was also 
associated with ADG Post Vx (-log10P = 5.6) (Fig. 5.2), and was located at 17_57. 
However, the effect of this SNP on ADG Post Vx was not significant when analyzed for 
Vx (-log10P = 5.1) or Non-Vx (-log10P = 1.0) pigs separately (Fig. 5.1b). 
 
GWAS post co-infection 
Viral load  
Genomic regions associated with host response to co-infection are presented in 
Fig. 5.3. One SNP, located at 7_20 (Fig. 5.3b) was significantly (-log10P = 6.1) 
associated with PCV2b VL of Non-Vx pigs (Table 5.1). No SNPs were significantly 
associated with PCV2b VL of Vx pigs (-log10P ≤ 5.1)(Fig. 5.3 Panel b), PRRS VL of Vx 
pigs (-log10P ≤ 4.3)(Fig. 5.3 Panel a), or PRRS VL of Non-Vx pigs (-log10P ≤ 4.3) (Fig. 
5.3 Panel a). 
SNPs with a significant main effect on host response to co-infection were 
identified for some traits Post Co-X (Fig. 5.4). SNPs associated with main and interaction 
effects of SNP for PRRS VL, PCV2b VL, and ADG are presented in Figures 5.4a, 5.4b, 
and 5.4c, respectively. Four SNPs had significant (-log10P ≥ 5.5) main effects on PCV2b 
VL (Table 5.2), all of which were located on SSC7 at 19, 20, 32, and 41 Mb (Fig. 5.4 
Panel b). Of these SNPs, the effect of SNP H3GA0020199 (7_20) was significant for 
PCV2b VL of Non-Vx pigs (-log10P = 6.1), but not Vx pigs (-log10P = 4.8) (Fig 5.3b). 
The interaction effect of SNP genotype by VxStatus was not significant for any SNP for 
  
134 
analysis of PCV2b VL (-log10P ≤ 4.4) (Fig. 5.3b). No SNPs had a significant (-log10P ≤ 
4.6) main or interaction effect on PRRS VL Post Co-X (Fig. 5.4a). 
 
Average daily gain 
Three SNPs, located at 1_47 and 14_61 to 14_62 (Fig. 5.3c) were significantly (-
log10P ≥ 5.5) associated with ADG Post Co-X of Vx pigs (Table 5.1). SNPs at 7_27 and 
15_140 (Fig. 5.3c) were significantly (-log10P ≥ 5.4) associated with ADG Post Co-X of 
Non-Vx pigs (Table 5.1).  
Three SNPs had a significant (-log10P ≥ 6.0) main effect on ADG Post Co-X 
(Table 5.2). These SNPs were located at 1_47, 7_24, and 15_140 (Fig. 5.4c). Of these 
SNPs, MARC0021766 (1_47) was also significant for ADG Post Co-X of Vx pigs (-
log10P = 6.9), but not Non-Vx pigs (-log10P = 0.5) (Fig. 5.3c). Conversely, 
WU_10.2_15_140171163 (15_140) was significantly (-log10P = 5.4) associated with 
ADG Post Co-X for Non-Vx pigs, but not Vx pigs (-log10P = 1.0) (Fig. 5.3c).  
The second SNP (WU_10.2_4_6084304) with a significant (-log10P = 5.5) 
interaction effect of SNP genotype by VxStatus identified in this study was associated 
with ADG Post Co-X (Table 5.2) located at 4_6 (Fig. 5.4c). However, the effect of this 
SNP was not significant for ADG Post Co-X when analyzed separately for Vx (-log10P = 
5.2) or Non-Vx (-log10P = 0.5) pigs (Fig. 5.3c).  
 
Pathway analyses post vaccination 
 
 For each trait, only GO terms that were significantly (P < 0.05 following 
Bonferroni correction) associated with genes near SNPs for each SNP list (i.e. T2, T2.5, 
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and T3) are presented. These significant associations include several protein pathways 
that were significantly underrepresented, which are presented but will not be discussed. 
The number of mapped ENSEMBL IDs and the total number of ENSEMBL IDs (i.e. 
mapped and unmapped) are presented in Table 5.S2 for each trait analyzed separately by 
VxStatus and in Table 5.S3 for the main and interaction effects of SNP genotype by 
VxStatus.  
 
Vaccination viral load 
GO terms enriched for genes near SNPs for host response to PRRS vaccination 
are presented in Table 5.3. Genes near SNPs associated with vaccination VL were 
enriched for pathways related to cell proliferation, response to stimuli/stress, behavior, 
cell movement, and cell signaling.  
 
Average daily gain 
No pathways were significantly enriched for genes near SNPs associated with 
ADG of Vx or Non-Vx pigs (Table 5.3) or for genes near SNPs associated with ADG 
Post Vx for the main or interaction effects of SNP (Table 5.S4).  
 
Pathway analyses post co-infection  
Viral load 
GO terms enriched for genes near SNPs associated with host response to PRRSV 
and PCV2b co-infection by VxStatus are presented in Table 5.4. Immune-related 
pathways, including the G-protein coupled receptor signaling pathway and chromatin 
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organization pathway were enriched for PRRS VL of Vx pigs. None of these same 
pathways, but rather, sensory-related pathways, were enriched for PRRS VL of Non-Vx 
pigs. Chromatin organization was enriched for genes near SNPs for PCV2b VL of Vx 
and Non-Vx pigs. Additional enriched pathways for Vx pigs included cellular defense 
response, cell-cell adhesion, and nucleobase-containing compound metabolic process.  
Genes near SNPs associated with the interaction effect of SNP genotype by 
VxStatus were enriched for the response to stimulus and chromatin organization 
pathways for PRRS VL (Table 5.S5). No pathways were significantly enriched for SNPs 
associated with the main effect of SNP for PRRS VL. The chromatin organization, 
response to interferon (IFN)-γ, and primary metabolic process pathways were 
significantly enriched for genes near SNPs associated with the main effect of SNP for 
PCV2b VL (Table 5.S6). Only the transport pathway was enriched for the interaction 
effect of SNP genotype by VxStatus for PCV2b VL (Table 5.S6).   
 
Average daily gain 
Consistent with results for PRRS VL of Vx pigs and PCV2b VL of both Vx and 
Non-Vx pigs, genes near SNPs were significantly enriched for chromatin organization for 
ADG of Vx and Non-Vx pigs Post Co-X (Table 5.4). Another significantly enriched 
pathway for ADG Post Co-X of Vx pigs included the cholesterol metabolic process 
pathway (Table 5.4).   
Only the chromatin organization pathway was significantly enriched for genes 
near SNPs associated with the main effect of SNP for ADG Post Co-X (Table 5.S7). This 
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same pathway was enriched for the interaction effect of SNP genotype by VxStatus, in 
addition to lipid transport and localization (Table 5.S7).   
 
QTL Test 
 
The QTL Test was performed to assess overrepresentation of health or growth 
QTL for SNPs associated with VL or ADG, respectively. Results for analyses of each 
trait by VxStatus are presented in Table 5.5 and Tables 5.S8 and 5.S9. Results for 
analyses of the main and interaction effects of SNP for each trait are presented in Tables 
5.6 and 5.7.   
 
Viral load 
Results indicated that SNPs associated with vaccination VL were significantly (P 
= 6.5E-14) overrepresented for health QTL for T2 (Table 5.5). SNPs associated with the 
main effect of SNP genotype on PRRS VL were significantly (P = 4.6E-7) 
overrepresented for health QTL for T3 (Table 5.6). The latter result was driven by 
significant (P = 7.9E-7) overrepresentation of health QTL for SNPs associated with 
PRRS VL of Vx pigs for T3 (Table 5.S8). SNPs associated with the interaction effect of 
SNP genotype by VxStatus on PRRS VL were also significantly (P = 0.02) 
overrepresented for health QTL for T2 (Table 5.6). This result was driven by significant 
overrepresentation of health QTL for SNPs associated with PRRS VL of both Vx (P = 
6.7E-12) and Non-Vx (P = 3.3E-18) pigs for T2 (Table 5.S8). 
All three lists of SNPs associated with the main effect of SNP on PCV2b VL 
showed significant (P = 0.03, 2.3E-8, and 1.5E-8) overrepresentation of health QTL 
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(Table 5.6), driven by significant overrepresentation of health QTL for all three lists of 
SNPs for PCV2b VL for Vx (P = 6.7E-5 to 6.0E-4) and Non-Vx (P = 1.7E-9 to 4.0E-4) 
pigs (Table 5.S8).  
 
Average daily gain post vaccination 
Results indicated little evidence of overrepresentation of growth QTL for SNPs 
associated with ADG Post Vx of Vx (P ≥ 0.15) or Non-Vx (P ≥ 0.04) pigs (Table 5.S9). 
However, SNPs associated with the main effect of SNP on ADG Post Vx were 
significantly overrepresented for growth QTL for T2.5 (P = 0.01) and T3 (P = 0.03) 
(Table 5.7).  
 
Average daily gain post co-infection 
SNPs associated with ADG Post Co-X were not significantly overrepresented for 
growth QTL for Vx (P ≥ 0.36) or Non-Vx (P ≥ 0.74) pigs (Table 5.S9), or for the main 
(P ≥ 0.32) or interaction (P ≥ 0.12) effects of SNP by VxStatus (Table 5.7). 
 
SNP Test 
The SNP Test was conducted to assess overrepresentation of health or growth 
QTL based on the number of unique SNPs mapping to trait QTL. Results for analysis of 
each trait by VxStatus are presented in Table 5.8 and Tables 5.S10 and 5.S11 and results 
for the main and interaction effects of SNP by VxStatus are presented in Tables 5.9 and 
5.10. 
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Viral load 
Consistent with results for the QTL Test, SNPs associated with vaccination VL 
were significantly (P = 2.2E-5) overrepresented for health QTL for T2 (Table 5.8). A 
tendency (P = 0.06) for significant overrepresentation of health QTL was also detected 
for T2.5, but not T3 (P = 0.26) (Table 5.8). For analysis of the main and interaction 
effects of SNP genotype by VxStatus on PRRS and PCV2b VL, the same SNP lists that 
showed significant overrepresentation of health QTL for the QTL Test also showed 
significant overrepresentation of health QTL for the SNP Test (Table 5.9). An exception 
was for SNPs associated with the main effect of SNP genotype on PRRS VL for T3, 
which was not significant (P = 0.88) for the SNP Test (Table 5.9). SNPs associated with 
PRRS VL of Vx pigs, PCV2b VL of Non-Vx pigs, and PCV2b VL of Vx pigs were 
significantly (P = 7.0E-12 to 7.0E-3; P = 1.1E-4 to 0.02; P = 0.04 to 0.01) 
overrepresented for health QTL (Table 5.S10). One exception was T3 for PCV2b VL of 
Vx pigs, which did not show significant (P = 0.26) overrepresentation of health QTL 
(Table 5.S10). 
 
Average daily gain post vaccination 
SNPs associated with the main effect of SNP on ADG Post Vx showed significant 
overrepresentation of growth QTL for T2 (P = 0.01) and T2.5 (P = 7.1E-6)(Table 5.10). 
SNPs associated with the interaction effect of SNP genotype by VxStatus on ADG Post 
Vx also showed significant overrepresentation of growth QTL for T2.5 (P = 0.05) and T3 
(P = 2.8E-6) (Table 5.10). For T2, overrepresentation of growth QTL for SNPs 
associated with the main effect of SNP was driven by significant overrepresentation of 
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growth QTL for Non-Vx pigs for T2 (P = 2.0E-4)(Table 5.S11). Overrepresentation of 
growth QTL for SNPs associated with the interaction effect of SNP was driven by 
significant overrepresentation of growth QTL for Non-Vx pigs for T3 (P = 8.7E-6) 
(Table 5.S11).  
 
Average daily gain post co-infection 
SNPs associated with the main effect (P ≥ 0.11) and interaction effect (P ≥ 0.44) 
of SNP on ADG Post Co-X were not significantly overrepresented for any of the SNP 
lists (Table 5.10). Similarly, growth QTL were not significantly overrepresented for 
SNPs associated with ADG of Vx (P ≥ 0.29) or Non-Vx (P ≥ 0.53) pigs Post Co-X 
(Table 5.S11).  
Discussion 
 
This is the first study to identify genomic regions (other than WUR) associated 
with host response to PRRS MLV vaccination and co-infection with PRRSV and PCV2b. 
Significant regions were detected for PCV2b VL, ADG Post Vx, and ADG Post Co-X 
and results from functional annotation analyses provided biological evidence that 
supported these statistically associated regions. Results of the functional annotation 
analyses also supported the many regions with small effects that were detected. Multiple 
SNPs on SSC7 were significantly associated with PCV2b VL, regardless of prior 
vaccination against PRRSV. However, regions with a significantly different effect on 
ADG, depending on prior vaccination against PRRSV, were detected for ADG Post Vx 
and Post Co-X. These findings indicate that multiple genomic regions have potential to 
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be used to select pigs for decreased PCV2b VL following PRRSV/PCV2b co-infection, 
regardless of prior vaccination against PRRSV, but the same is not true for ADG.  
This study also introduced a novel approach of using previously-reported QTL to 
provide evidence for statistically-associated regions from GWAS. Other studies have 
assessed clustering of health QTL throughout the rice genome [15] and the gene density 
of QTL regions compared to the rest of the genome in cattle [16], but this is the first 
study to use a catalog of previously-reported QTL to assess overrepresentation of a QTL 
category as a means of providing evidence for regions identified from GWAS. 
The WUR SNP, a genetic marker for a major QTL for PRRS on SSC4, was 
identified in a previous study. Results showed that WUR was associated with 15.7% and 
11.2% of genetic variation in PRRS VL and WG under PRRSV-only infection, 
respectively [1]. Follow-up studies identified GBP5 as the putative causative gene for the 
mutation [2], which has been shown to play a role in innate immune response to infection 
in mice [17]. In recent years, additional studies have validated the effect of WUR on host 
response to PRRS using multiple breeds, populations, and following infection with two 
different PRRSV isolates [3–6]. Results from these studies showed that WUR had a 
significant effect on PRRS VL following infection with both the NVSL and KS06 
PRRSV isolates, but not WG following infection with KS06 [5]. Authors suggested that 
this non-significant effect was related to reduced virulence of the KS06 versus the NVSL 
strain. Taken together, results from these studies showed that WUR had a significant 
effect on viral titer with different isolates of PRRSV and for different genetic 
backgrounds. 
  
142 
A natural follow-up question to these studies was whether WUR also has a significant 
effect on host response to PRRSV-infection following co-infection with another 
pathogen. This is a practical question since PRRSV is known to suppress the host’s 
immune response, making pigs more susceptible to secondary infections [18]. Co-
infection with PRRSV and PCV2b was used as a co-infection model to address this 
question, given the ubiquitous nature of PCV2b [19,20], prevalence of PRRSV/PCV2b 
co-infection in the field (when pigs are not vaccinated against PCV2b), and previous 
experience working with and conducting PCV2b-experimental infection trials. An 
additional objective was to estimate the effect of WUR on host response to PRRS MLV 
vaccination since commercial PRRS MLV vaccines are widely used [21,22]. Although 
PRRS MLV vaccines are modified so as not to result in clinical pathology, live virus still 
causes infection.  
Results from Dunkelberger et al. [7] showed that WUR had a significant effect on 
vaccination VL as well as PRRS VL and PCV2b VL of Vx pigs, but not Non-Vx pigs. 
Results also showed that, numerically, the effect of WUR on PRRS VL was greater 
following primary versus secondary PRRSV exposure, which is consistent with the 
biological role of GBP5. Using these same data, the first objective of the current study 
was to identify genomic regions other than WUR associated with host response to PRRS 
MLV vaccination and PRRSV/PCV2b co-infection.  
 
Genome-wide association studies 
 
Viral load 
When Vx and Non-Vx pigs were analyzed separately, H3GA0020199, located at 
SSC7_20, was the only SNP significantly associated with PCV2b VL, and only in Non-
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Vx pigs. This SNP is located within the gene KIAA0319, which has a known role in 
neuronal growth and migration in humans [23]. Multiple SNPs on SSC7 (located between 
7_19 and 7_41) were significantly associated with the main effect of SNP genotype on 
PCV2b VL. Interestingly, this region overlaps the swine leukocyte antigen (SLA) 
complex, one of the most gene-dense regions of the genome and is known to harbor many 
genes associated with the immune response [24,25].  
A SNP within the SLA was also associated with host response to PCV2b infection in 
a previous study. This SNP, (referred to as SNP1; name not published) located at 7_28 
was associated with host response to experimental infection with PCV2b in commercial 
crossbred pigs [8]. Although the effect of SNP1 did not reach genome-wise significance 
for the current study, when the effect of SNP1 was fitted as a fixed effect with the effect 
of other candidates SNPs for PRRS and PCV2b simultaneously, the AA genotype for 
SNP1 was associated with significantly greater ADG and numerically lower PCV2b VL 
for Non-Vx pigs [7]. The direction of these effects are consistent with previously reported 
results, except that Engle et al. [8] did not detect a significant association of SNP1 with 
ADG post-infection. 
There is also evidence of associations of SNPs within the SLA region with host 
response to PRRSV-infection from other studies, including experimental PRRSV-
infection [5] and following a natural PRRSV outbreak [26]. Results from the study 
conducted by Hess et al. [5] showed that SNPs at 26 and 29 Mb were associated with 10-
45% of the total genetic variation for PRRS antibody response, depending on infection 
with the NVSL versus KS06 PRRSV isolate. For the study conducted by Serão et al. [26], 
SNPs spanning 24 to 30 Mb on SSC7 jointly explained 25% of the total genetic variation 
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in antibody response following a natural outbreak in a commercial herd of gestating 
females.  
Despite these sizeable associations of the SLA region with PRRS antibody response, 
no SNPs within this region, or any other region of the genome, were significantly 
associated with vaccination VL or PRRS VL for the current study. In general, the lack of 
significant associations for vaccination VL and PRRS VL is consistent with the 
conclusion reported by Waide et al. [6] that genomic regions other than WUR explained 
little to no genetic variation in PRRS VL following experimental infection with the 
NVSL or KS06 PRRSV isolate. One exception was the 7_30 Mb window, located within 
the SLA class II region, which was associated with a small percentage (0.32%) of the 
total genetic variation in PRRS VL following infection with the KS06 PRRSV isolate [6]. 
Although not genome-wise significant, a SNP within this same window (ASGA0032151) 
was the second-most significant SNP (-log10P = 4.25) associated with PRRS VL in Vx 
pigs for the current study.  
 
Average daily gain post vaccination 
Contrary to analysis of vaccination VL and PRRS VL, we identified multiple SNPs 
that were significantly associated with ADG Post Vx and Post Co-X. This finding 
conflicts with results reported by Waide et al. [6] who reported no significant associations 
with WG post PRRSV-only infection, other than the WUR region. 
Most genomic regions associated with ADG Post Vx in the current study were also 
associated with ADG in previous studies. However, for all but one of the identified 
regions, associations with ADG in other studies were in a disease-free environment. For 
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example, the SSC15_129 region associated with ADG of Non-Vx pigs Post Vx, was also 
associated with ADG in non-challenged pigs by Rückert and Bennewitz [27]. Regions 
associated with ADG Post Vx of Vx pigs at SSC9_52 (ALGA0052956) and SSC11_53 
(WU_10.2_11_53143619 and ALGA0062289) were also associated with ADG in other 
studies [27,28]. A region associated with ADG of Non-Vx pigs (WU_10.2_5_5635354) 
and ADG of Vx pigs Post Vx (WU_10.2_5_5693454), located at 5_5, was the only 
region associated with ADG Post Vx that was not associated with ADG in a previous 
study. Therefore, this region may represent a novel QTL for ADG. Interestingly, this 
SNP (WU_10.2_5_5693454) is located within the GRAP2 gene in pigs, which encodes 
the protein GRB2-reltated adaptor protein 2, also known as GRB2-related adaptor 
downstream of Sch, or GADS. In humans, GADS is involved in the formation of the T 
cell receptor complex [29] and has a known role in T cell development and signaling 
[30]. However, there was no evidence that this SNP was significantly associated with any 
of the VL traits.  
None of the SNPs that were significantly associated with ADG of Non-Vx pigs were 
also significantly associated with ADG of Vx pigs. However, several other SNPs had a 
significant effect on ADG Post Vx, regardless of vaccination status, which agrees with 
the high, positive (0.92 ± 0.92) genetic correlation identified between ADG of Vx and 
Non-Vx pigs Post Vx reported in our previous study using these same data [7]. These 
SNPs, with significant main effects, were located at 6_108, 7_10, 7_81, 7_82, and 18_4, 
all of which were associated with ADG in previous studies [31–34]. Given the significant 
main effect detected for these SNPs, these five SNPs may be used to select pigs for 
improved host response to PRRSV/PCV2b co-infection, regardless of prior vaccination 
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against PRRSV. Interestingly, the SNP located on SSC6 (ALGA0036437) is located 
within the RNF125 gene, which is a negative regulator of the RIG-1 like receptor 
signaling pathway [35]. The RIG-1 like receptor is a known recognition receptor of RNA 
viruses. Activated RIG-1 like protein signals for the production of cytokines, including 
type I IFN in the innate immune response pathway [35]. Suggestive evidence of a 
significant (-log10P = 3.16) association of this SNP with the main effect of SNP genotype 
on PRRS VL was also detected.  
The effect of ASGA0077518 (17_57) on ADG Post Vx depended on prior 
vaccination for PRRS, where the effect of this SNP on ADG was near genome-wise 
significance for Vx pigs, but not Non-Vx pigs. The nearest QTL for ADG reported in a 
previous study spans 17_64 to 17_66 [36]. During the vaccination period, ADG of Vx 
pigs represented growth under PRRSV-infection (albeit a modified PRRSV infection), 
while ADG of Non-Vx pigs represented growth under non-challenged conditions.  
Therefore, the significant interaction identified for ASGA0077518 indicates that this SNP 
had a significantly different effect on growth rate Post Vx, depending on PRRS 
vaccination status. 
 
Average daily gain post co-infection 
Similar to analysis of ADG Post Vx, several SNPs were also significantly associated 
with ADG Post Co-X, including the only SNP that was previously associated with growth 
under disease challenged conditions in a separate study [3].  This SNP, H3GA0020408, is 
located in the SLA region (7_27) and was associated with ADG of Non-Vx pigs Post Co-
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X. This same 1-Mb window was also associated with WG following PRRSV-only 
infection for analysis of PHGC trials 1-8 [3].  
Other significant SNPs associated with ADG Post Co-X included a SNP 
(WU_10.2_15_140171163) located at 15_140. This same region was associated with 
ADG of non-challenged pigs in a previous study [37]. MARC0021766, located at 1_47, 
was associated with ADG of Vx pigs and this same region was also associated with ADG 
in a previous study [27]. Associations of SNPs located on SSC14 (H3GA0040428 and 
ALGA0077929) at 61 and 62 Mb, respectively, with ADG of Vx pigs have not been 
previously reported and may represent novel QTL for ADG under challenged conditions. 
No candidate genes were identified for H3GA0040428, but ALGA0077929 is located 
within the PCNXL2 gene. In humans, PCNXL2 has been associated with susceptibility to 
colorectal cancer [38].  
Similar to results for ADG Post Vx, none of the SNPs that were significantly 
associated with ADG of Non-Vx pigs were also significantly associated with ADG of Vx 
pigs Post Co-X. However, several other SNPs had a significant effect on ADG regardless 
of prior vaccination against PRRSV, which agrees with our previous finding of a 
moderate to high (0.75 ± 0.37) genetic correlation between ADG of Vx and Non-Vx pigs 
[7]. These SNPs included MARC0021766 on SSC1 (significant for Vx pigs) and 
WU_10.2_15_140171163 on SSC15 (significant for Non-Vx pigs). Therefore, 
MARC0021766 and WU_10.2_15_140171163 can be used to select pigs for improved 
host response to PRRSV/PCV2b co-infection, regardless of prior vaccination against 
PRRSV. WU_10.2_4_6084304, located at 4_6, was also associated with ADG in a 
previous study [34].  
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Protein pathway analyses 
 
In addition to identifying genomic regions associated with host response to PRRS 
vaccination and PRRSV and PCV2b co-infection, another objective of this study was to 
provide biological evidence for regions identified from GWAS. PANTHER software was 
used to test for enrichment of genes near SNPs associated with each trait.  
 
Viral load 
Pathways enriched in genes near SNPs associated with vaccination VL included cell 
proliferation, cell movement, cell signaling, and cytokine signaling. Enrichment of these 
pathways is consistent with the literature regarding PRRS MLV vaccination response. 
Compared to infection with a field isolate of PRRSV, PRRS MLV vaccination is known 
to result in a delayed humoral and cell-mediated immune response [39]. Cell-mediated 
immunity is often characterized by lymphocyte proliferation and increased cytokine 
production, mainly production of IFN-γ [40,41]. The pathways “cell proliferation” and 
“cell signaling” reflect these processes.  
Consistent with results reported by Waide et al. [6], the G-protein coupled receptor 
signaling pathway was enriched for genes near SNPs for analysis of PRRS VL of Vx 
pigs. Enrichment of this pathway is an interesting result since this protein receptor class 
plays a role in T cell immunity, including T cell migration by regulating chemotaxis [42]. 
No  pathways were enriched in genes near SNPs associated with the main effect of SNP 
genotype for PRRS VL, which is consistent with GWAS results for this trait.  
Immune-related pathways were also enriched for genes near SNPs associated with 
PCV2b VL, including but not limited to: cellular defense response, cell-to-cell adhesion, 
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and nucleobase metabolic processes for Vx pigs only, and the chromatin organization 
pathway for both Vx and Non-Vx pigs. This result agrees with the finding that several 
SNPs near the SLA region were significant for the main effects of SNP on PCV2b VL. It 
is also consistent with the high, positive genetic correlation between PCV2b VL of Vx 
and Non-Vx pigs (0.99 ± 0.94) reported for our previous analyses of these same data [7]. 
Based on this estimate, it is expected that the same genomic regions, and therefore the 
same protein pathways, are associated with PCV2b VL Post Co-X, regardless of previous 
vaccination against PRRSV.  
For PCV2b VL, genes near SNPs associated with the main effect of SNP were 
enriched for primary metabolic process and response to IFN-γ.  The “primary metabolic 
process” pathway was previously found to be associated with PRRS VL following 
infection with the KS06 and NVSL PRRSV isolates [6]. This pathway likely reflects the 
need for metabolizable energy to mount and maintain an immune response [43]. 
Enrichment of genes in the “response to IFN-γ” pathway is particularly interesting, given 
the well-known role of IFN-γ in response to viral infection. There is evidence that IFN-γ 
production increases with increasing replication of PCV2b [44] and that PCV2b 
replication increases in pigs that are already infected with PRRSV [45,46].   
 
Average daily gain 
Results of protein pathways analyses showed enrichment of metabolism-related 
pathways for genes near SNPs associated with ADG of Vx and Non-Vx pigs Post Co-X. 
Lipid transport was also enriched for genes near SNPs associated with the interaction 
effect of SNP genotype by VxStatus on ADG Post Co-X. Metabolic processes are clearly 
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associated with growth rate and such pathways were also enriched for WG following 
PRRSV-only infection in a previous study [6].   
 
QTL and SNP Tests 
 
The QTL and SNP Tests proposed in this study were then used to provide another 
piece of evidence for regions identified from GWAS. A significant result for the QTL 
Test indicated that SNPs identified from GWAS mapped to significantly more unique 
trait QTL (i.e. health or growth QTL) reported in previous studies than expected by 
chance. The SNP Test was designed to answer a similar question, where the objective 
was to assess whether the proportion of SNPs within a SNP list that mapped to health or 
growth QTL was greater than expected by chance. In general, similar results were 
obtained for the QTL and SNP Tests for analyses of each trait.  
 
Viral load 
Results of the QTL Test for the main and interaction effects of SNP for PRRS and 
PCV2b VL were consistent with results of the SNP Test, except that for T3, the main 
effect of SNP was not significant for SNPs associated with PRRS VL for the SNP Test. 
When PRRS and PCV2b VL were analyzed separately by vaccination status, every SNP 
list showed significant overrepresentation of health QTL, expect for T3 for PRRS VL of 
Non-Vx pigs. These results were consistent with those obtained for the SNP Test, except 
that none of the SNP lists were significant for analysis of PRRS VL of Non-Vx pigs. This 
was driven by the fact that, compared to PRRS VL of Vx pigs, similar numbers of SNPs 
were identified for each SNP list, but fewer SNPs mapped to health QTL for Non-Vx 
versus Vx pigs.  
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Collectively, results of these tests indicate that regions associated with PRRSV and 
PCV2b VL showed significant overrepresentation for health QTL identified from 
previous studies, especially when Vx and Non-Vx pigs were analyzed separately. Results 
of the SNP Test show that mapping of SNPs to health QTL was non-random. Non-
significant results obtained for the main/interaction effects of SNP likely reflect noise 
since relaxed –log10 p-value thresholds were used to construct the SNP lists, thereby 
including SNPs with smaller effects on the trait of interest. Non-significant results for the 
main/interaction effects of SNP on PRRS VL and for the interaction effect for PCV2b VL 
indeed appear to be consistent with GWAS results for these traits, for which no SNPs 
reached genome-wise significance for these effects.  
 
Average daily gain 
Few significant results were obtained for the QTL Test for ADG. Only two SNP lists, 
both for the main effect of SNP on ADG Post Vx, showed a significant result. 
Overrepresentation of growth QTL was not detected for any of the SNP lists for SNPs 
associated with ADG Post Co-X, except for T3 for ADG of Non-Vx pigs. An additional 
SNP list (T2) showed significant overrepresentation of growth QTL for ADG of Non-Vx 
pigs Post Vx for the SNP Test. Possibly, significant results for the QTL and SNP Tests 
were obtained for Non-Vx pigs Post Vx only because this trait represents growth in a 
healthy environment, which is the same condition under which growth traits were 
measured for the majority of previously-identified growth QTL. Therefore, non-
significant results for analysis of ADG of Vx pigs Post Vx or ADG Post Co-X might 
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indicate the identification of novel QTL for ADG, and/or QTL specific to growth under 
challenge.  
Collectively, results of the QTL and SNP Tests for SNPs associated with ADG 
indicate significant overrepresentation of growth QTL for growth rate under non-
challenged conditions, but not under challenged conditions. For growth under challenged 
conditions, significant results for the SNP Test also indicate non-random associations of 
SNPs mapped to growth QTL.  
The QTL Test and SNP Test used in this study are novel approaches used to provide 
evidence for statistically associated regions from GWAS. Although these tests have 
shown to provide valuable evidence for regions identified in this study, it is also 
important to note that results obtained from these tests are contingent on several factors. 
For example, several necessary steps for preparing the filtered QTL list are subject to 
modification, including the criteria used to determine a “unique” QTL entry and the 
length of the QTL interval used to retain unique entries. In addition, a limiting factor of 
the QTL and SNP Tests is that it is only possible to test for significant overrepresentation 
of QTL using QTL that have already been identified. Therefore, a non-significant result 
merely implies that QTL of a particular category are not significantly overrepresented for 
a subset of SNPs based on the current catalog of QTL for the pig genome. Consequently, 
non-significant results are obtained for SNPs mapping to undiscovered QTL.  
Other possible limitations are that results are also subject to the window size used to 
identify genes mapping to significant SNPs, as well as the significance thresholds used to 
construct the SNP lists. For the current study, 1-Mb SNP windows were used to allow for 
the possibility of trans-acting QTL and SNP list thresholds were selected to be consistent 
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with the procedure described by Waide et al. [6], as previously mentioned. These 
thresholds were purposefully selected to include SNPs that did not reach genome-wise 
significance in order to capture the effects of all SNPs affecting the trait of interest, 
including those with small effects. This was important because disease-related traits are 
considered complex traits, and are therefore assumed to be controlled by many loci with 
small effects [47].  
Conclusions 
 
In conclusion, other than WUR, several other genomic regions were associated with 
host response to PRRS MLV vaccination and co-infection with PRRSV and PCV2b, but 
in general, host response was highly polygenic. Multiple SNPs near the SLA region were 
associated with PCV2b VL, regardless of previous vaccination against PRRSV. Several 
regions associated with ADG Post Vx and Post Co-X were also identified, but SNPs with 
a significantly different effect on ADG, depending on vaccination status, were identified 
for ADG during both periods. Taken together, results indicate that multiple SNPs within 
the SLA region have the potential to be used to select pigs for decreased PCV2b VL 
following PRRSV/PCV2b co-infection, but that different SNPs were associated with 
ADG following PRRS vaccination and PRRSV/PCV2b co-infection, depending on 
previous vaccination against PRRSV. 
Results from the protein pathway enrichment analyses supported GWAS results, 
showing that immune-related pathways were enriched for genes near SNPs associated 
with vaccination VL, PRRS VL, and PCV2b VL and that metabolic pathways were 
enriched for genes near SNPs associated with ADG. Results of the QTL and SNP Tests 
provided additional evidence for the identified regions and similar results were obtained 
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for both tests. Results showed that SNPs associated with vaccination VL, PRRS VL, and 
PCV2b VL were significantly overrepresented for health QTL when Vx and Non-Vx pigs 
were analyzed separately and results of the SNP Test showed that mapping of SNPs to 
health QTL was non-random. Results for ADG showed that, for Non-Vx pigs prior to co-
infection, SNPs associated with ADG were significantly overrepresented for growth QTL 
and results of the SNP Test showed that mapping of SNPs to growth QTL was non-
random.  These findings likely reflect the fact that most QTL used for these tests were 
associated with growth under non-challenged conditions.  
Collectively, results of functional annotation analyses provide valuable insight 
regarding the biological pathways underlying host response to PRRS MLV vaccination 
and PRRSV/PCV2b co-infection, biological evidence for regions statistically associated 
with the traits of interest, and a means of summarizing GWAS results for complex traits, 
including host response to disease challenge.  
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Table 5.1. Significant single nucleotide polymorphisms (SNPs) associated with host 
response to porcine reproductive and respiratory syndrome (PRRS) vaccination and co-
infection with PRRS and porcine circovirus type 2b (PCV2b) for genome-wide 
association studies of each trait by vaccination status.   
 
Infection Period Trait VxStatus1 SNP Name Chromosome Mb2 P-value3 
Post Vaccination 
Vaccination 
VL4 
Vx -- -- -- -- 
 
Vx 
ALGA0052956 9 52 5.7 
ADG5 
WU_10.2_11_53143619 11 53 7.2 
ALGA0062289 11 53 6.1 
ASGA0083776 12 5 6.3 
ISU10000072 12 6 5.6 
Non-Vx 
WU_10.2_5_5635354 5 5 5.6 
WU_10.2_5_5693454 5 5 5.4 
MARC0034977 15 129 6.8 
Post 
Co-Infection 
PRRS VL 
Vx -- -- -- -- 
Non-Vx -- -- -- -- 
PCV2b VL 
Vx -- -- -- -- 
Non-Vx H3GA0020199 7 20 6.1 
ADG 
Vx 
MARC0021766 1 47 6.9 
ALGA0077929 14 61 5.5 
H3GA0040428 14 62 5.5 
Non-Vx 
H3GA0020408 7 27 5.8 
WU_10.2_15_140171163 15 140 5.4 
 
 
1VxStatus, vaccination status: Pigs were either vaccinated (Vx) or not (Non-Vx) against 
PRRS virus prior to co-infection with PRRS virus and PCV2b 28 days later.   
2Mb, megabase. 
3P-value: -log10 p-value. 
4VL, viral load: calculated as the area under the curve from -28 to 0, 0 to 21, or 0 to 42 
days post-infection (dpi) for vaccination VL, PRRS VL, and PCV2b VL, respectively.  
5ADG, average daily gain: calculated as the regression of body weight on dpi post 
vaccination and post PRRS virus/PCV2b co-infection.  
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Table 5.2. Single nucleotide polymorphisms (SNPs) with significant main and interaction 
effects with vaccination status for host response to porcine reproductive and respiratory 
syndrome (PRRS) vaccination and co-infection with PRRS and porcine circovirus type 
2b (PCV2b). 
 
 
 
1Effect: The effect of SNP across groups vaccinated, or not, against PRRS virus (main) 
versus the effect of SNP interacting with vaccination status (interaction).  
2Mb, megabase.  
3P-value: -log10 p-value. 
4ADG, average daily gain: calculated as the regression of body weight on day post-
infection (dpi) post PRRS vaccination and post PRRS virus/PCV2b co-infection.  
5VL, viral load: calculated as the area under the curve from -28 to 0, 0 to 21, or 0 to 42 
dpi for vaccination VL, PRRS VL, and PCV2b VL, respectively.  
 
Infection Period Trait Effect1 SNP Name Chromosome Mb2 P-value3 
Post Vaccination ADG4 
Main 
ALGA0036437 6 108 7.7 
ALGA0107326 7 81 6.1 
MARC0056209 7 81 5.6 
ALGA0042683 7 82 5.6 
WU_10.2_17_32849954 17 32 6.9 
WU_10.2_18_4027654 18 4 6.3 
WU_10.2_18_4233046 18 4 6.1 
Interaction ASGA0077518 17 57 5.6 
Post Co-Infection 
PRRS VL5 
Main -- -- -- -- 
Interaction -- -- -- -- 
 
Main 
DRGA0007276 7 19 6.2 
PCV2b VL 
H3GA0020199 7 20 8.7 
ASGA0032282 7 32 5.5 
MARC0060135 7 41 7.3 
Interaction -- -- -- -- 
 
Main 
MARC0021766 1 47 7.1 
ADG 
MARC0059955 7 24 7.7 
WU_10.2_15_140171163 15 140 6.0 
Interaction WU_10.2_4_6084304 4 6 5.5 
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Table 5.3. Significantly enriched gene ontology (GO) terms for genes near single 
nucleotide polymorphisms (SNPs) associated with vaccination viral load (VL) and 
average daily gain (ADG) following vaccination for porcine reproductive and respiratory 
syndrome.  
 
Trait SNP List1 GO term 
Fold 
change 
P-
value2 
Vaccination 
VL 
2 Sensory perception of chemical stimulus 0.53 4.9E-2 
2.5 
Behavior 7.38 4.0E-3 
Response to biotic stimulus 5.98 2.2E-3 
Cell proliferation 3.55 2.4E-2 
3 
Behavior 23.09 7.1E-7 
Response to biotic stimulus 18.72 5.4E-8 
Cell proliferation 11.12 5.7E-8 
Locomotion 9.30 1.6E-4 
Cytokine-mediated signaling pathway 7.07 4.4E-4 
Cell surface receptor signaling pathway 2.29 3.5E-2 
Signal transduction 1.96 2.2E-2 
Response to external stimulus 5.82 2.4E-3 
Cellular component movement 4.87 7.4E-4 
Response to stress 3.40 4.8E-3 
ADG 
Non-Vx3 
2 Sensory perception of smell 0.53 1.7E-2 
2.5 -- -- -- 
3 -- -- -- 
ADG 
Vx 
2 
G-protein coupled receptor signaling pathway 0.61 2.4E-2 
Cell surface receptor signaling pathway 0.68 7.4E-3 
Sensory perception of smell < 0.20 1.2E-17 
Sensory perception of chemical stimulus 0.40 2.4E-8 
Sensory perception 0.55 2.6E-5 
Neurological system process 0.69 3.0E-3 
System process 0.73 2.1E-2 
2.5 
Sensory perception of smell < 0.20 7.5E-9 
Sensory perception of chemical stimulus 0.45 2.4E-2 
3 Sensory perception of smell < 0.20 4.4E-3 
 
1SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
2P-value: Bonferroni corrected p-value.  
3Non-Vx, Non-Vaccinated: Pigs were either vaccinated (Vx) or not (Non-Vx) against 
PRRS virus.  
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Table 5.4. Significantly enriched gene ontology (GO) terms for genes near single 
nucleotide polymorphisms (SNPs) associated with viral load (VL) and average daily gain 
(ADG) following co-infection with porcine reproductive and respiratory syndrome 
(PRRS) and porcine circovirus type 2b (PCV2b).   
 
 
Trait SNP List1 GO term 
Fold 
change 
P-value2 
PRRS VL  
Non-Vx3 
2 Sensory perception of smell 1.67 3.5E-3 
2.5 Sensory perception 1.85 4.3E-2 
3 -- -- -- 
PRRS VL  
Vx 
2 
Cellular protein modification process 0.53 1.2E-2 
Immune response 0.47 4.9E-2 
2.5 
Chromatin organization 2.80 2.7E-2 
G-protein coupled receptor signaling pathway 1.82 2.7E-2 
3 -- -- -- 
PCV2b VL 
Non-Vx 
2 
Sensory perception of chemical stimulus 0.50 2.9E-4 
Sensory perception 0.63 2.5E-2 
2.5 Chromatin organization 2.82 2.4E-2 
3 -- -- -- 
PCV2b VL 
Vx 
2 
Cellular defense response 2.61 1.0E-2 
Cell-cell adhesion 2.26 4.7E-3 
Sensory perception of chemical stimulus 0.54 1.4E-2 
Sensory perception 0.61 4.3E-2 
2.5 
Cellular defense response 4.38 1.4E-3 
Chromatin organization 3.75 3.2E-4 
Nucleobase-containing compound metabolic process 1.47 3.6E-2 
3 Cellular defense response 8.52 3.3E-4 
ADG 
Non-Vx 
2 Chromatin organization 2.07 3.9E-2 
2.5 Chromatin organization 3.14 1.4E-3 
3 
Chromatin organization 4.75 8.5E-6 
Nucleobase-containing compound metabolic process 1.53 3.6E-2 
 Primary metabolic process 1.35 3.7E-2 
ADG 
Vx 
2 
Chromatin organization 1.86 2.5E-2 
JAK-STAT cascade < 0.20 4.1E-2 
2.5 Cholesterol metabolic process 3.54 4.9E-2 
3 
Chromatin organization 2.73 1.1E-2 
Sensory perception of chemical stimulus 0.31 9.8E-4 
 
 
1SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
2P-value: Bonferroni corrected p-value.  
3Non-Vx, Non-Vaccinated: Pigs were either vaccinated (Vx) or not (Non-Vx) against 
PRRS virus.  
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Table 5.5. Results of the QTL Test to assess overrepresentation of health-related QTL for 
single nucleotide polymorphisms (SNPs) associated with porcine reproductive and 
respiratory syndrome vaccination viral load. 
 
Trait SNP List1 
# SNPs above 
threshold 
# health QTL in 
region2 
Total # QTL 
in region3 
P-value 
Vaccination VL 
2 392 290 1,092 6.5E-14 
2.5 124 37 367 0.99 
3 51 16 100 0.69 
 
1SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
2The total number of health QTL in the genome (after filtering) is 1,732.  
3The total number of QTL in the genome (i.e. across all QTL types and after filtering) is 
9,892 
 
Table 5.6. Results of the QTL Test to assess overrepresentation of health-related QTL 
mapping to single nucleotide polymorphisms (SNPs) associated with porcine 
reproductive and respiratory syndrome (PRRS) and porcine circovirus type 2b (PCV2b) 
viral load (VL).  
 
Trait Effect1 SNP List2 
# of SNPs 
above 
threshold 
# of health 
QTL in 
region3 
Total # of 
QTL in 
region4 
P-value 
PRRS VL 
Main 
2 528 189 1046 0.33 
2.5 168 64 382 0.67 
3 37 34 83 4.6E-7 
Interaction 
2 516 246 1239 0.02 
2.5 159 79 442 0.44 
3 42 2 97 0.99 
PCV2b VL 
Main 
2 823 372 1943 0.03 
2.5 350 260 1076 2.3E-8 
3 160 162 609 1.5E-8 
Interaction 
2 520 182 1140 0.92 
2.5 156 42 399 0.99 
3 44 9 126 0.99 
 
1Effect: The effect of SNP across groups vaccinated, or not, against PRRS virus (main) 
or the effect of SNP interacting with PRRS vaccination status (interaction).  
2SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
3The total number of health QTL in the genome (after filtering) is 1,732.  
4The total number of QTL in the genome (i.e. across all QTL types and after filtering) is 
9,892. 
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Table 5.7. Results of the QTL Test to assess overrepresentation of growth-related QTL 
mapping to single nucleotide polymorphisms (SNPs) associated with average daily gain 
(ADG) following porcine reproductive and respiratory syndrome (PRRS) vaccination and 
co-infection with PRRS and porcine circovirus type 2b (PCV2b).  
 
Infection Period Effect1 SNP List2 
# of SNPs 
above 
threshold 
# of growth 
QTL in 
region3 
Total # 
QTL in 
region4 
P-value 
Post Vaccination 
Main 
2 902 85 1633 0.32 
2.5 365 45 643 0.01 
3 141 23 300 0.03 
Interaction 
2 687 62 1323 0.68 
2.5 251 20 443 0.69 
3 110 11 230 0.58 
Post Co-Infection 
Main 
2 870 107 2069 0.32 
2.5 364 55 1065 0.38 
3 176 23 502 0.67 
Interaction 
2 682 77 1519 0.42 
2.5 291 29 536 0.33 
3 120 20 305 0.12 
 
1Effect: The effect of SNP across groups vaccinated, or not, against PRRS virus (main) 
or the effect of SNP interacting with PRRS vaccination status (interaction).  
2SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
3The total number of growth QTL in the genome (after filtering) is 488.  
4The total number of QTL in the genome (i.e. across all QTL types after filtering) is 
9,892. 
 
Table 5.8. Results of the SNP Test to assess overrepresentation of health-related QTL 
mapping to single nucleotide polymorphisms (SNPs) associated with porcine 
reproductive and respiratory syndrome (PRRS) vaccination viral load (VL).  
 
Trait SNP List1 
# SNPs mapping to health 
QTL in SNP list2 
# SNPs 
in SNP list3 
P-value 
Vaccination VL 
2 125 392 2.2E-5 
2.5 36 124 0.06 
3 14 51 0.26 
 
1SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
2The number of unique SNPs mapping to health QTL in the genome is 14,063. 
3The total number of SNPs used for the genome-wide association study was 61,729.  
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Table 5.9. Results of the SNP Test to assess overrepresentation of health-related QTL 
mapping to single nucleotide polymorphisms (SNPs) associated with porcine 
reproductive and respiratory syndrome (PRRS) and porcine circovirus type 2b (PCV2b) 
viral load (VL).  
 
 
Trait Effect1 SNP List2 
# SNPs 
mapping to 
health QTL  
in SNP list3 
# SNPs 
in SNP list4 
P-value 
PRRS VL 
Main 
2 120 528 0.53 
2.5 27 168 0.99 
3 6 37 0.88 
Interaction 
2 155 516 8.4E-5 
2.5 45 159 0.06 
3 3 42 0.99 
PCV2b VL 
Main 
2 221 823 3.0E-3 
2.5 105 350 1.0E-3 
3 52 160 3.0E-3 
Interaction 
2 110 520 0.83 
2.5 33 156 0.72 
3 8 44 0.82 
 
 
1Effect: The effect of SNP across groups vaccinated, or not, against PRRS virus (main) 
or the effect of SNP interacting with PRRS vaccination status (interaction).  
2SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
3The number of unique SNPs mapping to health QTL in the genome is 14,063. 
4The total number of SNPs used for the genome-wide association study was 61,729.  
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Table 5.10. Results of the SNP Test to assess overrepresentation of growth-related QTL 
mapping to single nucleotide polymorphisms (SNPs) associated with average daily gain 
following porcine reproductive and respiratory syndrome (PRRS) vaccination and co-
infection with PRRS and porcine circovirus type 2b (PCV2b).  
 
 
Infection Period Effect1 SNP List2 
# SNPs mapping 
to growth QTL  
in SNP list3 
# SNPs 
in SNP list4 
P-value 
Post Vaccination 
Main 
2 161 902 0.01 
2.5 87 365 7.1E-6 
3 26 141 0.16 
Interaction 
2 103 687 0.53 
2.5 48 251 0.05 
3 36 110 2.8E-6 
Post Co-Infection 
Main 
2 126 870 0.70 
2.5 62 364 0.16 
3 33 176 0.11 
Interaction 
2 87 682 0.96 
2.5 33 291 0.97 
3 19 120 0.44 
 
 
1Effect: The effect of SNP across groups vaccinated, or not, against PRRS virus (main) 
or the effect of SNP interacting with PRRS vaccination status (interaction).  
2SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
3The number of unique SNPs mapping to growth QTL in the genome is 9,294. 
4The total number of SNPs used for the genome-wide association study was 61,729.  
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Figure 5.1. Significance of genome-wide association analyses of vaccination viral load 
(a) and average daily gain (b) following vaccination.   
 
 
 
Figure 5.2. Significance of main and interaction effects of vaccination from genome-
wide association analyses of average daily gain following vaccination. 
 
 
 
a 
b 
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Figure 5.3. Significance of genome-wide association analyses of porcine reproductive 
and respiratory syndrome viral load (a), porcine circovirus type 2b viral load (b), and 
average daily gain (c) following co-infection.  
 
 
 
a 
b 
c 
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Figure 5.4. Significance of main and interaction effects of vaccination from genome-
wide association analyses of porcine reproductive and respiratory syndrome viral load 
(a), porcine circovirus type 2b viral load (b), and average daily gain (c) following co-
infection. 
 
 
a 
b 
c 
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Table 5.S1. Number of independent principal components per chromosome required to 
capture 99.5% of the total genetic variation.  
 
 
Chromosome # SNPs1 # Principal Components 
1 5,730 2,466 
2 3,784 1,677 
3 3,398 1,569 
4 3,623 1,574 
5 2,792 1,263 
6 4,330 1,862 
7 3,680 1,570 
8 3,309 1,503 
9 3,576 1,634 
10 2,564 1,180 
11 2,176 994 
12 2,309 970 
13 4,241 1,740 
14 3,866 1,504 
15 3,360 1,480 
16 2,210 975 
17 1,978 855 
18 1,630 672 
X 2,581 783 
Y 10 1 
 
 
1SNPs, single nucleotide polymorphisms.  
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Table 5.S2. Number of gene ontology (GO) terms corresponding to lists of single 
nucleotide polymorphisms (SNPs) associated with each trait for pigs vaccinated (Vx) or 
not (Non-Vx) against porcine reproductive and respiratory syndrome (PRRS) virus.  
 
Infection 
Period1 
Trait 
Vaccination 
Status 
SNP List2 
# of SNPs 
above 
threshold 
Total # 
Ensembl 
IDs 
# Ensembl 
IDs with GO 
annotation 
 
Vaccination 
VL3 
Vx 
2 392 1,101 919 
Post 
Vaccination 
2.5 124 472 403 
3 51 147 128 
ADG4 
Non-Vx 
2 828 1,649 1,368 
2.5 355 707 562 
3 161 297 232 
Vx 
2 769 2,017 1,664 
2.5 295 863 717 
3 120 376 314 
Post  
Co-Infection 
PRRS VL 
Non-Vx 
2 534 1,309 1,103 
2.5 164 386 330 
3 36 99 84 
Vx 
2 582 1,467 1,197 
2.5 170 614 502 
3 50 231 181 
PCV2b VL 
 2 723 1,674 1,376 
Non-Vx 2.5 232 605 496 
 3 66 229 177 
 2 566 1,341 1,106 
Vx 2.5 178 483 393 
 3 51 161 130 
ADG 
 2 577 1,450 1,190 
Non-Vx 2.5 227 667 534 
 3 119 397 316 
 2 978 2,314 1,878 
Vx 2.5 502 1,260 1,025 
 3 285 736 602 
 
1Infection Period: Pigs were Vx or Non-Vx against PRRS virus prior to co-infection with 
PRRS and porcine circovirus type 2b (PCV2b) 28 days later.  
2SNP List: List of SNPs from the genome-wide association analysis with a –log10 p-value 
above 2, 2.5, or 3. 
3VL, viral load: Calculated as the area under the curve of serum viremia between -28 and 
0, 0 and 21, or 0 and 42 days post-infection (dpi) for vaccination VL, PRRS VL, and 
PCV2b VL, respectively.  
4ADG, average daily gain.  
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Table 5.S3. Number of gene ontology (GO) terms corresponding to lists of single 
nucleotide polymorphisms (SNPs) associated with the main or interaction effect of SNP 
for each trait for pigs vaccinated (Vx) or not (Non-Vx) against porcine reproductive and 
respiratory syndrome (PRRS) virus.  
 
 
Infection Period1 Trait Effect2 SNP List3 
# SNPs 
above 
threshold 
Total # 
Ensembl 
IDs 
# Ensembl 
IDs with GO 
annotation 
 
ADG4 
Main 
2 902 1,920 1,590 
Post Vaccination 
2.5 365 859 694 
3 141 449 371 
 2 687 1,556 1,244 
Interaction 2.5 251 562 444 
 3 110 284 231 
Post 
Co-Infection 
PRRS VL5 
Main 
2 528 1,320 1,078 
2.5 168 479 380 
3 37 136 116 
 2 516 1,313 1,066 
Interaction 2.5 159 487 398 
 3 42 125 108 
PCV2b VL 
Main 
2 823 1,644 1,344 
2.5 350 743 596 
3 160 365 290 
 2 520 1,150 918 
Interaction 2.5 156 363 291 
 3 44 98 69 
ADG 
Main 
2 870 2,084 1,687 
2.5 364 1,093 886 
3 176 555 449 
 
Interaction 
2 682 1,592 1,306 
 2.5 291 727 602 
 3 120 357 300 
 
 
1Infection Period: Pigs were Vx or Non-Vx against PRRS virus prior to co-infection with 
PRRS and porcine circovirus type 2b (PCV2b) 28 days later.  
2Effect: The effect of SNP across groups vaccinated, or not, against PRRS virus (main) 
versus the effect of SNP interacting with vaccination status (interaction).  
3SNP List: List of SNPs from the genome-wide association analysis with a –log10 p-value 
above 2, 2.5, or 3. 
4ADG, average daily gain. 
5VL, viral load: Calculated as the area under the curve of serum viremia between 0 and 
21 or 0 and 42 days post-infection (dpi) for PRRS VL and PCV2b VL, respectively.  
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Table 5.S4. Significantly enriched gene ontology (GO) terms for genes near single 
nucleotide polymorphisms (SNPs) associated with average daily gain following 
vaccination against porcine reproductive and respiratory syndrome (PRRS) virus.  
 
 
Effect1 SNP List2 GO term 
Fold 
change 
P-value3 
Main 
2 Sensory perception of smell 0.47 2.2E-4 
2.5 Sensory perception of smell < 0.20 9.0E-6 
3 Sensory perception of smell < 0.20 5.0E-4 
Interaction 
2 
Response to stimulus 0.76 3.7E-2 
Regulation of biological process 0.58 1.3E-6 
Biological regulation 0.64 1.3E-5 
G-protein coupled receptor signaling pathway 0.51 4.2E-3 
Sensory perception of smell < 0.20 9.6E-17 
Sensory perception of chemical stimulus 0.28 5.5E-10 
Sensory perception 0.52 1.8E-4 
Neurological system process 0.64 3.2E-3 
System process 0.68 1.3E-2 
Single-multicellular organism process 0.73 3.6E-2 
Multicellular organismal process 0.73 4.7E-2 
2.5 
G-protein coupled receptor signaling pathway 0.24 6.6E-3 
Cell surface receptor signaling pathway 0.46 4.6E-2 
Sensory perception of smell < 0.20 3.9E-5 
Sensory perception of chemical stimulus < 0.20 4.2E-6 
Sensory perception 0.32 4.0E-3 
3 
Secondary metabolic process < 0.20 8.7E-3 
Endocytosis < 0.20 3.3E-2 
Sensory perception of chemical stimulus < 0.20 1.6E-2 
 
 
1Effect: The effect of SNP across groups vaccinated, or not, against PRRS virus (main) 
versus the effect of SNP interacting with vaccination status (interaction).  
2SNP List: List of SNPs from the genome-wide association analysis with a –log10 p-value 
above 2, 2.5, or 3. 
3P-value: Bonferroni corrected p-value.  
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Table 5.S5. Significantly enriched gene ontology (GO) terms for genes near single nucleotide 
polymorphisms (SNPs) associated with porcine reproductive and respiratory syndrome (PRRS) 
viral load following co-infection with PRRS and porcine circovirus type 2b.  
 
Effect1 SNP List2 GO term Fold change P-value3 
Main 
2 -- -- -- 
2.5 -- -- -- 
3 -- -- -- 
Interaction 
2 
Response to stimulus 1.29 2.1E-2 
Cellular protein modification process 0.44 8.2E-4 
2.5 Chromatin organization 3.11 1.9E-2 
3 -- -- -- 
1Effect: The effect of SNP across groups vaccinated, or not, against PRRS virus (main) versus 
the effect of SNP interacting with vaccination status (interaction).  
2SNP List: List of SNPs from the genome-wide association analysis with a –log10 p-value above 
2, 2.5, or 3. 
3P-value: Bonferroni corrected p-value.  
Table 5.S6. Significantly enriched gene ontology (GO) terms for genes near single nucleotide 
polymorphism (SNPs) associated with porcine circovirus type 2b (PCV2b) viral load following 
co-infection with porcine reproductive and respiratory syndrome and PCV2b. 
 
Effect1 SNP List2 GO term 
Fold 
change 
P-value3 
Main 
2 -- -- -- 
2.5 
Response to interferon-gamma 5.27 1.6E-2 
Chromatin organization 2.77 9.0E-3 
3 
Chromatin organization 4.23 4.4E-4 
Primary metabolic process 1.36 4.9E-2 
Interaction 
2 
Regulation of biological process 0.55 2.1E-5 
Biological regulation 0.65 1.7E-3 
Sensory perception of chemical stimulus < 0.20 4.0E-15 
Sensory perception 0.21 1.8E-11 
Neurological system process 0.58 3.6E-3 
System process 0.64 2.2E-2 
Single-multicellular organism process 0.64 3.4E-3 
Multicellular organismal process 0.64 3.1E-3 
2.5 
Transport 1.73 4.6E-2 
Regulation of biological process 0.41 1.1E-2 
G-protein coupled receptor signaling pathway < 0.20 2.4E-2 
3 -- -- -- 
1Effect: The effect of SNP across groups vaccinated, or not, against PRRS virus (main) versus 
the effect of SNP interacting with vaccination status (interaction).  
2SNP List: List of SNPs from the genome-wide association analysis with a –log10 p-value above 
2, 2.5, or 3. 
3P-value: Bonferroni corrected p-value. 
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Table 5.S7. Significantly enriched gene ontology (GO) terms for genes near single 
nucleotide polymorphisms (SNPs) associated with average daily gain following co-
infection with porcine reproductive and respiratory syndrome and porcine circovirus type 
2b.  
 
 
Effect1 SNP List2 GO term 
Fold 
change 
P-value3 
Main 
2 -- -- -- 
2.5 Chromatin organization 2.59 1.3E-3 
3 Chromatin organization 4.20 1.6E-6 
Interaction 
2 
Localization 1.31 3.4E-2 
Cell surface receptor signaling pathway 0.65 1.2E-2 
Sensory perception of smell 0.20 1.3E-10 
Sensory perception of chemical 
stimulus 
0.31 2.1E-9 
Sensory perception 0.41 5.9E-8 
Neurological system process 0.68 2.3E-2 
System process 0.70 1.8E-2 
Single-multicellular organism process 0.68 1.2E-3 
Multicellular organismal process 0.68 1.1E-3 
2.5 
Lipid transport 4.06 1.4E-2 
Chromatin organization 2.62 2.8E-2 
Sensory perception of chemical 
stimulus 
0.38 1.0E-2 
3 -- -- -- 
 
 
1Effect: The effect of SNP across groups vaccinated, or not, against PRRS virus (main) 
versus the effect of SNP interacting with vaccination status (interaction).  
2SNP List: List of SNPs from the genome-wide association analysis with a –log10 p-value 
above 2, 2.5, or 3. 
3P-value: Bonferroni corrected p-value.  
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Table 5.S8. Results of the QTL Test to assess overrepresentation of health-related QTL 
for single nucleotide polymorphisms (SNPs) associated with porcine reproductive and 
respiratory syndrome (PRRS) and porcine circovirus type 2b (PCV2b) viral load (VL). 
  
 
Trait1 SNP List2 
# of SNPs 
above 
threshold 
# of health 
QTL in 
region3 
Total # 
QTL in 
region4 
P-value 
PRRS VL Non-Vx 
2 534 295 1039 3.3E-18 
2.5 164 98 315 2.9E-9 
3 36 14 66 0.26 
PRRS VL Vx 
2 582 353 1432 6.7E-12 
2.5 170 122 473 4.2E-6 
3 50 78 262 7.9E-7 
PCV2b VL Non-Vx 
2 723 432 1887 1.7E-9 
2.5 232 207 856 5.2E-7 
3 66 77 304 4.0E-4 
PCV2b VL Vx 
2 566 349 1694 6.0E-4 
2.5 178 174 789 6.0E-4 
3 51 67 243 6.7E-5 
 
 
1Trait: Each trait was recorded on pigs vaccinated (Vx) or not (Non-Vx) against PRRS 
virus prior to co-infection with PRRS virus and PCV2b 28 days later.  
2SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
3The total number of health QTL in the genome (after filtering) is 1,732.  
4The total number of QTL in the genome (i.e. across all QTL types after filtering) is 
9,892. 
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Table 5.S9. Results of the QTL Test to assess overrepresentation of growth-related QTL 
for single nucleotide polymorphisms (SNPs) associated with average daily gain following 
porcine reproductive and respiratory syndrome (PRRS) vaccination and co-infection with 
PRRS and porcine circovirus type 2b (PCV2b). 
  
 
Infection 
Period 
Trait1 SNP List2 
# of SNPs 
above 
threshold 
# of 
growth 
QTL in 
region3 
Total # of 
QTL in 
region4 
P-value 
 
Non-Vx 
2 828 71 1456 0.56 
Post 
Vaccination 
2.5 355 33 603 0.30 
3 161 20 267 0.04 
Vx 
2 769 84 1514 0.15 
2.5 295 35 614 0.21 
 3 120 13 220 0.29 
 
Non-Vx 
2 577 62 1352 0.74 
Post 
Co-Infection 
2.5 227 35 785 0.75 
3 119 19 489 0.88 
Vx 
2 978 110 2156 0.37 
2.5 502 62 1196 0.36 
3 285 40 781 0.43 
 
 
1Trait: Each trait was recorded on pigs vaccinated (Vx) or not (Non-Vx) against PRRS 
virus prior to co-infection with PRRS virus and PCV2b 28 days later.  
2SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
3The total number of growth QTL in the genome (after filtering) is 488.  
4The total number of QTL in the genome (i.e. across all QTL types after filtering) is 
9,892. 
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Table 5.S10. Results of the SNP Test to assess overrepresentation of health-related QTL 
for single nucleotide polymorphisms (SNPs) associated with porcine reproductive and 
respiratory syndrome (PRRS) and porcine circovirus type 2b (PCV2b) viral load (VL).  
 
 
Trait1 SNP List2 
# SNPs mapping to 
health QTL in SNP list3 
# SNPs 
in SNP list4 
P-value 
PRRS VL Non-Vx 
2 125 534 0.38 
2.5 40 164 0.34 
3 7 36 0.74 
PRRS VL Vx 
2 205 582 7.0E-12 
2.5 53 170 7.0E-3 
3 22 50 7.0E-4 
PCV2b VL Non-Vx 
2 208 723 1.1E-4 
2.5 67 232 0.02 
3 25 66 4.0E-3 
PCV2b VL Vx 
2 153 566 0.01 
2.5 51 178 0.04 
3 14 51 0.26 
 
 
1Trait: Each trait was recorded on pigs vaccinated (Vx) or not (Non-Vx) against PRRS 
virus prior to co-infection with PRRS virus and PCV2b 28 days later.  
2SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
3The number of unique SNPs mapping to health QTL in the genome is 14,063. 
4The total number of SNPs used for the genome-wide association study was 61,729.  
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Table 5.S11. Results of the SNP Test to assess overrepresentation of growth-related QTL 
for single nucleotide polymorphisms (SNPs) associated with average daily gain following 
porcine reproductive and respiratory syndrome (PRRS) vaccination and co-infection with 
PRRS and porcine circovirus type 2b (PCV2b).  
 
 
 
1Trait: Each trait was recorded on pigs vaccinated (Vx) or not (Non-Vx) against PRRS 
virus prior to co-infection with PRRS virus and PCV2b 28 days later.  
2SNP List: Lists of SNPs from the genome-wide association analysis with a –log10 p-
value above 2, 2.5 or 3.  
3The number of unique SNPs mapping to growth QTL in the genome is 9,294. 
4The total number of SNPs used for the genome-wide association study was 61,729.  
 
 
Infection Period Trait1 SNP List2 
# SNPs mapping to 
growth QTL  in 
SNP list3 
# SNPs 
in SNP list4 
P-value 
Post Vaccination 
Non-Vx 
2 163 828 2.0E-4 
2.5 60 355 0.18 
3 46 161 8.7E-6 
Vx 
2 115 769 0.55 
2.5 43 295 0.62 
3 19 120 0.44 
Post Co-Infection 
Non-Vx 
2 72 577 0.97 
2.5 31 227 0.75 
3 18 119 0.53 
Vx 
2 154 978 0.29 
2.5 65 502 0.92 
3 40 285 0.71 
  
181 
CHAPTER 6. GENOMIC PREDICTION OF HOST RESPONSE TO CO-
INFECTION OF PORCINE REPRODUCTIVE AND RESPIRATORY 
SYNDROME (PRRS) VIRUS WITH PORCINE CIRCOVIRUS TYPE 2B USING 
A PRRS VACCINATED OR PRRS VIRUS-ONLY INFECTED TRAINING 
POPULATION1 
 
 
Abstract 
 
Background 
Porcine reproductive and respiratory syndrome (PRRS) is the most economically 
devastating disease to the swine industry. Co-infection with PRRS and other pathogens is 
common in commercial settings. The primary objectives of this study were to evaluate 
the predictive ability of using a PRRS virus (PRRSV)-only infected training population 
to predict host response to co-infection with PRRSV and porcine circovirus type 2b 
(PCV2b), and to assess the predictive ability of using PRRS vaccination response for 
response to infection with a field isolate of PRRSV. Genomic prediction (GP) accuracies 
were evaluated for the WUR10000125 (WUR) region (WUR Only), a tag single 
nucleotide polymorphism (SNP) for a major quantitative trait locus (QTL) for PRRS, 
versus SNPs across the genome, and SNPs outside of the WUR region.  
 
 
 
                                                        
1 Co-authors: E H Waide,a,b N V L Serão,a M C Niederwerder,c M A Kerrigan,c M 
Schroyen,a C K Tuggle,a J K Lunney,d R R R Rowland,c and J C M Dekkersa 
aDepartment of Animal Science, Iowa State University, Ames, Iowa 
bThe Seeing Eye Inc., Morristown, NJ, 07960 
cCollege of Veterinary Medicine, Kansas State University, Manhattan, Kansas 
dUSDA, ARS, BARC, Beltsville, Maryland 
 
  
182 
Methods 
PRRS viral load (VL) and weight gain (WG) were recorded on pigs from 9 
PRRSV-only infected trials, and PRRS VL, PCV2b VL, and average daily gain (ADG) 
were recorded on pigs from 4 PRRSV/PCV2b co-infection (Co-X) trials. Vaccination VL 
was also recorded on 3 of the 4 Co-X trials, for which half of the pigs were vaccinated 
(Vx) for PRRS prior to co-infection. Training/validation scenarios were: PRRSV-
only/Co-X, Co-X/Co-X, and Co-X/PRRSV-only to assess the predictive ability of: 
response to PRRSV-only infection on response to Co-X; and vaccination response on 
response to infection with a field PRRSV isolate by Co-X or PRRSV-only infection, 
respectively. Analyses were performed using related and unrelated populations. 
 
Results 
When using SNPs within WUR Only for training and validation, PRRS VL had 
moderate predictive ability (ranging from 0.23 to 0.57) for vaccination VL, PRRS VL, 
and PCV2b VL and WG had moderate predictive ability (ranging from -0.27 to 0.40) for 
ADG of Vx pigs Post Vx. Vaccination VL had low to moderate predictive ability for 
PRRS VL following infection with a field isolate by PRRSV-only infection or co-
infection using WUR Only, ranging from 0.14 to 0.46. Except for PRRS VL of Vx pigs 
and ADG, WUR Only yielded higher GP accuracy than using SNPs across the genome 
and for most traits, using SNPs across the genome had superior predictive ability to using 
SNPs outside of the WUR region. 
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Conclusions 
A PRRSV-only infected training population can be used to predict host response 
to PRRSV/PCV2b co-infection in an unrelated validation population and vaccination 
response can be used as an indicator of response to infection with a field isolate of 
PRRSV by PRRSV-only or PRRSV/PCV2b co-infection for related populations. In 
general, using SNPs within WUR Only and SNPs across the genome had the highest GP 
accuracy for VL and ADG, respectively.  
 
Background 
 
Porcine reproductive and respiratory syndrome (PRRS) is the most economically 
devastating disease to the swine industry [1]. PRRS affects pigs during all stages of 
production, causing reproductive failure in gestating females and respiratory signs and 
symptoms in growing pigs [2]. A difficulty of selecting pigs for improved host response 
to PRRS is that breeding animals must maintain a high-health status, meaning that 
disease phenotypes are not available on these animals. Therefore, the ability to identify 
selection candidates expected to have improved host response to PRRS virus (PRRSV)-
infection using only genotypic information presents an attractive solution to this 
challenge. Using genomic selection, the effects of SNPs across the genome can be 
estimated from a training population to predict the genomic merit of individuals within a 
validation population [3]. Pigs from the PRRS Host Genetics Consortium (PHGC) trials, 
for which groups of pigs were experimentally infected with PRRSV [4], have both high 
density single nucleotide polymorphism (SNP) genotypes and disease phenotypes and 
can therefore be used as a training population for such GP studies.  
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Results from a previous study showed that PRRS viral load (VL) and weight gain 
(WG) recorded on pigs from three related PHGC trials could be used to predict PRRS 
VL in an unrelated PHGC trial with low to moderate prediction accuracy [5]. Results 
from a follow-up study showed that using only SNPs located within the 1-megabase 
(Mb) region harboring a major quantitative trait locus (QTL) for host response to PRRS, 
resulted in higher prediction accuracy compared to training and validating on SNPs 
across the genome [6]. The SNP WUR10000125 (WUR) is used as a tag SNP for this 
QTL [7]. Results from an additional study conducted by Waide [8] showed that, using 
only SNPs within the 1-Mb WUR region, PHGC trials infected with one isolate of 
PRRSV could be used to predict host response to infection with a different isolate of 
PRRSV with low to moderate predictive accuracy.  
Taken together, results from these studies show that PRRS VL and WG recorded 
on individuals from a PRRSV-only infected training population can be used to predict 
PRRS VL and WG in a PRRSV-only infected validation population from independent 
genetic sources infected with the same, or different isolates of PRRSV. It is unclear, 
however, whether a PRRSV-infected training population can be used to predict host 
response to co-infection with PRRS and another pathogen. This is of interest because 
PRRSV is known to suppress the immune response, making pigs more susceptible to 
secondary infections [9]. Co-infection with PRRSV and porcine circovirus type 2b 
(PCV2b) is common (when pigs are not previously vaccinated for PCV2b) and increases 
the severity of clinical signs and symptoms of infection, compared to infection with 
PRRSV alone [10,11]. Secondly, it is also unclear whether host response to PRRS 
vaccination can be used to predict host response to infection with a field isolate of 
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PRRSV. Since breeding animals may be vaccinated for PRRS, using vaccination 
response as an indicator of host response to infection with a field isolate would be 
another attractive approach of identifying breeding animals with improved host response 
to PRRSV-infection.  
Therefore, the primary objectives of this study were to assess the predictive 
ability of a PRRSV-only infected training population for host response to PRRSV/PCV2b 
co-infection in an unrelated validation population and to assess the predictive ability of 
host response to vaccination with a PRRS modified live virus (MLV) vaccine for host 
response to infection with a field isolate of PRRSV. A secondary objective was to 
evaluate the predictive ability of training and validating on: SNPs across the genome, 
SNPs within the 1-Mb WUR region, or SNPs outside of the WUR region.  
 
Materials & Methods 
 
All experimental protocols for the animals used in this study were approved by the 
Kansas State University (KSU) Animal Care and Use Committee. 
 
Animals 
PRRSV-only infection trials 
PHGC trials 1-8, 10-12, 14, and 15 were used as the PRRSV-only infection trials. 
Detailed descriptions of PHGC trials 1-8 [4], 9 [12], and 10-15 [13] were previously 
published. Descriptive statistics of pigs from trials 1-8, 10-12, 14, and 15 used for the 
current study were presented by Waide [8]. Pigs from trials 9 and 13 were excluded 
because pigs from trial 9 were part of a divergent selection experiment for feed efficiency 
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[12] and trial 13 pigs had especially high variability in viremia profiles between 
individuals [13]. Pigs from trials 1-9, 15 and 10-14 were experimentally infected with the 
NVSL 97-7985 (NVSL) and KS2006-72109 (KS06) PRRSV isolates, respectively.   
For each PRRSV-only infection trial, groups of approximately 200 piglets were 
shipped to a bio-secure facility at KSU at weaning age and given approximately 1 week 
to acclimate to their surroundings, after which they were inoculated intranasally and 
intramuscularly with 105 TCID50 of NVSL (trials 1-9 and 15) and 105 TCID50 of KS06 
(trials 10-14) [13]. Compared to NVSL, KS06 has shown to be a less virulent PRRSV 
strain, resulting in lower peak viremia, lower PRRS VL, and faster growth post-infection 
[13]. Following experimental infection, pigs were followed for 42 days, during which 
time repeated body weights (at 0, 7, 14, 21, 28, 35, and 42 days post-infection (dpi)) and 
viremia (at 0, 4, 7, 11, 14, 21, 28, 35, and 42 dpi) measurements were collected on each 
pig.  All pigs were euthanized at 42 dpi, except for pigs from trials 7 and 8, which were 
euthanized at 35 dpi, due to limits on the availability of the facility.  
 
PRRSV/PCV2b co-infection trials 
PHGC trials 16, 19, 20, and 22 were used as the PRRSV/PCV2b co-infection trials. 
Trials 16, 20, and 22 had identical experimental designs, which has been described in 
detail for trials 16 and 20 by Dunkelberger et al. [14]. Briefly, piglets were pre-selected 
for WUR genotype at the genetic supplier (approximately half for AA and half for AB) 
prior to shipment to KSU at weaning. Pigs with the BB genotype were not used since the 
B allele has shown to be completely dominant to A, but has a low frequency within 
commercial populations [7]. Upon arrival at KSU, pigs were randomly sorted into one of 
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2 rooms and all pigs within one room received a 2 mL dose of a commercial PRRS MLV 
vaccine (Ingelvac PRRS; Boehringer Ingelheim Vetmedica Inc., St. Joseph, MO). Four 
weeks later, both vaccinated (Vx) and non-vaccinated (Non-Vx) pigs were co-infected 
with field strains of PRRSV and PCV2b and followed for 42 days. Repeated body weight 
measurements were collected on all pigs post vaccination (Post Vx) and post co-infection 
(Post Co-X) at -28, -21, -14, and -7 and 0, 7, 14, 21, 28, 35, and 42 dpi, respectively. 
Serum samples were collected on each vaccinated (Vx) pig Post Vx at -28, -24, -21, -17, -
14, and -7 dpi and on all pigs Post Co-X at 0, 4, 7, 11, 14, 21, 28, 35, and 42 dpi.  
A detailed description of trial 19 is in Niederwerder et al. [15]. In contrast to trials 16, 
20, and 22, trial 19 consisted of only 100 pigs, which were not pre-selected for WUR 
genotype or vaccinated for PRRS, were given 2 weeks to acclimate prior to experimental 
co-infection, and the co-infection period was extended until 70 dpi, rather than 42 dpi. 
Weekly body weights were recorded on each pig from -14 to 70 dpi and repeated serum 
samples were collected at 0, 4, 7, 11, 14, 21, 35, 42, 56, and 70 dpi. 
 
Traits 
PRRSV-only infection trials  
For trials 1-15, body weight measurements were used to calculate WG as the 
difference in body weight between 42 and 0 dpi (or 35 and 0 dpi for trials 7 and 8). PRRS 
VL was calculated as the area under the curve (AUC) of serum viremia from 0 to 21 dpi, 
according to Boddicker et al. [7].  
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PRRSV/PCV2b confection trials 
Descriptive statisitcs for pigs from each PHGC co-infection trial (16, 19, 20, and 22) 
are presented in Table 6.1. For trials 16, 20, and 22, average daily gain (ADG) was 
calculated as the regression of body weight on dpi from -28 to 0 and 0 to 42 dpi for the 
Post Vx and Post Co-X periods, respectively, as described in Dunkelberger et al. [14]. 
ADG Post Co-X for trial 19 was calculated as the regression of body weight on dpi from 
0 to 70 dpi.  
For trials 16, 20, and 22, vaccination VL was calculated as the AUC of serum vaccine 
viremia from -28 to 0 dpi. For trials 16, 19, 20, and 22, PRRS and PCV2b VL were 
calculated as the AUC of serum PRRS viremia from 0 to 21 dpi and of PCV2b viremia 
from 0 to 42 dpi, respectively, according to Dunkelberger et al. [14]. 
 
Genotype data 
PRRSV-only infection trials 
Ear tissue was used to genotype pigs from trials 1-15 using the Illumina Porcine 
SNP60 BeadChip (San Diego, CA) by GeneSeek Inc. (Lincoln, NE). Quality control of 
genotype data for these trials has been previously described [16]. In summary, 52, 386 
SNPs remained post quality control, with an overall genotyping rate of 99.2%. 
 
PRRSV/PCV2b co-infection trials 
Ear tissue was also used to genotype pigs from trials 16, 19, 20, and 22 but using 
the GeneSeek-Neogen PorcineSNP80 BeadChip (GeneSeek, Igenity; Lincoln, NE). 
Separate genotype files were constructed for each co-infection trial to be used as separate 
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validation populations and a combined genotype file was constructed for trials 16, 20, 
and 22 when vaccination VL was used for training.  
Quality control was performed separately by genotype file according to the following 
steps: 1) genotypes with a gene call score lower than 0.7 were set to missing; 2) SNPs 
with at least 15% missing genotypes were removed; 3) individuals missing > 25% of 
SNP genotypes were removed; 4) fixed SNPs were removed; and 5) missing genotypes 
were replaced with the average genotype (on a -10/0/10 scale) by SNP. The number of 
individuals and SNPs remaining post quality control for each genotype file are presented 
in Table 6.2.  
 
Training and validation scenarios  
All training and validation scenarios are presented in Table 6.3 and each scenario 
was conducted using the following SNP subsets: SNPs across the genome (Whole 
Genome), SNPs within the 1-Mb region containing WUR (WUR Only), and SNPs 
across the genome except those located within 2.5 Mb on either side of WUR (Rest). The 
5 Mb region surrounding WUR was excluded in order to remove the effect of the major 
QTL for PRRS and any nearby SNPs in linkage disequilibrium with WUR.  
 
Scenario 1 
The motivation of the first training and validation scenario was to assess the 
predictive ability of using a PRRSV-only infected training population to predict host 
response to PRRSV/PCV2b co-infection in an unrelated validation population. For this 
scenario, PRRS VL or WG recorded on pigs from trials infected with the NVSL PRRSV 
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isolate (trials 4-8 and 15), KS06 isolate (trials 10, 12, and 14), or all trials (4-8, 10, 12, 
15), was used to predict vaccination VL, PRRS VL, PCV2b VL, or ADG for pigs from 
the PRRSV/PCV2b co-infection trials. Co-infection trials (16, 19, 20, and 22) were 
validated on separately, due to differences in experimental design between trials 16/20/22 
and 19 and to assess the variability of GP across trials.  
 
Scenario 2 
The motivation of this training and validation scenario was to assess the 
predictive ability of using vaccination response to predict host response to infection with 
a field isolate of PRRSV in an unrelated validation population. For this scenario, PRRS 
vaccination VL, recorded on individuals from trials 16, 20, and 22 was used to predict 
PRRS VL for pigs from trials infected with the NVSL PRRSV isolate (trials 4-8 and 15), 
KS06 isolate (trials 10, 12, and 14), or all trials (4-8, 10, 12, 15).  
 
Scenario 3 
The third training and validation scenario was designed to assess the predictive 
ability of vaccination response to predict host response to infection with a field isolate of 
PRRSV in a related validation population. For this scenario, vaccination VL recorded on 
individuals from trials 16 and 20 was used to predict PRRS VL recorded on pigs from 
trials infected with the NVSL PRRSV isolate (trials 1-3), KS06 isolate (trials 11), or all 
trials (1-3 and 11).  
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Scenario 4 
This training and validation scenario was used to assess the predictive ability of 
using vaccination response to predict host response to PRRSV/PCV2b co-infection using 
trials from different genetic sources for training and validation. For this scenario, PRRS 
vaccination VL, recorded on individuals from trials 16, 20, and 22 was used to predict 
PRRS VL recorded on Non-Vx pigs from these same trials. Pigs from trials 19 and 22 
originated from a different genetic source than pigs from trials 16 and 20.  
 
Scenario 5 
A final training and validation scenario was used to assess the predictive ability of 
PRRS vaccination response for host response to PRRSV/PCV2b co-infection using a 
related validation population. For this scenario, vaccination VL, recorded on individuals 
from trials 16 and 20 was used to predict PRRS VL recorded on Non-Vx pigs for these 
same trials, since pigs from trials 16 and 20 originated from the same genetic source.  
 
Genomic prediction analyses 
PRRSV-only infection trials used for training 
When the PRRSV-only infection trials were used to predict performance for the 
PRRSV/PCV2b co-infection trials (i.e. Scenario 1), the BayesB GP method was used to 
estimate the effects of 39,880 SNPs shared between the different SNP platforms used for 
the training and validation datasets. Analyses were performed using the following model:  
𝐲i = 𝐗𝐛 + ∑𝐳ij𝛂j𝛅j
k
j=1
+ 𝛆i 
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where y = phenotype for individual i; X = incidence matrix relating phenotypes to fixed 
effects; b = corresponding vector of solutions; z = SNP genotype (coded as -10/0/10) for 
the ith individual for SNP j through SNP k; α = allele substitution effect of the jth SNP; δ 
= indicator variable for whether or not the jth SNP was fitted in the model for a given 
iteration; and ε = vector of residuals. The proportion of SNPs fitted in the model that 
were assumed to have no effect on the trait (π) was set to 0.99 for the Whole Genome and 
Rest SNP subsets, and 0 for the WUR Only subset 
Fixed effects included: Isolate  (NVSL or KS06); ExpPar (combined effect of 
parity (first, second, or third) of dam and trial); Sex; WUR (WUR SNP genotype: AA, 
AB, or BB); Age (partial regression coefficient for the covariate of age at infection (0 
dpi)); Wt (partial regression coefficient for the covariate weight at infection (0 dpi)); and 
ExpPen (pen nested within trial). The fixed effect of WUR genotype was fitted in the 
model for training using SNPs included in the Rest subset, but not when using the Whole 
Genome or WUR Only subsets.  
 
PRRSV/PCV2b co-infection trials used for training 
When the co-infection trials were used to predict host response to infection with a 
field isolate of PRRSV (i.e. Scenarios 2-5) the BayesB GP method with π = 0.9953 was 
used to estimate the effects of 54, 239 SNPs for the Whole Genome and Rest SNP 
subsets and π = 0 for the WUR Only subset.  
Fixed effects included: Trial; WUR (WUR genotype: AA or AB); WtVx (partial 
regression coefficient for the covariate weight at -28 dpi); VxAge (partial regression 
coefficient for the covariate age at -28 dpi); PCV2_0 (partial regression coefficient for 
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the covariate level of PCV2b viremia at 0 dpi); and ExpPen (pen nested within trial).  As 
with the PRRSV-only infection trials, the fixed effect of WUR genotype was fitted in the 
model for training using SNPs included in the Rest subset, but not when using the Whole 
Genome or WUR Only subsets. 
All analyses were performed using GenSel 4.0 [17].  
 
Pre-adjustment of validation phenotypes 
 Pre-adjusted phenotypes (Y*) were calculated for each validation population for 
each trait to evaluate the accuracy of GP as the correlation between genomic estimated 
breeding value (GEBV) and Y*, divided by the square root of heritability for the 
validation trait. Heritability estimates used for each trait are presented in Dunkelberger et 
al. [14].  
Pre-adjusted phenotypes for validation were calculated for each individual for 
each trait as the sum of random effects for the Rest subset and as the sum of random 
effects + the effect of WUR for the Whole Genome and WUR Only subsets. Estimates 
were obtained using the models described below.  
 
PRRSV-only infection trials used for validation 
Fixed effects were the same as those described for GP analyses of Scenario 1, 
except that the overall mean was fitted as an additional fixed effect and “ExpPen” was 
fitted as fixed, rather than random. Additional random effects included “Animal”  = 
random animal genetic effect with a variance-covariance structure proportional to the 
pedigree-based numerator relationship matrix (A) with the assumption ~ N(0, 𝐀σα) and 
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“Litter” = random litter effect. The numerator relationship matrix was constructed using a 
1-generation pedigree with records on 3,688 individuals. Animal, Litter, and ExpPen 
were fitted as random effects to account for genetic, common environmental, and random 
environmental effects, respectively. PRRS VL for the NVSL trials (1-8 and 15) and KS06 
trials (10-12 and 14) were analyzed using the same model but without “Isolate” fitted as a 
fixed effect.  
 
Co-infection trials used for validation 
Vaccination VL, PRRS VL, PCV2b VL, and ADG were analyzed separately by 
vaccination group (Vx or Non-Vx), co-infection period (Post Vx or Post Co-X), and trial 
(16, 19, 20, or 22). Fixed effects used were the same as those described for GP analyses 
of Scenarios 2-5, except that the overall mean was fitted as an additional fixed effect, the 
effect of “Trial” was not included as a fixed effect, and “Pen” was fitted as random, 
rather than fixed. Other random effects fitted included: “Animal” = random animal 
genetic effect with a variance-covariance structure proportional to the genomic 
relationship matrix based on SNP genotypes with the assumption ~ N(0, 𝐆σg
2) and 
“Litter” = random litter effect. Animal, Litter, and Pen were fitted as random effects to 
account for genetic, common environmental, and random environmental effects, 
respectively.  
The same model was used when PRRS VL recorded on Non-Vx pigs from trials 
16, 20, and 22 combined were used for validation (i.e. Scenario 4), except that the effect 
of “Trial” was retained as a fixed effect and “Pen(Trial)” was fitted in place of “Pen”. 
  
195 
The interaction of “Trial” with each fixed effect was also fitted and removed if not 
significant (P > 0.10).  
Animal genetic effects were accounted for using a genomic relationship matrix 
(GRM). Separate GRMs were constructed for trials 16, 19, 20, and 22 and a combined 
GRM was constructed for joint analysis of trials 16, 20, and 22. Because trial 16 
consisted of 20 non-genotyped pigs, GRMs containing pigs from trial 16 were 
constructed using an H matrix [18]. GRMs for trials 19, 20, and 22 were constructed 
according to the method described by VanRaden [19] using SNP genotypes coded as 
0/1/2 which were then centered and scaled.  
All analyses were performed using ASReml 4.0 [20]. 
 
Results 
 
Scenario 1 
Vaccination viral load and PRRS viral load 
Results of GP analyses training on PRRS VL of PRRSV-only infected pigs and 
validating on vaccination VL, PRRS VL of Vx pigs, or PRRS VL of Non-Vx pigs from 
the PRRSV/PCV2b co-infection trials are presented in Fig. 6.1. In the following, 
prediction accuracy is the average prediction accuracy across trials, where each trial (16, 
19, 20, or 22) was validated on separately.  
Of the PRRS VL traits used for validation, the maximum prediction accuracy 
(ignoring SNP subset used) was obtained for PRRS VL of Non-Vx pigs, followed by 
vaccination VL, then PRRS VL of Vx pigs when training on all PRRSV-only infected 
trials (Fig. 6.1 Panel A). The same pattern was observed when training on the NVSL 
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trials only (Fig. 6.1 Panel B). Similar to training on all trials or on only the NVSL trials, 
the maximum prediction accuracy was obtained for PRRS VL of Non-Vx pigs when 
training on only the KS06 trials. However, the next highest prediction accuracy was 
obtained when validating on PRRS VL of Vx pigs, followed by vaccination VL (Fig. 6.1 
Panel C).  
Prediction accuracies obtained using the Whole Genome versus Rest or WUR 
Only subsets for a given trait were comparable whether training on all PRRSV-only 
trials, or only on NVSL or KS06 trials. Regardless of trials used for training, using the 
WUR Only subset resulted in the highest prediction accuracy for vaccination VL and 
PRRS VL of Non-Vx pigs (Fig. 6.1). Using the WUR Only subset also resulted in higher 
prediction accuracy (0.24) compared to the Whole Genome (0.20) or Rest (0.15) subsets 
when validating on PRRS VL of Vx pigs for the NVSL trials (Fig. 6.1 Panel B). 
However, using the Whole Genome subset resulted in the highest prediction accuracy for 
PRRS VL of Vx pigs when training on all trials (0.28; Fig. 6.1 Panel A) or on only the 
KS06 trials (0.31; Fig 6.1. Panel C). Regardless of the PRRS VL trait or trials used for 
training, prediction accuracies obtained using the Whole Genome subset were always 
superior to those obtained using the Rest subset. Prediction accuracies obtained when 
training and validating on SNPs within the Rest subset was low for vaccination VL and 
PRRS VL of Non-Vx pigs (-0.07 to 0.07) and low to moderate for PRRS VL of Vx pigs 
(0.15 to 0.19).  
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PCV2b viral load 
Prediction accuracies obtained when training on PRRS VL of the PRRSV-only 
infection trials and validating on PCV2b VL for the PRRSV/PCV2b co-infection trials 
ranged from -0.31 to 0.07 when validating on Non-Vx pigs and from -0.35 to 0.57 when 
validating on Vx pigs (Fig 6.1.).  
Within trait, prediction accuracies obtained using the Whole Genome versus Rest 
or the WUR Only SNP subsets were comparable, whether training on all trials, or on only 
the NVSL or KS06 trials (Fig 6.1.). The exception was training and validating using 
SNPs within the WUR Only subset for PCV2b VL of Non-Vx pigs: whereas training and 
validating using the WUR Only subset had low predictive ability when training on all 
trials (0.06; Fig. 6.1 Panel A) or the NVSL trials only (0.07; Fig. 6.1 Panel B), a 
negative prediction accuracy (-0.11; Fig. 6.1 Panel C) was obtained when training on the 
KS06 trials only.  
Whether training on all trials, or on only the NVSL or KS06 trials, prediction 
accuracies of PCV2b VL of Vx pigs was highest when using the WUR Only subset (0.44 
to 0.57) (Fig. 6.1). Using the Whole Genome subset resulted in positive prediction 
accuracies (0.22 to 0.26), whereas using the Rest subset yielded consistently negative 
prediction accuracies (-0.30 to -0.35). In general, regardless of SNP subset used, negative 
prediction accuracies were obtained when training on all trials (-0.31 to 0.06), on the 
NVSL trials only (-0.21 to 0.07), or KS06 trials only (-0.18 to -0.11) to predict PCV2b 
VL of Non-Vx pigs. An exception was training on all trials and on only the NVSL trials 
using the WUR Only subset, which resulted in small positive prediction accuracies of 
0.06 and 0.07, respectively (Fig 6.1. Panels A and B).  
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Average daily gain 
Results of GP analyses when training on WG for the PRRSV-only infection trials 
and validating on ADG for the PRRSV/PCV2b co-infected pigs Post Vx or Post Co-X are 
presented in Fig. 6.2. Of the 4 ADG traits used for validation, the highest prediction 
accuracy (ignoring SNP subset used) was obtained for ADG of Vx pigs Post Vx (-0.27 to 
0.48) (Fig 6.2.). Regardless of trials used for training or the SNP subset used, prediction 
accuracy validating on ADG of Non-Vx pigs Post Vx, ADG of Non-Vx pigs Post Co-X, 
or ADG of Vx pigs Post Co-X resulted in low prediction accuracies, ranging from -0.04 
to 0.10, -0.02 to 0.13, and -0.11 to 0.15, respectively.  
Within trait, prediction accuracies obtained using the Whole Genome versus Rest 
or WUR Only SNP subsets for the PRRSV-only infection trials mirrored those obtained 
when training on the NVSL trials only, but not when using the KS06 trials only (Fig 6.2.) 
Using the Whole Genome SNP subset resulted in the highest prediction accuracy for 
ADG of Vx pigs Post Vx when training on all trials (0.46; Fig. 6.2 Panel A) or on only 
the NVSL trials (0.48; Fig. 6.2 Panel B) but the Rest subset yielded the highest 
prediction accuracy using the KS06 trials only (0.04; Fig. 6.2 Panel C). For the other 3 
ADG traits, using the Rest subset resulted in higher prediction accuracy than the Whole 
Genome or WUR Only subsets, except for ADG of Non-Vx pigs Post Vx or ADG of 
Non-Vx pigs Post Co-X when training on the KS06 trials only (Fig. 6.2 Panel C).  
 
Scenario 2   
Results of GP analyses using vaccination VL recorded on Vx pigs from trials 16, 
20, and 22 to predict PRRS VL recorded on pigs from the PRRSV-only infection trials 
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are presented in Fig. 6.3. Results show that, when using pigs from different genetic 
sources for training and validation (i.e. validating on trials 4-8, 10, 12, 14, 15), the 
highest prediction accuracy was obtained using the WUR Only subset, whether validating 
on all trials, or on only the NVSL trials or KS06 trials. Prediction accuracies obtained 
when training and validating on the WUR Only subset was highest when validating on 
the NVSL trials only (0.24), followed by all trials (0.21), and on the KS06 trials only 
(0.14). Small positive prediction accuracies were obtained when training and validating 
on the Whole Genome subset for all trials (0.01) or on the NVSL trials only (0.02), but a 
small, negative prediction accuracy was obtained when validating on the KS06 trials only 
(-0.004). Training and validating on SNPs within the Rest subset resulted in negative 
prediction accuracies (-0.03 to -0.06), regardless of trials used for validation (Fig. 6.3).  
 
Scenario 3 
Upon repeating the above analysis using pigs that originated from the same 
genetic source for training and validation (i.e. validating on trials 1-3 and 11), prediction 
accuracies increased for every scenario (Fig. 6.3). Similar to results obtained using pigs 
from different genetic sources for training and validation (i.e. Scenario 2), the highest 
prediction accuracy was obtained using the WUR Only subset, regardless of validating on 
all trials, or on only the NVSL trials or KS06 trials. For this SNP subset, prediction 
accuracy was highest when validating on the NVSL trials only (0.33), followed by all 
trials (0.31), and on the KS06 trials only (0.21). Compared to training and validating on 
trials from different genetic sources, using the WUR Only subset increased prediction 
accuracy by 0.10, 0.09, and 0.07 when validating on all trials, on the NVSL trials only, or 
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on the KS06 trials only, respectively. Prediction accuracies increased by 0.09, 0.11, and 
0.002 using the Whole Genome subset and by 0.09, 0.10, and 0.03 using the Rest subset 
when validating on all trials, on the NVSL trials only, and on the KS06 trials only, 
respectively.  
 
Scenario 4 
Results of GP analyses using vaccination VL recorded on Vx pigs from trials 16, 
20, and 22 to predict PRRS VL of Non-Vx pigs from these same trials are presented in 
Fig. 6.4. Compared to results obtained for Scenario 2, prediction accuracy using the 
Whole SNP subset increased by 0.27 (versus the maximum prediction accuracy obtained 
whether validating on the NVSL trials only, KS06 trials only, or on all trials), by 0.30 for 
the Rest SNP subset, and by 0.12 for the WUR Only SNP subset. Compared to Scenario 
3, prediction accuracy using the Whole Genome SNP subset increased by 0.16, by 0.20 
for Rest, and by 0.03 for the WUR Only SNP subset. Prediction accuracies obtained for 
Scenario 4 were 0.36, 0.29, and 0.27 when using the WUR Only, Whole Genome, and 
Rest SNP subsets, respectively (Fig. 6.4).  
 
Scenario 5 
As with Scenario 4, when using only trials that originated from the same genetic 
source for both training and validation (i.e. trials 16 and 20), the WUR Only SNP subset 
resulted in the highest prediction accuracy, followed by the Whole Genome and Rest 
SNP subsets (Fig. 6.4). Compared to results obtained for Scenario 4, prediction 
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accuracies increased by 0.02, 0.01, and 0.09 using the Whole Genome, Rest, and WUR 
Only SNP subsets, respectively (Fig. 6.4). 
 
Discussion 
 
This is the first study to assess the predictive ability of a PRRSV-only infected 
training population for host response to co-infection with PRRSV and another pathogen. 
This is also the first study to evaluate the predictive ability of training on PRRS 
vaccination response to predict host response to infection with a field isolate of PRRSV. 
Results show that a PRRSV-only infected training population has moderate predictive 
ability for host response to co-infection with PRRSV and PCV2b in an unrelated 
validation population for vaccination VL, PRRS VL, and PCV2b VL of Vx pigs, but low 
predictive ability for ADG Post Vx or Post Co-X, except for ADG of Vx pigs Post Vx. 
Results also show that vaccination VL had moderate predictive ability for host response 
to infection with a field isolate following PRRSV/PCV2b co-infection and low predictive 
ability following PRRSV-only infection for related training and validation populations. 
Using SNPs within the 1-Mb WUR region yielded higher prediction accuracy than using 
SNPs across the genome or SNPs other than those in the WUR region for all VL traits, 
except PRRS VL of Vx pigs. Training and validating on SNPs within the Whole Genome 
or Rest subsets yielded higher prediction accuracy than the WUR Only subset for the 
ADG traits.  
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Prediction of vaccination/co-infection viral load using PRRS virus-only infection 
data  
 Boddicker et al. [5] were the first to investigate whether training on host response 
to PRRSV-infection can be used to predict host response to PRRSV-infection in an 
unrelated, validation population. Pigs from PHGC trials 1-3, all of which originated from 
the same genetic source, were used as the training population and pigs from PHGC trials 
4 and 5, which originated from different genetic sources than training, were used as 
separate validation populations. Results of GP analyses showed low to moderate 
predictive ability for PRRS VL when training and validating on SNPs across the genome 
[5]. However, limiting the number of SNPs used for training and validation to only those 
within the 1-Mb WUR region resulted in higher prediction accuracy compared to using 
SNPs across the genome for some cases. For example, using only SNPs within the 1-Mb 
WUR region yielded higher prediction accuracy than the whole genome for PRRS VL 
when trial 4 was used as the validation population, but the opposite result was obtained 
when trial 5 was used as the validation population [5].  
Results of the current study also show that training on a PRRSV-only infected 
training population had low to moderate predictive ability for vaccination VL, PRRS VL, 
and PCV2b VL of Vx pigs in a PRRSV/PCV2b co-infected population, depending on 
SNP subset used. Consistent with results reported by Boddicker et al. [5], training and 
validating on SNPs within the 1-Mb WUR region resulted in higher prediction accuracy 
compared to using SNPs across the genome for some cases. For example, using SNPs 
within the 1-Mb WUR region resulted in higher prediction accuracy than using the Whole 
Genome subset for vaccination VL and PRRS VL of Non-Vx pigs, regardless of training 
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on all trials, or on only the NVSL trials or KS06 trials. For a separate study, results 
reported by Serão et al. [21] also showed that training and validating on two major QTL 
associated with PRRS antibody response resulted in higher prediction accuracy compared 
to using SNPs across the genome [21]. However, our result conflicts with results reported 
by Waide et al. [8] who showed that, when training on PRRS VL of the NVSL trials to 
predict PRRS VL in the KS06 trials (and visa versa), using SNPs across the genome had 
superior predictive ability compared to using SNPs with the WUR region. Some possible 
explanations for the discrepancy between this result and results reported by Boddicker et 
al. [5] include: different trials used for training and/or validation, different models used to 
analyze the data, and different methods of calculating adjusted phenotypes.  
The finding that using SNPs within the WUR region resulted in superior 
prediction accuracy compared to using SNPs across the genome for vaccination VL and 
PRRS VL of Non-Vx pigs, but not PRRS VL of Vx pigs, is also consistent with results 
regarding the effect of WUR on these traits from a previous study for analyses of these 
same data. Results reported by Dunkelberger et al. [14] showed that numerically, the 
effect of WUR genotype on vaccination VL and PRRS VL of Non-Vx pigs (both 
indicative of primary PRRSV exposure) was greater than the effect of WUR on PRRS VL 
of Vx pigs (indicative of secondary PRRSV exposure). Results from the current study 
confirm these results because they indicate that training and validating on SNPs within 
the WUR Only subset generally resulted in the highest prediction accuracy for the 2 
primary exposure traits, followed by the secondary exposure trait. For PRRS VL of Vx 
pigs, the finding that training and validating on SNPs across the genome had higher 
prediction accuracy than the WUR Only subset suggests that other regions throughout the 
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genome are associated with secondary response to PRRSV-infection. Since no genome-
wise significant SNPs were associated with PRRS VL of Vx pigs for a previous study of 
these same data, these other regions are likely a host of SNPs with small effects. 
Therefore, training and validating on SNPs across the genome, which includes these 
SNPs, as well as the WUR SNP, may be the optimal approach for predicting host 
response to PRRSV-infection following secondary PRRSV exposure.   
Apart from having predictive ability for PRRS VL traits in a PRRSV/PCV2b co-
infected population, results from the current study also show that a PRRSV-only infected 
training population had positive, moderate predictive ability for PCV2b VL of Vx pigs, 
but negative predictive ability for PCV2b VL of Non-Vx pigs, whether training on all 
trials, or on only the NVSL trials or KS06 trials. These results are also consistent with 
those reported by Dunkelberger et al. [14] for analyses of these same data, which showed 
that the effect of WUR genotype on PCV2b VL was significant for PCV2b VL recorded 
on Vx, but not Non-Vx pigs. For PCV2b VL of Vx pigs, results showed that training and 
validating on SNPs within the WUR region resulted in the highest prediction accuracy, 
followed by using SNPs across the genome. However, using the Rest SNP subset resulted 
in consistently negative prediction accuracy. These results suggest that training and 
validating on SNPs within the WUR region is superior to using SNPs across the genome 
since a subset of SNPs resulted in negative prediction accuracy, thereby reducing the 
overall predictive ability of using SNPs throughout the genome. Of all SNP subsets used, 
the WUR Only subset also had the best predictive ability for PCV2b VL of Non-Vx pigs, 
but even so, prediction accuracies were lowly negative to lowly positive.  
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Taken together, results from these analyses show that it is possible to predict host 
response to PRRSV/PCV2b co-infection using PRRS VL recorded on individuals from 
an unrelated, PRRSV-only infected training population. Furthermore, of the PRRSV-only 
infection trials used for training, only pigs from trial 12 (infected with the KS06 isolate) 
were comprised of the same breed as those in the validation populations, but originated 
from different genetic sources. Other studies have shown that GP across breeds had low 
to no predictive ability [22,23]. However, results from this study showed low to moderate 
predictive ability when using different breeds for training and validation. This result 
agrees with results reported by Boddicker et al. [5] and Waide [8] who also showed that 
across-breed prediction had low to moderate predictive ability, depending on trait. 
Therefore, results from this study indicate that the PHGC trials have potential to be used 
as a multi-breed reference population to predict viral load traits following 
PRRSV/PCV2b co-infection in other unrelated, validation populations. 
  
Prediction of vaccination/co-infection average daily gain using PRRS virus-only 
infection data  
In general, results show that training on WG for pigs from the PRRSV-only 
infected trials had low predictive ability for ADG recorded on pigs from the 
PRRSV/PCV2b co-infected trials. The exception was for ADG of Vx pigs recorded 
during the vaccination period. Of all ADG traits used for validation, this trait was most 
similar to the trait recorded on the training populations. For example, both of these traits 
(WG and ADG of Vx pigs Post Vx) were recorded on pigs challenged with PRRSV-only, 
not co-infected with PRRSV and PCV2b. Both traits were also recorded on pigs exposed 
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to PRRSV for the first time.  Contrary to results for the VL traits, the Whole Genome 
subset generally resulted in higher prediction accuracy than the WUR Only subset for 
ADG of Vx pigs Post Vx. 
Results of GP analyses for the other ADG traits also showed that training and 
validating on either the Whole Genome or Rest SNP subsets yielded consistently higher 
prediction accuracy than training and validating on SNPs within the WUR Only subset. 
These results are consistent with the effect of WUR on ADG reported by Dunkelberger et 
al. [14] for analyses of these same data, which showed that WUR did not have a 
significant effect on any of the ADG traits, except for ADG of Vx pigs Post Vx.  
Results reported by Boddicker et al. [5] showed that training on PHGC trials 1-3 
and validating on trials 4 and 5 separately resulted in low to moderate prediction accuracy 
for WG post PRRSV-infection using SNPs across the genome. However, in contrast to 
results reported for the current study, Boddicker et al. [5] showed that using only SNPs 
within the 1-Mb WUR region resulted in higher prediction accuracy than using all SNPs 
when validating on one of the trials. Additional PHGC trials were later conducted and a 
follow-up study was performed using PHGC trials 1-8 and a leave-one-out training and 
validation procedure. Contrary to results reported for the current study, except for ADG 
of Vx pigs Post Vx, results showed that using SNPs within the WUR region only yielded 
higher prediction accuracy than using SNPs outside of the WUR region (i.e. Rest subset) 
[6]. This finding is consistent with results reported by Waide [8] using PHGC trials 1-15, 
which showed that using SNPs within the WUR region had better predictive ability than 
using SNPs across the genome or the Rest subset when training on WG using the KS06 
trials and validating on the NVSL trials. However, using SNPs across the genome yielded 
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higher prediction accuracy than using SNPs within the WUR region when training on the 
NVSL trials and validating on the KS06 trials, which agrees with results reported for all 
ADG traits for the current study [8]. 
There are several possible explanations for the discrepancy in results for WG 
reported by Boddicker et al. [5,6] with those reported for ADG from the current study. 
First, Boddicker [5,6] presented results using the NVSL-infected trials for training and 
validation only, whereas Waide [8] presented results training on the NVSL trials and 
validating on the KS06 trials and visa versa. Results presented by Waide [8] showed that 
using SNPs within the WUR region was superior to using SNPs across the genome to 
predict WG when training on the KS06 trials and validating on the NVSL trials, but that 
the opposite was true when training on the NVSL trials and validating on KS06 trials. 
This finding agrees with results reported by Hess et al. [13], who reported a significant 
effect of WUR on WG following infection with the NVSL, but not KS06 isolate. Taken 
together, these results suggest that using SNPs within the WUR region only was superior 
to using SNPs across the genome when the effect of WUR on WG was significant, but 
that the opposite was true when the effect was not significant. Since results from a 
previous study of these same data showed that the effect of WUR on ADG was not 
significant for any of the ADG traits, except ADG of Vx pigs Post Vx [14], this may 
partially explain why using SNPs within the WUR region was not superior to using SNPs 
across the genome for any of the scenarios evaluated for the current study.  
Another obvious difference between PHGC trials 1-15 used for validation for the 
studies conducted by Boddicker [5,6] and Waide [8] with the validation populations used 
for the current study, is that the trials used for validation for the current study were co-
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infected with PRRSV and PCV2b. In addition, half of the pigs per trial for 3 of the 4 co-
infection trials were vaccinated for PRRS prior to co-infection. The field PRRSV strain 
used for co-infection (KS62) was also different from the field strain used for PHGC trials 
1-8 and 15 (NVSL 97-7985) or PHGC trials 10-14 (KS2006-72109) and previous 
research shows that the effect of WUR on WG is not consistent following infection with 
different PRRSV isolates [13]. Lastly, pigs from the co-infection trials were 4 weeks 
older at co-infection than pigs from PHGC trials 1-15 at PRRSV-infection.  
Collectively, results from these analyses show that it is possible to predict ADG 
following PRRS vaccination using WG recorded on individuals from an unrelated, 
PRRSV-only infected training population. However, a PRRSV-only infected training 
population had low to no predictive ability for ADG in an unrelated, PRRSV/PCV2b co-
infected population. Similar to results for the viral load traits, since WG had predictive 
ability for ADG post vaccination where training/validation populations were comprised 
of different breeds, this result also implies that the PHGC trials have potential to be used 
as a multi-breed reference population for growth rate following PRRS vaccination.  
However, growth rate following PRRS vaccination is not expected to be a good indicator 
of growth rate following co-infection since results from a previous study for analyses of 
these same data [14] showed that ADG Post Vx had a low genetic correlation with ADG 
Post Co-X for Non-Vx pigs and a moderate, negative genetic correlation with ADG Post 
Co-X for Vx pigs.  
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Prediction of PRRSV-only/co-infection response using vaccination data  
 An additional objective of this study was to assess the predictive ability of 
training on host response to PRRS vaccination to predict host response to infection with a 
field isolate of PRRSV. This objective was formulated to address whether host response 
to vaccination can be used as an indicator of host response to infection with a field isolate 
of PRRSV. This was assessed using training and validation populations from the same 
(Scenarios 3 and 5) or different (Scenarios 2 and 4) genetic sources and validation 
populations infected with a field isolate by PRRSV-only infection (Scenarios 2 and 3) or 
PRRSV/PCV2b co-infection (Scenarios 4 and 5).  
 The predictive ability of training on vaccination VL to predict host response to 
infection with a field isolate of PRRSV was assessed using the PRRSV-only infected 
trials as validation populations (i.e. Scenarios 2 and 3). Results showed that, whether 
training on all trials, or on only the NVSL trials or KS06 trials, training and validating on 
the WUR Only subset resulted in the highest prediction accuracy. In fact, low to no 
predictive ability was obtained when training and validating on the Whole Genome 
subset and small, negative prediction accuracies were obtained using the Rest subset. 
Based on prediction accuracies obtained for the latter 2 scenarios, we can conclude that 
training on vaccination VL had little to no predictive ability for PRRS VL following 
PRRSV-only infection for unrelated populations (i.e. Scenario 2). The low to moderate 
prediction accuracies obtained when training and validating on the WUR Only subset 
simply reflects the already-known effect of WUR on PRRS VL within a PRRSV-only 
infected population that was originally identified using these same trials [5,6,13,16].  
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This analysis was repeated using only trials for training and validation that 
originated from the same genetic source (i.e. Scenario 3). For this scenario, prediction 
accuracies increased for all evaluated scenarios, as expected. In fact, results indicated that 
training on vaccination VL resulted in low to moderately low prediction accuracy for 
PRRS VL recorded on a PRRSV-only infected validation population using the Whole 
Genome SNP subset.  
 When Vx pigs and Non-Vx pigs from trials 16, 20, and 22 were used for training 
and validation, respectively (i.e. Scenario 4), results showed that, whether using the 
Whole Genome, Rest, or WUR Only SNP subsets, training on vaccination VL had 
moderate predictive ability for PRRS VL in a PRRSV/PCV2b co-infected population. 
Although pigs from trials 16 and 20 were from the same genetic source, dams and sires 
were unique to each trial. However, within trial, some Vx and Non-Vx pigs were related 
as half-sibs or full sibs. 
To evaluate the predictive ability of training on vaccination VL to predict host 
response to infection with a field PRRSV isolate using animals from the same genetic 
source, the analysis was repeated using only pigs from trials 16 and 20 for training and 
validation (i.e. Scenario 5). Compared to results obtained for Scenario 4, prediction 
accuracy increased for all SNP subsets used. This result was expected, since individuals 
from the same genetic source are more related than individuals from different genetic 
sources and studies have shown that using related animals in training and validation 
increases prediction accuracy [24,25]. The result is also consistent with results reported 
by Waide [8] who showed that, even when training and validating on trials infected with 
different isolates of PRRSV, prediction accuracy increased when including trials from the 
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same genetic source for training and validation. However, unlike results presented for the 
current study, prediction accuracy increased most when training and validating on the 
Rest SNP subset and the least for the WUR Only subset [8].  
Whether using pigs from trials 16, 20, and 22 or 16 and 20 only for training, it 
was surprising that using the Whole Genome and Rest SNPs subset yielded similar 
prediction accuracies. Given that using SNPs within the WUR Only subset resulted in 
higher prediction accuracy than the Whole Genome subset, it was expected that the Rest 
subset would have resulted in negative prediction accuracy. This would indicate that 
SNPs outside of the WUR region contributed noise to GP, thereby reducing the 
prediction accuracy of using SNPs across the genome. If fact, only slightly lower 
prediction accuracy was obtained when using the Rest subset for training and validation 
compared to using the Whole Genome subset, whether training and validating on trials 
from different (Scenario 4) or the same (Scenario 5) genetic source. One explanation for 
this may be that GP accuracy for the Whole Genome subset was underestimated because 
of over-shrinkage of the WUR effect. One way to avoid this problem may be to re-
estimate marker effects for the training data by fitting WUR in the model as a fixed effect 
to obtain the marker effect estimates.  
 Collectively, results from training and validation scenarios 2-5 show that 
vaccination VL can be used to predict PRRS VL recorded on a PRRSV/PCV2b co-
infected population with moderate predictive ability and PRRSV-only infection with low 
predictive ability for a related population. These results were be to expected, especially 
those for Scenario 5, since results from a previous study for analyses of these same data 
showed a high, positive genetic correlation between vaccination VL and PRRS VL of 
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Non-Vx pigs Post Co-X [14]. The high, positive genetic correlation suggests that host 
response to PRRSV-infection, whether by vaccination or co-infection with PCV2b, are 
controlled by similar genomic regions. 
The ability to predict host response to infection with a field isolate of PRRSV 
using host response to vaccination is an important result because it implies that, within a 
breeding company, selection candidates could be vaccinated for PRRS and vaccination 
VL used as an indicator of host response to PRRSV-infection. This is an attractive 
approach, especially for companies that already vaccinate breeding herds for PRRS, 
because it would enable breeders to identify selection candidates with improved host 
response to PRRS based on own phenotype.  
 
Summary  
In summary, results from the current study show that PRRS VL following 
PRRSV-only infection had low to moderate predictive ability for vaccination VL and 
PRRS VL following co-infection with PRRSV and PCV2b for unrelated validation 
populations. For PRRS VL traits indicative of primary PRRSV exposure (vaccination VL 
and PRRS VL of Non-Vx pigs) and PCV2b VL recorded on Vx pigs, using SNPs within 
the WUR region yielded higher prediction accuracies than using SNPs across the 
genome, which supports the biological role of GBP5, the putative causative gene for 
WUR, in the innate immune response.  
Weight gain following PRRSV-only infection also had moderate predictive ability 
for ADG Post Vx, but low to no predictive ability for ADG following PRRSV/PCV2b 
co-infection in an unrelated, validation population. For this trait, using the Whole 
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Genome subset had better predictive ability than using the Rest or WUR Only subsets. 
This finding is consistent with results from a previous study for analyses of these same 
data [14], which showed that WUR did not have a significant effect on ADG, whether 
analyzed post vaccination or post co-infection.  
Only the BayesB GP method was used for this study. BayesB was identified as 
the ideal method for training and validating on all SNPs within the Whole Genome and 
WUR Only SNP subsets since it is the preferred genomic selection method for traits with 
large-effect QTL [3]. It may be beneficial to repeat analyses using the BayesC method 
when training and validating on SNPs within the Rest SNP subset, since BayesC is the 
preferred method for traits expected to be controlled by many loci with small effects [26]. 
However, results reported by Waide et al. [8] showed that, using the same pi value, 
repeating analyses by training and validating on SNPs within the Rest subset with 
BayesC rather than BayesB decreased prediction accuracy for WG, but did not have an 
impact on results for PRRS VL.  
 
Conclusions 
 
Taken together, results from this study indicate that the PHGC PRRSV-only 
infection trials have the potential to be used as a multi-breed reference population to 
predict PRRS VL and PCV2b VL of Vx pigs following PRRSV/PCV2b co-infection and 
vaccination VL and growth rate following PRRS vaccination in an unrelated validation 
population. Furthermore, PRRS vaccination response has the potential to be used to 
predict host response to infection with a field isolate of PRRSV by PRRSV/PCV2b co-
infection or PRRSV-only infection in a related validation population. If using the PHGC 
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trials as a reference population, only genotypes would be required to predict host 
response to PRRS for selection candidates. If using vaccination response to predict 
response to infection with a field isolate, both genotypes and phenotypes for vaccination 
VL would be required for selection candidates. The latter scenario presents a unique 
opportunity to utilize own phenotypes to predict host response to PRRSV-infection. 
Together, these strategies present different opportunities to use GP to facilitate selection 
for improved host response to PRRSV-infection. 
 Results of GP analyses presented in this study also showed that training and 
validating on SNPs within the WUR region was superior to using SNPs across the 
genome to predict VL Post Co-X (except for PRRS VL of Vx pigs) using a PRRSV-only 
infected training population. Using SNPs within the WUR Only subset also had superior 
predictive ability for PRRS VL (whether by PRRSV-only infection or co-infection) when 
using a vaccinated training population. However, SNPs across the genome had the 
highest predictive ability for growth rate following PRRS vaccination using a PRRSV-
only infected training population.  
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 Table 6.1. Descriptive statistics of the co-infection trials.  
  
1Post Vaccination: Pigs were vaccinated (Vx) or not (Non-Vx) against porcine reproductive and respiratory syndrome (PRRS) virus 
prior to co-infection with PRRS and porcine circovirus type 2b (PCV2b) 28 days later.  
2VL, Viral Load: Calculated as the area under the curve of log-transformed viremia between -28 and 0 days post-infection (dpi) for 
vaccination VL, 0 and 21 dpi for PRRS VL, and 0 and 42 dpi for PCV2b VL. 
3ADG, Average Daily Gain: Calculated as the regression of body weight on dpi from -28 to 0 dpi for the post vaccination period  
and from 0 to 42 dpi for the post co-infection period.  
4Trial: Co-infection trial. Trials with the same letters in brackets originated from the same genetic source.  
 
 
 Post Vaccination1  Post Co-Infection 
Trial4 
Vaccination 
VL2 
ADG3 
 
PRRS VL PCV2b VL ADG 
Vx Vx Non-Vx  Vx Non-Vx Vx Non-Vx Vx Non-Vx 
n Mean n Mean n Mean  n Mean n Mean n Mean n Mean n Mean n Mean 
16 [A] 98 55.02 101 0.34 98 0.36  96 66.79 93 88.69 83 164.91 87 155.55 90 0.82 91 0.86 
19 [B] -- -- -- -- 96 0.38  -- -- 87 79.29 -- -- 73 135.20 -- -- 74 0.58 
20 [A] 88 87.59 94 0.51 93 0.53  89 50.17 86 76.40 79 102.31 84 86.89 84 0.87 88 0.81 
22 [B] 84 82.55 91 0.46 91 0.47  86 51.69 89 73.20 86 57.25 87 53.98 87 0.86 90 0.84 
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Table 6.2. Number of individuals and single nucleotide polymorphisms (SNPs) per 
genotype file post quality control (QC).  
 
 
Trial(s) n SNPs Post QC1 Final Genotyping Rate2 
16 181 53, 043 99.41 
19 99 52, 796 99.63 
20 197 54, 149 99.57 
22 194 53, 375 99.64 
16, 20, 22 573 54, 239 99.43 
 
 
1SNPs Post QC: The GeneSeek-Neogen PorcineSNP80 BeadChip (GeneSeek, Igenity; 
Lincoln, NE) contains 68,528 SNPs prior to QC.  
2Final Genotyping Rate: the percent of SNP genotypes called out of the total number of 
genotypes after replacing genotypes with a gene call score lower than 0.7 with missing, 
removing SNPs missing at least 15% of genotypes, and removing individuals missing > 
25% of SNP genotypes.  
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Table 6.3. Training and validation scenarios for genomic prediction analyses. 
 
Training  Validation 
Trait Trials1 n  Trait Trials 
Scenario 1: Prediction of vaccination and co-infection response using PRRS virus-only infection data from 
unrelated genetics 
PRRS VL2 
(NVSL)3 
 
4-8, 15 1,047 
 Vaccination VL 16, 20, 22 
 PRRS VL, Non-Vx4 16, 19, 20, 22 
 PRRS VL, Vx 16, 20, 22 
 PCV2b VL, Non-Vx 16, 19, 20, 22 
 PCV2b VL, Vx 16, 20, 22 
PRRS VL 
(KS06) 
 
10, 12, 14 525 
 Vaccination VL 16, 20, 22 
 PRRS VL, Non-Vx 16, 19, 20, 22 
 PRRS VL, Vx 16, 20, 22 
 PCV2b VL, Non-Vx 16, 19, 20, 22 
 PCV2b VL, Vx 16, 20, 22 
PRRS VL 
(All) 
4-8, 10, 12, 14-15 1,572 
 Vaccination VL 16, 20, 22 
 PRRS VL, Non-Vx 16, 19, 20, 22 
 PRRS VL, Vx 16, 20, 22 
 PCV2b VL, Non-Vx 16, 19, 20, 22 
 PCV2b VL, Vx 16, 20, 22 
WG5 
(NVSL) 
4-8, 15 1,015 
 ADG6 Post Vx, Non-Vx 16, 20, 22 
 ADG Post Vx, Vx 16, 20, 22 
 ADG Post Co-X, Non-Vx 16, 19, 20, 22 
 ADG Post Co-X, Vx 16, 20, 22 
WG 
(KS06) 
10, 12, 14 519 
 ADG Post Vx, Non-Vx 16, 20, 22 
 ADG Post Vx, Vx 16, 20, 22 
 ADG Post Co-X, Non-Vx 16, 19, 20, 22 
 ADG Post Co-X, Vx 16, 20, 22 
WG 
(All) 
4-8, 10, 12, 14-15 1,535 
 ADG Post Vx, Non-Vx 16, 20, 22 
 ADG Post Vx, Vx 16, 20, 22 
 ADG Post Co-X, Non-Vx 16, 19, 20, 22 
 ADG Post Co-X, Vx 16, 20, 22 
Scenario 2: Prediction of PRRS virus-only response using vaccination data from unrelated genetics 
Vaccination VL 16, 20, 22 257 
 PRRS VL (NVSL) 4-8, 15  
PRRS VL (KS06) 10, 12, 14  
PRRS VL (All) 4-8, 10, 12, 14-15  
Scenario 3: Prediction of PRRS virus-only response using vaccination data from related genetics 
Vaccination VL 16, 20 173 
 PRRS VL (NVSL) 1-3 
 PRRS VL (KS06) 11 
 PRRS VL (All) 1-3, 11 
Scenario 4: Prediction of co-infection response using vaccination data from unrelated genetics 
Vaccination VL 16, 20, 22 257  PRRS VL, Non-Vx 16, 20, 22 
Scenario 5: Prediction of co-infection response using vaccination data from related genetics 
Vaccination VL 16, 20 173  PRRS VL, Non-Vx 16, 20 
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1Trials: Porcine reproductive and respiratory syndrome (PRRS) Host Genetics 
Consortium trial. 
2VL, Viral Load: PRRS vaccination VL was calculated as the area under the curve of 
serum viremia from -28 to 0 days post-infection (dpi) during the vaccination period or 
from 0 to 21 dpi or 0 to 42 dpi during the PRRS and porcine circovirus type 2b (PCV2b) 
co-infection period for PRRS VL and PCV2b VL, respectively.  
3NVSL: PRRS virus (PRRSV)-only infected trials consisted of pigs infected with the 
NVSL or KS06 PRRSV isolate. Training/validation populations consisted of pigs from 
NVSL trials only (NVSL), KS06 trials only (KS06), or all trials (All).  
4Non-Vx, Non-Vaccinated: Pigs were either vaccinated (Vx) or not (Non-Vx) against 
PRRSV prior to co-infection with PRRSV and PCV2b 28 days later.  
5WG, Weight Gain: calculated for the PRRSV only-infected trials as the difference in 
body weight between 42 and 0 dpi.  
6ADG, Average Daily Gain: Calculated as the regression of body weight on dpi from -28 
to 0 dpi for the vaccination period and from 0 to 42 dpi for the co-infection period. 
  
222 
-0.8 
-0.6 
-0.4 
-0.2 
0 
0.2 
0.4 
0.6 
0.8 
P
re
d
ic
ti
o
n
 A
cc
u
ra
cy
 
Whole Genome 
Rest 
WUR Only 
Trial 16 
Trial 19 
Trial 20 
Trial 22 
-0.8 
-0.6 
-0.4 
-0.2 
0 
0.2 
0.4 
0.6 
0.8 
P
re
d
ic
ti
o
n
 A
cc
u
ra
cy
 
-0.8 
-0.6 
-0.4 
-0.2 
0 
0.2 
0.4 
0.6 
0.8 
P
re
d
ic
ti
o
n
 A
cc
u
ra
cy
 
A 
B 
C 
      Vacc VL      PRRS VL (Non-Vx)  PRRS VL (Vx)   PCV2b VL (Non-Vx) PCV2b VL (Vx) 
      Vacc VL      PRRS VL (Non-Vx)  PRRS VL (Vx)   PCV2b VL (Non-Vx) PCV2b VL (Vx) 
      Vacc VL      PRRS VL (Non-Vx)  PRRS VL (Vx)   PCV2b VL (Non-Vx) PCV2b VL (Vx) 
P
re
d
ic
ti
o
n
 A
cc
u
ra
cy
 
Whole Genome 
Rest 
WUR Only 
Trial 16 
Trial 19 
Trial 20 
Trial 22 
  
223 
Figure 6.1. Prediction accuracies when training on porcine reproductive and respiratory 
syndrome (PRRS) viral load (VL) of PRRS virus (PRRSV)-only trials and validating on 
vaccination VL (Vacc VL), PRRS VL, or porcine circovirus type 2b (PCV2b) VL of co-
infection trials.  
 
Traits used for validation were recorded on pigs vaccinated (Vx), or not (Non-Vx), for 
PRRS prior to co-infection. Results are presented when training on trials infected with the 
NVSL or KS06 PRRSV isolate combined (A), NVSL trials only (B), and KS06 trials only 
(C) and validating on single nucleotide polymorphisms (SNPs) throughout the genome 
(Whole Genome), SNPs within the 1 megabase region containing SNP WUR10000125 
(WUR Only) and SNPs not within the WUR10000125 region (Rest). Prediction 
accuracy was evaluated as the correlation between genomic estimated breeding value and 
pre-adjusted phenotype divided by the square root of the heritability for the trait used for 
validation. Points within each bar represent prediction accuracies obtained for each 
validation trial.  
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Figure 6.2. Prediction accuracies when training on weight gain of porcine reproductive 
and respiratory syndrome (PRRS) virus (PRRSV)-only trials and validating on average 
daily gain of the PRRS/porcine circovirus type 2b (PCV2b) co-infection trials.  
 
Results are presented when training on trials infected with the NVSL or KS06 PRRSV 
isolates combined (A), NVSL trials only (B), and KS06 trials only (C). Traits used for 
validation were recorded on pigs vaccinated (Vx), or not (Non-Vx), for PRRS during the 
vaccination and co-infection periods as separate traits. Each scenario was repeated by 
validating on single nucleotide polymorphisms (SNPs) throughout the genome (Whole 
Genome), SNPs within the 1 megabase region containing SNP WUR10000125 (WUR 
Only) and SNPs not within the WUR10000125 region (Rest). Prediction accuracy was 
evaluated as the correlation between genomic estimated breeding value and pre-adjusted 
phenotype divided by the square root of heritability for the trait used for validation. 
Points within each bar represent prediction accuracies obtained per trial.  
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Figure 6.3. Prediction accuracies when training on porcine reproductive and respiratory 
syndrome (PRRS) vaccination viral load (VL) and validating on PRRS VL of non-
vaccinated pigs from the PRRS virus (PRRSV)-only trials.  
 
Results are presented when validating on trials from different genetic sources than 
training (Trials 4-8, 10, 12, 14, and 15) and the same genetic source as training (Trials 1-
3, 11). Trials infected with the NVSL PRRSV isolate (NVSL), KS06 isolate (KS06), or 
all trials (All) were validated on separately. Results are also presented when training and 
validating on single nucleotide polymorphisms (SNPs) throughout the genome (Whole 
Genome), SNPs within the 1 megabase WUR10000125 region only (WUR Only), and 
SNPs not within the WUR10000125 region (Rest). Prediction accuracy was evaluated as 
the correlation between genomic estimated breeding value and pre-adjusted phenotype 
divided by the square root of heritability for PRRS VL of non-vaccinated pigs.  
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Figure 6.4. Prediction accuracies when training on porcine reproductive and respiratory 
syndrome (PRRS) vaccination viral load (VL) and validating on PRRS VL recorded on 
non-vaccinated pigs from the same trials.  
 
Results are presented when using pigs from different genetic sources for training and 
validation (Trials 16, 20, and 22) and pigs from the same genetic source (16 and 20) for 
training and validation. Results are also presented when training and validating on single 
nucleotide polymorphisms (SNPs) throughout the genome (Whole Genome), SNPs 
within the 1 megabase WUR10000125 region only (WUR Only) and SNPs not within 
the WUR10000125 region (Rest). Prediction accuracy was evaluated as the correlation 
between genomic estimated breeding value and pre-adjusted phenotype divided by the 
square root of heritability for PRRS VL of non-vaccinated pigs. 
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CHAPTER 7. A MAJOR GENE FOR HOST RESPONSE TO PORCINE 
REPRODUCTIVE AND RESPIRATORY SYNDROME IS NOT UNFAVORABLY 
ASSOCIATED WITH OVERALL PERFORMANCE UNDER NON-
CHALLENGING CONDITIONS IN COMMERCIAL PIG LINES 
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Abstract 
 
A QTL for host response to porcine reproductive and respiratory syndrome 
(PRRS) was identified in a previous study. The SNP WUR10000125 (WUR) is used as a 
tag SNP for this QTL. The favorable (B) allele at this SNP is in low frequency in 
commercial populations, possibly because this allele is unfavorably associated with an 
important trait under non-challenging conditions and, thus, may have been selected 
against. Therefore, objectives of this study were to estimate the effect of WUR on traits 
under selection in commercial lines in a clean environment and to estimate the effect of 
WUR genotype of parents on performance of crossbred progeny. Data were collected on 
4 purebred lines: a Landrace maternal line (D1), a Large White maternal line (D2), a 
synthetic boar line (S1), and a Pietrain boar line (S2). Traits analyzed included total 
number born, number stillborn, farrowing survival, lactation survival, litter mortality 
(LMO), daily feed intake (DFI), backfat, average daily gain during test (TGR), average 
lifetime daily gain (LGR), and Topigs Selection Index (TSI) value, indicative of overall 
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economic value. Deregressed estimated breeding values were calculated for each trait 
(except TSI) and analyzed within line. In the S1 line, AB and BB pigs had significantly 
lower TGR (P = 0.002) and LGR (P = 0.001) than AA pigs, but also lower DFI (P = 
0.004). Conversely, AB and BB pigs had significantly higher DFI (P < 0.001) and AB 
pigs had significantly higher TGR (P = 0.03) than AA pigs in the S2 line. The effect of 
WUR on TSI was not significant for any line (P ≥ 0.15). Analyses of phenotypic records 
collected on crossbred progeny of S1 line sires and D1D2 F1 females showed no 
significant effect of parent WUR genotype on DFI, BFE, TGR, or LGR (P ≥ 0.07). In 
conclusion, the effect of WUR was non-significant for most traits but the magnitude and 
direction of the effect differed by trait and by line. The favorable allele for host response 
to PRRS was associated with greater DFI and a tendency for greater TGR in the S2 line, 
but the opposite direction of effect was detected for the S1 line. Regardless of the effect 
on individual traits, no significant effect of WUR on TSI was detected for any line. 
Therefore, selecting for the B allele is expected to result in progeny with increased 
resistance to PRRS without compromising overall economic value under normal, non-
challenging conditions.  
Introduction 
 
Previously, a major QTL for host response to porcine reproductive and respiratory 
syndrome (PRRS) was identified on chromosome 4 (Boddicker et al., 2012). SNP 
WUR10000125 (WUR) is in complete linkage disequilibrium with the causative 
mutation and can be used as a tag SNP for this QTL (Boddicker et al., 2014a,b; Koltes et 
al., 2015). Guanylate binding protein 5 (GBP5), which plays a role in the innate immune 
response (Shenoy et al., 2012) was recently identified as the causative gene for this QTL 
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(Koltes et al., 2015). The effect of WUR has been validated across breeds and genetic 
sources (Boddicker et al., 2014b) and following: infection with 2 North American PRRS 
virus (PRRSV) isolates (Hess et al., 2016), vaccination with a PRRS modified live virus 
(MLV) vaccine (Abella et al., 2016; Dunkelberger et al., 2017), and co-infection with 
PRRS and porcine circovirus type 2b (PCV2b) (Dunkelberger et al., 2017). 
Surprisingly, the frequency of the favorable (B) allele under PRRS challenge is 
low in commercial populations (i.e. average frequency across 8 PRRS Host Genetics 
Consortium (PHGC) trials was 0.14, where each trial was comprised of pigs sourced 
from different breeding companies) (Boddicker et al., 2014b). One hypothesis for the low 
frequency of the B allele is that it is unfavorably associated with an important trait in a 
clean environment and, thus, has been selected against in commercial breeding schemes.  
Until now, information regarding the effect of WUR on performance under non-
challenging conditions has been limited, except for results from a recent study in which 
AB pigs had significantly slower growth than AA pigs under non-challenging conditions 
(Abella et al., 2016). Therefore, the objectives of this study were to estimate the effect of 
WUR on traits under selection in commercial lines in a clean environment and to estimate 
the effect of parent WUR genotype on performance of crossbred progeny in a 
commercial-like environment.  
 
Materials & Methods 
 
 The data used for this study were obtained as part of routine data recording in a 
commercial breeding program. Samples collected for DNA extraction were only used for 
routine diagnostic purpose of the breeding program. Data recording and sample collection 
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were conducted strictly in line with the rules given by the Dutch law on the protection of 
animals (Gezondheids- en welzijnswet voor dieren). 
 
Animals and genotypes 
 
Data used for this study were from 2 purebred dam lines (D1 and D2) and 2 
purebred sire lines (S1 and S2) from Topigs Norsvin high-health nucleus farms. The 
number of individuals, sires, and dams per line used for analyses are presented in Table 
1. The D1 line is a purebred Landrace maternal line, the D2 line is a Large White 
maternal line, the S1 line is a synthetic boar line, and the S2 line is a Pietrain boar line. 
Records were collected on selection candidates from 40, 34, 8, and 19 farms for lines D1, 
D2, S1, and S2, respectively, from 2015 through 2016. Some farms routinely vaccinate 
against PRRSV using a type 1 PRRS MLV vaccine. For these farms, some pigs are 
vaccinated at weaning (i.e. 3 weeks of age), all pigs are vaccinated at 26 weeks of age, 
dams are vaccinated at d 60 of gestation, and dams receive a booster vaccine at 6 d post-
farrowing.  
Data were also collected on S1x(D1xD2) crossbred finishing pigs of S1 sires and 
D1D2 F1 females to estimate the effect of parent WUR genotype on performance of 
crossbred progeny. Phenotypic records collected on 2,184 S1x(D1xD2) individuals from 
2 Combined Crossbred and Purebred Selection (CCPS) (Wei and van der Werf, 1994) 
farms, which mimic commercial conditions, were used for analyses. Pigs were from 148 
purebred S1 line sires and 316 D1xD2 dams. CCPS farms had conventional health status, 
meaning that any of the following pathogens could have been present: Actinobacillus 
pleuroneumonia, Mycoplasma, Bordetella, non-toxigenic Pasteurella multocida, 
Streptococcus suis, Staphylococcus hyicus, Haemophilus parasuis, Escherichia coli, 
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Clostridium perfringens, Coccidiosis, Lawsonia, Salmonella spp, Influenza, PCV, 
porcine respiratory corona virus, or PRRS. Farms were free of Mange, Brachyspira, and 
Atrophic Rhinitis. Pigs were fed a conventional, commercial grow-to-finish ration ad 
libitum.   
Per routine breeding program procedure, all selection candidates were genotyped 
using the PorcineSNP60 BeadChip (Illumina Inc., San Diego, CA), GeneSeek Custom 
80K SNP chip (Lincoln, NE, USA), or the GeneSeek Custom 10K SNP chip (Lincoln, 
NE, USA). Crossbred progeny were genotyped using the GeneSeek Custom 10K SNP 
chip (Lincoln, NE, USA). Genotypes for the WUR SNP were extracted and a chi-square 
test was performed to determine whether the observed genotype frequencies significantly 
differed from the expected genotype frequencies under Hardy Weinberg Equilibrium. At 
the WUR SNP, the B allele corresponds to the “G” nucleotide and is favorable under 
PRRSV-infection. The B allele has shown to be dominant to the A allele, which 
corresponds to the “A” nucleotide (Boddicker et al., 2014b).  
 
Traits 
 
The 5 reproduction traits and 4 finishing traits that receive the greatest emphasis in 
the Topigs Selection Index (TSI) were analyzed. The TSI combines estimated breeding 
values and economic values of traits according to the specific breeding goals of each line. 
Reproduction traits recorded at the sow level included total number born (TNB), defined 
as the number of live born piglets plus the number of stillborn piglets within a litter, 
number of stillborn (STB) piglets within a litter, and litter mortality (LMO), recorded as 
the number of piglets that died between birth and weaning. Reproduction traits recorded 
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at the individual piglet level included farrowing survival (FSL) (whether a piglet did 
(=1)/did not (=0) survive farrowing) and lactation survival (LSL) (whether a live-born 
piglet did (=1)/did not (=0) survive until weaning). Although recorded as binary traits, 
FSL and LSL were analyzed as continuous traits as the probabilities of survival. 
Finishing traits included daily feed intake (DFI), recorded in g per d from start to end of 
the test period, backfat (BFE), recorded as fat depth at the end of the test period (~120 
kg) in mm, average test growth (TGR), expressed in g of weight gain per d from start to 
the end of the test period, and average lifetime daily gain (LGR), expressed in g of 
weight gain per d from birth to end of the test period.  
 
Statistical analyses 
Estimated breeding values (EBV) and deregressed EBVs (dEBV) 
EBV for all evaluated traits were obtained from routine genetic evaluation of 
Topigs Norsvin lines using a multitrait model with MiXBLUP software (Mulder et al., 
2012). dEBV were obtained for all individuals for all evaluated traits when the reliability 
of the EBV (r2) was greater than 20% using the method described by Garrick et al. 
(2009). Parent average effects were also removed as part of the deregression process to 
obtain more accurate estimates of the genetic merit of each individual. Reliabilities (r2) 
were extracted from the genetic evaluation and were based on the methodology of Tier 
and Meyer (2004). Residuals were weighted by corresponding reliability of dEBV using 
a value of 0.5 for the scalar c (Garrick et al., 2009).  
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Analyses of the effect of WUR on index traits 
The effect of WUR on each evaluated trait was analyzed using dEBVs for each 
trait as the response variable using a single-trait animal model in ASReml 4.0 (Gilmour et 
al., 2015). Each trait was analyzed by line using the following model: 
 
Model 1    
 
Yijk ∗ wtijk =  μ + PRRS_Vacci + WURj + PRRS_Vacci ∗ WURj + Animalk + eijk 
 
where Yijk = the observed dEBV; wtijk = corresponding reliability of dEBV used as a 
weighting factor for the residual; μ = the overall mean; PRRS_Vacci = fixed class effect 
for PRRS vaccination status of farm (whether the farm that the pig originated from 
vaccinates [Vx], or not [Non-Vx], against PRRSV); WURj = fixed class effect of WUR 
genotype (AA, AB, or BB); PRRS_Vacci ∗ WURj  = interaction of PRRS vaccination 
status by WUR genotype; Animalk = random animal genetic effect, and eijk = the random 
residual effect. The interaction of PRRS_Vacc x WUR was removed from the model 
when non-significant (P ≥ 0.10) and the analysis was re-run by replacing WUR with the 
terms WUR_add and WUR_dom, which represent contrasts fitted to obtain separate 
additive and dominance effects for WUR, respectively. When PRRS_Vacc x WUR was 
significant, the analysis was also re-run by replacing PRRS_Vacc x WUR with 
PRRS_Vacc x WUR_add and PRRS_Vacc x WUR_dom. However, because dEBVs are 
based on the additive genetic effect, little to no effect of WUR_dom or PRRS_Vacc x 
WUR_dom were expected for these analyses.  
The same model was used to estimate the effect of WUR on dEBV for each 
finishing trait for an analysis across lines with the following terms fitted as additional 
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fixed effects: Line (D1, D2, S1, or S2), Line x PRRS_Vacc, and Line x WUR. The latter 
interaction terms were removed from the model when non-significant (P ≥ 0.10).   
Animal genetic effects were assumed distributed N(0, 𝐀σa
2) , where A is the 
average numerator relationship matrix between individuals and σa
2 is the additive genetic 
variance. Genetic relationships were derived using a minimum of 13 generations of 
pedigree for each line. Residuals eijk were assumed distributed ~ N(0, 𝐈σe
2), where σe
2 is 
the residual variance. The same models described above were also used to estimate the 
effect of WUR on TSI for each line separately or across lines. However, because actual 
values, rather than dEBVs, were analyzed for TSI, no weighting factor was included.  
A second objective was to estimate the effect of parent WUR genotype on 
performance of crossbred progeny. The following model was used to analyze TGR and 
LGR, recorded as g of weight gain per d from the beginning of the test period or from 
birth to the end of the finishing period, respectively using ASReml 4.0 (Gilmour et al., 
2015), which is similar to that used for routine breeding value estimation:  
 
Model 2 
 
 
Yijklm =  μ + Trialj + FLSk + FCl + Bl ∗ BWSi + B2 ∗ Avgi + Animali + Litterm + eijklm 
 
where Yijklm = the observed phenotype recorded on S1x(D1xD2) progeny; μ  = the 
overall mean; Trialj =fixed class effect of trial (to account for differences in the feed 
formulation used); FLSk = fixed class effect of farm by line and sex; FCl =fixed class 
effect of farm compartment (i.e. group of pens within a farm); Bl ∗ BWSi = partial 
regression on scaled birth weight (birth weight – average birth weight); B2 ∗ Avgi  = 
partial regression on the average WUR genotype of parents (the average number of 
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copies of the B allele of the parents); Animali 
= random animal genetic effect, Litterm = 
random effect of litter, and eijklm = the random residual effect. Animal genetic effects 
were assumed distributed ~ N(0, 𝐀σa
2), where A is the numerator relationship matrix 
between individuals and σa
2 is the additive genetic variance. Litter effects were assumed 
distributed ~  N(0, 𝐈σL
2) , where I is the identity matrix and σL
2 is the unknown litter 
variance. Residuals eijklm were assumed distributed ~
 
N(0, 𝐈σe
2), where σe
2 is the residual 
variance.   
Model 2 was also used to analyze BFE and DFI, recorded as fat depth at the end 
of the finishing period and gain from start to end of the finishing period, respectively. For 
analysis of BFE, the effects Bl ∗ HCWi ∗ Groupk (partial regression on hot carcass 
weight) and B2 ∗  HCWi
2 ∗ Groupk  (partial regression on hot carcass weight squared) 
were fitted in place of Bl ∗ BWSi. For DFI, Bl ∗ Start Weighti (partial regression on age 
at start of the finishing period) was fitted instead of Bl ∗ BWSi.  
 
Results 
 
Number of individuals by line and WUR genotype are presented in Table 2. 
Frequency of the B allele for WUR was 0.20, 0.10, 0.22, and 0.18 for the D1, D2, S1, and 
S2 lines, respectively. Results of a chi square test indicated that the observed genotype 
frequencies significantly differed from expected for the D2 (P = 0.0008) and S2 (P < 
0.0001) lines. For both lines, fewer heterozygotes and more BB pigs were observed than 
expected.  
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Analyses of purebred data 
 
P-values and least square (LS) means for the effect of WUR on each evaluated 
trait by line are presented in Tables 3 and 4 for analyses of reproduction and finishing 
traits, respectively.  Results indicate that the effect of WUR was significant for analyses 
of some traits, but that the magnitude and direction of the effect differed by trait and by 
line. Because analyses of purebred lines were performed using dEBVs for each trait, 
dominance effects were expected to be minimal, and thus, only differences between the 
AA and AB genotypes will be discussed. At the WUR SNP, the B allele has also been 
shown to act in a completely dominant manner to the A allele (Boddicker et al., 2014b). 
 
Reproduction traits 
No significant effect of PRRS_Vacc*WUR or WUR was detected for analyses of 
reproduction traits for the D1 (P > 0.20) or D2 line (P ≥ 0.05). However, a tendency (P = 
0.05) for a significant effect of PRRS_Vacc*WUR was detected for analysis of FSL for 
the D2 line (Table 3). No difference (P > 0.34) in FSL was detected between WUR 
genotypes within the Non-Vx group, but AB pigs had significantly (P < 0.001) greater 
FSL than AA pigs within the Vx group. Within the Vx group, the effect size for AB pigs 
(0.18, expressed in genetic standard deviation [SD] units for the trait) was higher than for 
AA pigs.  
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Finishing traits 
No significant (P ≥ 0.33) effect of WUR on dEBV was detected for any of the 
finishing traits for the across-line analysis (Table 4). However, a significant (P = 0.004) 
effect of WUR x Line was detected for TGR, driven by a significant (P = 0.002) effect of 
WUR on TGR for the S1 line and a tendency for a significant (P = 0.09) effect of WUR 
on TGR for the S2 line. No significant (P ≥ 0.19) effect of WUR on TGR was detected 
for either of the dam lines. A significant (P = 0.004) effect of WUR x Line was also 
detected for LGR where a significant (P = 0.002) effect of WUR on LGR was detected 
for the Sl line, but not the S2, D1, or D2 lines (P  ≥ 0.26). 
When each dam line was analyzed separately, no significant effect of PRRS_Vacc 
x WUR or WUR was detected for analyses of finishing traits (P > 0.15). However, a 
tendency (P = 0.07) for a significant effect of PRRS_Vacc x WUR was detected for TGR 
for the D2 line (Table 4), where Vx AB pigs had significantly (P = 0.003) (0.39 genetic 
SD) lower TGR than Non-Vx AB pigs, and Non-Vx AA pigs and Vx AA pigs had 
significantly (P = 0.04 and 0.02, respectively) (0.10 and 0.32 genetic SD, respectively) 
lower TGR than Non-Vx AB pigs.  
Several significant associations of WUR with finishing traits were detected for 
analysis of each sire line separately (Table 4). For the S2 line, AB pigs had significantly 
(P = 0.0006) (0.17 genetic SD) greater DFI than AA pigs, but no difference in DFI was 
detected between BB and AB pigs (P = 0.13). Consequently, AB pigs also had 
significantly (P = 0.03) (0.09 genetic SD) greater TGR than AA pigs, but no difference in 
TGR was detected between AA and BB (P = 0.20) or AB and BB (P = 0.70) pigs.  
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The opposite direction of effect was detected for analyses of DFI and TGR for the 
S1 line, where AA pigs had significantly (P = 0.006) (0.14 genetic SD) greater DFI than 
AB pigs and significantly (P = 0.006) greater DFI than BB pigs. However, AA pigs also 
had significantly (P = 0.01) (0.12 genetic SD) greater TGR than AB pigs and 
significantly (P = 0.002) greater TGR than BB pigs. Results also indicate that AA pigs 
had significantly (P = 0.005) (0.13 genetic SD) greater LGR than AB pigs and 
significantly (P = 0.002) greater LGR than BB pigs.  
 
TSI 
Results for the effect of WUR genotype on TSI within and across lines are 
presented in Table 5. No significant effect of WUR was detected on TSI for any one line 
(P ≥ 0.15) or across lines (P = 0.56), although numerically, AB pigs had the greatest TSI 
value for analyses of the dam lines and AA pigs had the greatest TSI value for analyses 
of the sire lines.  
 
Analyses of crossbred data 
 
Results of phenotypic analyses of the S1x(D1xD2) crossbred progeny showed no 
significant effect of average parent WUR genotype on DFI, BFE, TGR, or LGR (P ≥ 
0.07) (Table 6). However, there was suggestive evidence (P = 0.07) for an effect of 
average parent WUR genotype on BFE, for which BFE of S1x(D1xD2) progeny 
increased by 0.59 ± 0.32 mm for every 1 unit increase in the average number of B alleles 
carried by parents at the WUR SNP. 
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Discussion 
 
This is the first study to estimate the effect of WUR genotype, a tag SNP for a 
major QTL for host response to PRRS, on both reproduction and finishing traits in 
commercial pig lines under non-challenging conditions. Since the initial identification of 
the QTL, other studies have validated the effect of WUR across breeds and breeding 
companies (Boddicker et al., 2014a; Boddicker et al., 2014b), upon infection with 2 
North American PRRSV isolates (Hess et al., 2016), following vaccination with a type 1 
(Abella et al., 2016) and type 2 PRRS MLV vaccine (Dunkelberger et al., 2017), and 
upon co-infection with PCV2b (Dunkelberger et al., 2017). However, prior to 
implementing selection for WUR to breed pigs for improved host response to PRRS, it 
must be established that the favorable (B) allele under PRRS challenge does not have a 
detrimental effect on an important selection index trait in a clean environment; hence, the 
motivation for this study.  
Results of the Chi-Square Test showed significant deviation from HWE for WUR 
for the D2 and S2 lines. For both lines, deviations from HWE were driven by fewer 
heterozygotes and more BB pigs than expected. The most likely explanation for this 
result is that with such large sample sizes, even small deviations of the observed 
genotype count from the expected genotype count can produce a significant result. For 
example, the observed/expected frequencies of the BB genotype were 1.25%/1.00% and 
3.90%/3.16%, for the D2 and S2 lines, respectively. Within line, differences between 
these observed and expected genotype frequencies were less than 0.75. Therefore, 
although significant departure from HWE was observed for WUR for these lines, these 
deviations are not of practical relevance.  
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 One reason that the association of the B allele with reproduction and/or finishing 
traits in a clean environment was brought into question is because there is a low 
frequency of the B allele within commercial populations. One hypothesis for the 
observed low frequency of this allele is that the B allele may be unfavorably associated 
with an index trait under non-challenging conditions and, thus, may have been selected 
against in high-health nucleus facilities. Although some potentially unfavorable 
associations of WUR with index traits were detected for analyses of the sire lines in 
support of this hypothesis, the magnitude and direction of effect differed by trait and by 
line and due to small effect sizes, are not considered to be of practical relevance.  
The 5 reproduction traits and 4 finishing traits evaluated in this study were 
selected for analysis since they receive the greatest emphasis in the selection index for 
dam lines and sire lines, respectively. Results showed no significant effect of WUR on 
any of the reproduction or finishing traits in the dam lines, except FSL, for which a 
significant interaction of PRRS_Vacc x WUR was detected for the D2 line. For this line, 
no evidence of a difference in FSL was detected between genotypes within the Non-Vx 
group, but AB pigs had significantly greater FSL than AA pigs within the Vx group. Pigs 
in the latter group originated from farms that vaccinate dams with a PRRS MLV vaccine 
at d 60 of gestation.  The PRRS MLV vaccine is a live virus vaccine, meaning that dams 
may have been positive for PRRSV at the time of gestation, exposing piglets to PRRSV. 
Therefore, this result indicates that, of piglets born to dams potentially positive for PRRS, 
AB pigs had a significantly higher chance of surviving farrowing than AA pigs, which is 
consistent with previously reported results of a protective effect of the B allele following 
PRRS MLV vaccination (Dunkelberger et al., 2017).  
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Some significant associations of WUR with index traits were detected for 
analyses of the sire lines, but the magnitude and direction of this effect differed by trait 
and by line. For DFI, TGR, and LGR, the direction of the WUR effect was consistent 
within each line, but the opposite direction of effect was detected across lines. For 
instance, AB pigs had significantly lower DFI, and consequently lower TGR and LGR 
than AA pigs for the S1 line, but the opposite direction of effect was detected for the S2 
line. For the S2 line, AB pigs had significantly greater DFI and significantly greater TGR 
than AA pigs. However, regardless of the magnitude or direction of these effects for the 
S1 and S2 lines, effect sizes of WUR for DFI, TGR, and LGR (expressed as a proportion 
of the genetic SD) were small. Therefore, although significant associations with WUR 
were detected for these traits, these associations are likely not of practical relevance. 
Furthermore, although AB pigs had lower DFI, TGR, and LGR for the S1 line, 
overall impact on feed efficiency may not be negative, because the direction of the effect 
was the same for feed intake and growth. This was evaluated for the S1 line using the 
WUR genotype effects for the S1 line and the phenotypic means for DFI and TGR for the 
S1x(D1xD2) individuals. The same gain:feed ratio (i.e. g of weight gain per d during the 
test period to g of feed consumed per d during the test period) was observed for AA, AB, 
and BB pigs (0.38:1). The gain:feed ratio for S1x(D1xD2) progeny was also 0.38:1 for 
AA, AB, and BB pigs. However, it is important to note that the SE of the WUR effect for 
BB pigs was large, due to a low number (n = 73) of BB S1x(D1xD2) individuals. 
Therefore, although differences in the magnitude of the WUR effect were observed for 
feed intake and growth for the S1 line, these differences are likely not practically relevant 
and do not appear to negatively impact gain:feed ratio of AB S1 line or crossbred 
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individuals, which might also explain why WUR had no significant effect on TSI for this 
line. 
Taken together, few significant associations of WUR with index traits were 
detected for the purebred commercial lines used for this study. For associations that were 
detected, the magnitude and direction of effect differed by trait and by line. For the 
significant associations that were detected, the small effect sizes indicate little practical 
relevance of WUR genotype on the trait of interest. Results from analyses of each line 
separately and the across-line analysis indicate failure to identify a significant, negative 
effect of WUR across lines for any one trait. Results for the TSI analyses showed no 
significant effect of WUR on overall TSI for analysis of each line separately, or analysis 
of TSI across lines. The results of the TSI analyses are particularly important because 
they indicate that the combined effect of WUR on all traits included in the selection index 
(whether favorable or unfavorable for individual traits) did not have a significant effect 
on the overall economic value of individuals within a line. This finding provides 
additional support to select for the B allele to breed pigs for improved host response to 
PRRS.   
Based on the finding that no consistent, negative association of WUR with any 
one trait was detected across lines, it remains unclear why the B allele is in low frequency 
in commercial populations. The negative association with growth rate for the S1 line may 
partially explain the low frequency of this allele in that line. However, the opposite 
direction of effect on growth rate was observed for the S2 line. This could be because the 
linkage phase between WUR and the causative mutation are opposite for these two lines. 
However, Koltes et al. (2015) showed that the putative causative mutation was perfectly 
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concordant with WUR genotype for pigs with different haplotypes in the WUR region. 
Analyzing growth rate at different stages of production as separate traits might also 
provide some clarity regarding the effect of WUR on growth. Secondly, we cannot rule-
out that the low frequency of the B allele may be due to a negative association of WUR 
with a trait that has been under (natural) selection and that was not analyzed in the current 
study. Perhaps the most likely reason for the low frequency of the favorable allele at 
WUR, however, is that there is no selective advantage in the absence of disease and, thus 
has not been selected for since most selection is performed in clean environments.  
Prior to this study, information regarding the effect of WUR in a clean 
environment was limited to the effect of WUR on reproductive performance in gestating 
sows (Serão et al., 2014) and growth rate in finishing pigs (Abella et al., 2016). Results 
from the current study are consistent with those reported by Serão et al. (2014) who 
showed that, prior to a natural PRRS outbreak, the effect on WUR on reproductive 
performance of commercial gestating females was non-significant for all traits analyzed, 
except number weaned. For this trait, an unfavorable association of WUR with 
reproductive performance was detected where the B allele was associated with 
significantly fewer piglets weaned (Serão et al., 2014). 
For the effect of WUR on growth rate under non-challenging conditions, results 
reported by Dunkelberger et al. (2017) showed that AB pigs grew significantly faster than 
AA pigs when vaccinated against PRRSV, but not significantly different from AA pigs 
when not vaccinated against PRRSV. These results conflict with findings from a recent 
study where AB pigs had significantly slower growth than AA pigs during finishing 
(Abella et al., 2016). Possibly, this discrepancy can be attributed to the fact that pigs used 
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for the Abella et al. (2016) study were 6 weeks older than those used for the study 
conducted by Dunkelberger et al. (2017). However, results reported by Abella et al. 
(2016) agree with results reported for the S1 line where the favorable (B) allele under 
PRRSV-infection was unfavorably associated with growth during finishing. Compared to 
the study conducted by Abella et al. (2016), for the current study, different breeds were 
used, growth rate was measured over a longer period of time, and at least 10 times the 
number of individuals per line were used for analyses.  
The second objective of this study was to estimate the effect of average parent 
WUR genotype on performance of crossbred progeny. The S1x(D1xD2) pigs that were 
used for this objective were the progeny of purebred S1 sires and D1D2 F1 females. DFI, 
BFE, TGR, and LGR were analyzed using phenotypic records collected on S1x(D1xD2) 
progeny in test stations. Results indicate no significant effect of average parent WUR 
genotype on performance for any of the traits. Thus, WUR genotype of the parents did 
not negatively impact DFI, BFE, TGR, or LGR of their commercial crossbred offspring. 
Further analysis of WUR genotype of the S1x(D1xD2) individuals themselves also 
showed no significant effect of own WUR genotype on DFI, BFE, TGR, or LGR (data 
not shown). Because the farms where the crossbred pigs were raised were designed to 
mimic commercial conditions, the finding that neither parent average WUR genotype, 
nor WUR genotype of the individual itself had a significant effect on any of the evaluated 
traits, indicates that WUR genotype did not negatively impact performance of 
commercial crossbred finishing pigs reared in a commercial setting. 
Based on these results, our recommendation to the industry is to sort boars for the 
B allele and to market these pigs as boars with naturally higher resistance to PRRS. This 
  
246 
approach may be used as a simpler and less time-intensive alternative to including WUR 
genotype in the selection index. Instead, index value calculation and identification of top-
ranking sires can be performed normally, followed by selection of sires with the BB 
genotype. It is expected that progeny of BB sires, which will have at least one copy of the 
B allele, will have increased resistance to PRRS and no significant difference in TSI from 
progeny of AA or AB sires. Of the lines analyzed in this study, we recommend to begin 
sorting S1 line sires. Although negative associations with WUR were detected for feed 
intake and growth rate for this line, no significant effect of WUR was detected on TSI, 
the frequency of the B allele is highest within the S1 line, and pigs from this line are 
already noted for increased robustness to disease challenge and environmental stressors 
in the field.  
Conclusions 
 
In conclusion, some significant associations of WUR with index traits were 
detected, but the magnitude and direction of the effect differed by trait and by line. With 
the exception of FSL, no effect of WUR was detected on reproduction or finishing traits 
for the dam lines in a clean environment. Significant associations of WUR with finishing 
traits were detected for the sire lines, but with the opposite direction of effect across lines. 
The favorable (B) allele for host response to PRRS was associated with significantly 
higher feed intake and a tendency for faster growth in the S2 line, but significantly lower 
feed intake and significantly slower growth in the S1 line.  
However, despite significant effects detected on individual traits, these effects are 
not expected to be practically relevant and no significant effect of WUR on overall 
selection index value was detected for any line. Furthermore, neither parent WUR 
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genotype, nor WUR genotype of the individual itself had a significant effect on 
performance of S1x(D1xD2) crossbred progeny reared in commercial-like conditions. 
Based on these results, selecting for the B allele is expected to result in progeny with 
increased resistance to PRRS without compromising overall economic value under 
normal, non-challenging conditions. 
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Table 7.1. Number of individuals, sires, and dams per line used for analyses. 
  
Linea n Number of sires Number of dams 
D1 9,264 628 2,946 
D2 18,458 710 4,330 
S1 7,228 497 2,175 
S2 8,868 449 2,353 
 
 
aLine: Lines D1, D2, S1, and S2 correspond to a purebred Landrace maternal line, Large 
White maternal line, synthetic boar line, and Pietrain boar line, respectively. 
 
 
 
Table 7.2. Genotype frequencies for WUR10000125 (WUR) by line. 
 
 
Linea MAFb 
 Genotype frequency  
P-valuec 
 AA AB BB  
D1 0.20  0.64 0.32 0.04  0.20 
D2 0.10  0.81 0.18 0.01  0.0008 
S1 0.22  0.61 0.34 0.05  0.26 
S2 0.18  0.68 0.28 0.04  <0.0001 
 
 
aLine: Lines D1, D2, S1, and S2 correspond to a purebred Landrace maternal line, Large 
White maternal line, synthetic boar line, and Pietrain boar line, respectively. 
bMAF, Minor Allele Frequency: frequency of the B allele.  
cP-value: P-value for a Chi Square Test of the observed versus expected genotype 
frequencies.  
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Table 7.3. P-values and Least Square (LS) means (± SE) for the effect of WUR10000125 (WUR) on de-regressed estimated breeding 
values by genotype and line for reproduction traits.  
 
 
Trait Linea 
LS Mean 
P-value Add Effectb P-value Dom Effectc P-value 
AA AB BB 
TNBd 
D1 -0.23a ± 0.08 -0.23a ± 0.09 -0.44a ± 0.22 0.61 -0.11 ± 0.11 0.32 0.10 ± 0.13 0.42 
D2 -0.23a ± 0.07 -0.34a ± 0.10 -0.42a ± 0.27 0.37 -0.10 ± 0.13 0.47 -0.02 ± 0.15 0.91 
STBe 
D1 -0.11a ± 0.03 -0.06a ± 0.03 -0.04a ± 0.08 0.20 0.03 ± 0.04 0.40 0.02 ± 0.05 0.68 
D2 -0.12a ± 0.03 -0.06a ± 0.04 0.003a ± 0.11 0.14 0.06 ± 0.05 0.24 -0.003 ± 0.06 0.96 
FSLf 
D1 1.67a ± 0.28 1.68a ± 0.30 1.61a ± 0.52 0.99 -0.03 ± 0.24 0.90 0.04 ± 0.27 0.88 
D2, NonVxg 1.37a ± 0.38 1.49a ± 0.42 1.03a ± 0.67 0.63 -0.17 ± 0.28  0.55 0.29 ± 0.31  0.35 
D2, Vxh 1.30b ± 0.24 1.96a ± 0.29 2.82a ± 0.77 <0.001 0.76 ± 0.37 0.04 -0.10 ± 0.39 0.79 
LSLj 
D1 2.40a ± 0.39 2.14a ± 0.42 2.13a ± 0.73 0.62 -0.14 ± 0.34 0.68 -0.13 ± 0.39 0.73 
D2 2.90a ± 0.40 2.77a ± 0.45 1.40a ± 0.88 0.17 -0.75 ± 0.40 0.06 0.62 ± 0.44 0.16 
LMOk 
D1 -0.44a ± 0.18 -0.57a ± 0.25 -0.95a ± 0.70 0.72 -0.26 ± 0.36 0.47 0.13 ± 0.43 0.76 
D2 -0.50a ± 0.24 -0.86a ± 0.32 -0.88a ± 0.84 0.37 -0.19 ± 0.41 0.64 -0.17 ± 0.47 0.70 
 
Within each row, estimates with different letter assignments significantly differ at P < 0.05. 
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aLine: Lines D1 and D2 correspond to a purebred Landrace maternal line and Large 
White maternal line, respectively. 
bAdd Effect: Additive effect of WUR. 
cDom Effect: Dominance effect of WUR.  
dTNB, Total Number Born: Defined as the number of live born piglets plus the number of 
stillborn piglets within a litter. 
eSTB, Stillborn: Defined as the number of stillborn piglets within a litter. 
fFSL, Farrowing Survival: Whether a piglet did(=1)/did not(=0) survive farrowing, 
analyzed as a continuous trait as the probability of surviving farrowing. There was 
suggestive evidence (P = 0.05) of a significant effect of WUR x PRRS vaccination status 
(PRRS_Vacc). P-values for the effect of PRRS_Vacc x WUR_add and PRRS_Vacc x 
WUR_dom were P = 0.16 and P = 0.02, respectively.  
gNonVx, Non Vaccinated: Pigs were not vaccinated against porcine reproductive and 
respiratory syndrome virus (PRRSV). 
hVx, Vaccinated: Pigs were vaccinated against PRRSV. 
iNC, No Convergence: Analysis did not converge. 
jLSL, Lactation Survival: whether a piglet did(=1)/did not(=0) survive until weaning, 
analyzed as a continuous trait as the probability of surviving until weaning.  
kLMO, Litter Mortality: Recorded as the number of piglets that died between birth and 
weaning. 
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Table 7.4. P-values and Least Square (LS) means (± SE) for the effect of WUR10000125 (WUR) on de-regressed estimated breeding 
values by genotype and line (or across lines) for finishing traits.  
 
 
 
Within each row, estimates with different letter assignments significantly differ at P < 0.05. 
Trait Linea 
LS Mean 
P-value Add Effectb P-value Dom Effectc P-value 
AA AB BB 
BFEd 
D1 0.10a ± 0.15 0.15a ± 0.16 0.09a ± 0.18 0.38 -0.003 ± 0.05 0.95 0.05 ± 0.05 0.28 
D2 0.55a ± 0.18 0.63a ± 0.18 0.58a ± 0.21 0.15 0.01 ± 0.06 0.83 0.06 ± 0.06 0.31 
S1 0.39a ± 0.13 0.36a ± 0.13 0.33a ± 0.15 0.62 -0.03 ± 0.04 0.45 -0.002 ± 0.05 0.96 
S2 -0.11a ± 0.09 -0.13a ± 0.10 -0.15a ± 0.11 0.62 -0.02 ± 0.03 0.55 -0.007 ± 0.04 0.85 
Across Lines 0.24a ± 0.08 0.25a ± 0.08 0.21a ± 0.09 0.36 -0.01 ± 0.02 0.62 0.03 ± 0.03 0.21 
DFIe 
D1 19.93a ± 13.43 30.76a ± 13.82 25.49a ± 19.97 0.24 2.78 ± 8.02 0.72 8.05 ± 8.93 0.37 
D2 31.91a ± 17.50 27.45a ± 18.34 34.18a ± 28.10 0.80 1.13 ± 11.20 0.92 -5.60 ± 12.01 0.64 
S1 22.94a ± 18.33 2.50b ± 18.73 -20.44b ± 23.24 0.004 -21.69 ± 7.94 0.01 1.25 ± 8.95 0.88 
S2 15.57b ± 22.46 40.79a ± 23.32 65.01a ± 27.82 <0.001 24.72 ± 8.43 0.004 0.50 ± 8.99 0.95 
Across Lines 22.23a ± 8.96 23.88a ± 9.28 22.50a ± 12.26 0.90 0.14 ± 4.43  0.97 1.52 ± 4.86 0.75 
TGRf 
D1 7.40a ± 4.59 10.22a ± 4.67 8.15a ± 6.11 0.28 0.37 ± 2.21 0.86 2.45 ± 2.41 0.31 
D2, NonVxg 11.17a ± 6.72 16.42a ± 7.07 15.32a ± 9.93 0.19 2.08 ± 3.76 0.58 3.17 ± 4.10 0.44 
D2, Vxh -0.51a ± 5.35 -4.59a ± 5.76 -7.61a ± 11.93 0.30 -3.55 ± 5.41 0.51 -0.54 ± 5.64 0.92 
S1 -3.49a ± 6.11 -9.66b ± 6.24 -19.16b ± 7.66 0.002 -7.84 ± 2.56 0.002 1.67 ± 2.87 0.56 
S2 -6.83b ± 7.64 -1.81a ± 7.91 0.17ab ± 9.34 0.09 3.50 ± 2.75 0.21 1.52 ± 2.91 0.60 
Across Linesi -0.91a ± 2.85 -0.24a ± 2.94 -2.35a ± 3.81 0.44 -0.72 ± 1.33  0.49 1.39 ± 1.45 0.21 
LGRj 
D1 7.00a ± 2.74 8.38a ± 2.80 5.91a ± 3.74 0.36 -0.55 ± 1.39 0.69 1.92 ± 1.52 0.21 
D2 3.21a ± 3.24 2.24a ± 3.38 2.00a ± 4.99 0.74 -0.60 ± 1.93 0.75 -0.36 ± 2.07 0.86 
S1 -0.27a  ± 3.94 -4.69b ± 4.02 -10.89b ± 4.96 0.001 -5.31 ± 1.67 0.002 0.89 ± 1.88 0.63 
S2 -3.87a  ± 4.83 -1.46a ± 5.00 -1.07a ± 5.89 0.26 1.40 ± 1.73 0.42 1.02 ± 1.83 0.58 
Across Linesk 1.66a ± 1.79 1.35a ± 1.85 -0.57a ± 2.41 0.33 -1.12  ± 0.85 0.14 0.81  ± 0.93 0.27 
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aLine: Lines D1, D2, S1, and S2 correspond to a purebred Landrace maternal line, Large 
White maternal line, synthetic boar line, and Pietrain boar line, respectively. 
bAdd Effect: Additive effect of WUR. 
cDom Effect: Dominance effect of WUR.  
dBFE, Backfat: Recorded as fat depth at the end of the test period (~120 Kg) in mm.  
eDFI, Daily Feed Intake: Recorded in g per d from start to end of the test period.  
fTGR, Test Daily Gain: Expressed in g of weight gain per d from start to end of the test 
period. There was suggestive evidence (P = 0.07) of a significant effect of WUR x PRRS 
vaccination status (PRRS_Vacc). P-values for the effect of PRRS_Vacc x WUR_add and 
PRRS_Vacc x WUR_dom were P = 0.85 and P = 0.17, respectively.  
gNonVx, Non-Vaccinated: Pigs were not vaccinated against porcine reproductive and 
respiratory syndrome virus (PRRSV). 
hVx, Vaccinated: Pigs were vaccinated against PRRSV. 
iAcross Lines: A significant effect of WUR x Line (P = 0.004) was detected. P-values for 
the effect of WUR_add x Line and WUR_dom x Line were P = 0.01 and P = 0.96, 
respectively.  
jLGR, Lifetime Daily Gain: Expressed in g of weight gain per d from birth until end of 
the test period.  
kAcross Lines: A significant effect of WUR x Line (P = 0.004) was detected. P-values for 
the effect of WUR_add x Line and WUR_dom x Line were P = 0.02 and P = 0.85, 
respectively.  
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Table 7.5. P-values and Least Square (LS) means (± SE) for the effect of WUR10000125 (WUR) genotype on Topigs Selection Index 
value by genotype and line or across lines.  
 
 
Linea 
 LS Mean  
P-value Add Effectb P-value Dom Effectc P-value 
 AA AB BB  
D1  93.77a ± 1.75 93.87a ± 1.75 93.39a ± 1.86  0.74 -0.19 ± 0.37 0.60 0.29 ± 0.38 0.44 
D2  82.40a ± 1.79 82.75a ± 1.80 81.72a ± 1.94  0.15 -0.34 ± 0.39 0.38 0.69 ± 0.38 0.07 
S1  90.07a ± 1.49 89.76a ± 1.50 89.69a ± 1.57  0.48 -0.19 ± 0.27 0.49 -0.12 ± 0.27 0.65 
S2  89.92a ± 1.46 89.78a ± 1.48 89.36a ± 1.59  0.69 -0.28 ± 0.33 0.39 0.13 ± 0.32 0.67 
Across Linesd  89.34a ± 0.86 89.35a ± 0.86 89.02a ± 0.91  0.56 -0.16 ± 0.17 0.35 0.17 ± 0.17 0.32 
 
 
Within each row, estimates with different letter assignments significantly differ at P < 0.05. 
 
aLine: Lines D1, D2, S1, and S2 correspond to a purebred Landrace maternal line, Large White maternal line, synthetic boar line, and 
Pietrain boar line, respectively. 
bAdd Effect: Additive effect of WUR. 
cDom Effect: Dominance effect of WUR.  
dAcross Lines: A significant effect of Line x PRRS vaccination status (P < 0.001) was detected.  
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Table 7.6. Estimate (± SE) and p-value for the effect of average parent WUR10000125 
(WUR) genotype for index traits of commercial crossbred progeny. 
 
 
Trait Raw trait mean SDa ASEb P-value 
DFIc 2332.2 255.9 9.80 ± 28.93 0.73 
BFEd 13.9 2.7 0.59 ± 0.32 0.07 
TGRe 894.6 86.7 3.90 ± 11.61 0.73 
LGRf 552.0 48.0 2.59 ± 6.03 0.66 
 
 
aSD, Standard Deviation.  
bASE, Allele Substitution Effect: Average WUR genotype of the parents where genotype 
was coded as the number of copies of the B allele.  
cDFI, Daily Feed Intake: Recorded in g per d from start to end of the finishing period.  
dBFE, Backfat: Recorded as fat depth at the end of the finishing period in mm.  
eTGR, Test Daily Gain: Expressed in g of weight gain per d from start to end of  
the finishing period. 
fLGR, Lifetime Daily Gain: Expressed in g of weight gain per d from birth to end of the 
finishing period.  
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CHAPTER 8. GENERAL DISCUSSION 
 
The focus of this thesis was to investigate the role of host genetics in 
susceptibility to viral disease in pigs. Porcine reproductive and respiratory syndrome 
(PRRS), which affects pigs during all stages of production and is considered the most 
costly of swine diseases, was used to address this objective. Several chapters of this thesis 
also addressed the role of host genetics in susceptibility to co-infection with PRRS and 
porcine circovirus type 2b (PCV2b), another common viral disease in swine. The co-
infection with PRRS virus (PRRSV) and another pathogen was emphasized since the co-
infection of PRRSV with other pathogens is commonly observed in commercial settings.  
The study described in Chapter 3 looked broadly at the effect of selection for 
increased feed efficiency on susceptibility to PRRSV-infection. Subsequent chapters 
sought to validate the effect of known genomic regions associated with PRRS resistance 
and to identify other genomic regions associated with host response to PRRS vaccination 
and PRRSV/PCV2b co-infection. The practicality of using only single nucleotide 
polymorphisms (SNPs) within the WUR10000125 (WUR) region (a genetic maker for a 
major gene for host response to PRRS) to predict host response to PRRSV/PCV2b co-
infection, was addressed in Chapter 6. The final study, presented in Chapter 7, was 
designed to investigate the effect of this genetic marker on economically important traits 
under non-challenged conditions.  
The objectives of this discussion are to expand on the findings from these studies 
by: discussing that selection for increased performance does not necessarily cause 
increased susceptibility to viral disease as a correlated response, describing the genetic 
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architecture of host response to PRRSV-infection by vaccination or co-infection with 
PRRSV and PCV2b, and to discuss the potential of using WUR and/or other identified 
regions to select pigs for improved host response to PRRS vaccination or PRRSV/PCV2b 
co-infection. The potential of selecting pigs for improved host response to PRRS, versus 
gene-editing for PRRS resistance, will also be discussed.  
 
Selection for Increased Performance Does Not Necessarily Cause Increased 
Susceptibility to Viral Disease 
 
Selecting livestock for increased performance is vital to livestock production. 
However, selection for increased performance is also hypothesized to be a potential cause 
of increased disease susceptibility. Resource Allocation Theory suggests that animals 
have a limited number of resources to perform biological processes (Rauw, 2012). 
Therefore, when increased selection pressure is placed on performance, such as growth, 
additional resources are directed towards these performance-related processes, leaving 
fewer available resources for other biological processes (Rauw et al., 1998). With fewer 
available resources for other processes, such as response to infection, an animal may be 
less able to cope with infectious disease stressors.  
There is evidence of this phenomena in some livestock species. In turkeys, 
increased incidence of mortality was identified in a line of turkeys selected for increased 
body weight following infection with Pasteurella multocida (Nestor et al., 1996). A study 
in dairy cattle also showed that cows selected for high milk production had greater 
incidence of mastitis, digestive disorders, and foot rot, compared to cows selected for low 
milk production (Shanks et al., 1978). Therefore, this theory was the motivation for the 
hypothesis presented in Chapter 3: when subjected to a PRRS challenge, pigs selected for 
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increased feed efficiency (low residual feed intake [LRFI] pigs) would be more affected 
by viral challenge than the less feed efficient (high RFI [HRFI]) pigs. This hypothesis 
was formulated based on the assumption that LRFI pigs direct more resources towards 
growth than HRFI pigs, and therefore have fewer available resources to mount and 
maintain an immune response.  
Results from the study described in Chapter 3 did not support this hypothesis. In 
fact, results showed that the more efficient (LRFI) pigs were less affected by the PRRS 
challenge than the feed inefficient (HRFI) pigs. Although no evidence of a difference in 
growth rate was detected between lines under non-challenged conditions or challenged 
conditions, the interaction effect of RFI line x challenge status was significant.  This 
significant interaction effect indicated that LFRI pigs had less reduction in growth rate 
following PRRS challenge than their HRFI counterparts. Analyses of antibody data also 
showed that LRFI pigs had a greater increase in antibody production from 7 to 11 days 
post-infection, compared to HRFI pigs.  
These results showed that, not only were LRFI pigs not more affected, but were 
actually less affected by the PRRS challenge than the HRFI pigs. Although not expected, 
these results are consistent with results reported from other studies using these same lines 
of pigs, suggesting that selection for decreased RFI may have had an inadvertent, positive 
effect on other traits. For example, results from one study showed that LRFI sows 
weaned significantly more piglets and had numerically better lactation efficiency (defined 
as the ratio of energy output to energy input) than HRFI sows (Young et al., 2016). Other 
studies showed that LRFI pigs had a protein profile better equipped to deal with 
physiological stressors (Grubbs et al., 2014) and had less behavioral reactivity to humans 
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and novel objects (Colpoys et al., 2014) than HRFI pigs. Under non-challenged 
conditions, LRFI pigs also had lower numbers of circulating lymphocytes, basophils, and 
monocytes and tended to have a lower white blood cell count than HRFI pigs. These 
results suggest that divergent selection for feed efficiency based on RFI has significantly 
impacted the immune cell profile of LRFI versus HRFI pigs. Results may also suggest 
that LRFI pigs have more efficient production of lymphocytes, basophils, and monocytes 
compared to HRFI pigs under non-challenged conditions by producing fewer, but 
sufficient levels of these cell types (Mpetile et al., 2015).  
A parallel divergent selection experiment based on residual feed intake was 
initiated at the National Institute of Agricultural Research (INRA) in France in the year 
2000. In general, results from studies conducted at INRA agree with those using the Iowa 
State lines. For example, consistent with findings presented by Young et al. (2016), 
results from INRA show that LRFI sows had larger litters and increased mobilization of 
body reserves compared to HRFI sows (Gilbert et al., 2012). For the INRA lines, piglets 
born to LRFI sows also had better growth than piglets born to HRFI sows (Gilbert et al., 
2012). Similar to findings presented by Grubbs et al. (2014), research conducted at INRA 
showed that mitochondria from LRFI pigs had lower production of reactive oxygen 
species than HRFI pigs (Vincent et al., 2015). Vincent et al. (2015) also showed that 
LRFI pigs had fewer, and therefore more efficient, mitochondria production. The INRA 
study most similar to the one described in Chapter 3 was conducted to determine whether 
LRFI pigs were more affected by an immune challenge than HRFI pigs. To test this, 
Freund’s adjuvant was administered to elicit an inflammatory immune response. Results 
from this study showed no evidence of a difference in fever, haptoglobin, or growth 
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between lines (Merlot et al., 2016), indicating that, in young pigs, no difference in 
response to inflammatory challenge was detected between LRFI and HRFI pigs.  
Collectively, these results from two independent selection experiments challenge 
the Resource Allocation Theory, indicating that there is still much to learn regarding the 
physiology of pigs divergently selected for feed efficiency based on RFI. Based on the 
results presented in Chapter 3, and from other studies conducted at Iowa State and INRA, 
a new working hypothesis is that LRFI pigs are not immuno-compromised following 
challenge with an infectious or environmental stressor because they are better at directing 
resources where needed. The biological processes by which the more feed efficient 
(LRFI) pigs are able to do this, however, is not yet known and deserves further study.  
 
Genomic Regions are Associated with Resistance to Viral Disease 
 
The study described in Chapter 3 was designed to investigate susceptibility to 
PRRS challenge as a result of selection for another trait. An additional question of 
interest in this thesis was to identify specific regions of the genome associated with 
PRRSV susceptibility by analyzing host response to PRRS vaccination and 
PRRSV/PCV2b co-infection.  
 
The WUR SNP 
The data analyzed in Chapters 3-6 originated from experimental challenge studies 
conducted by the PRRS Host Genetics Consortium (PHGC).  The PHGC was initially 
formed with the objective of identifying genes and/or genomic regions associated with 
host response to PRRSV-infection. Results from analyses of the first three PHGC trials 
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identified WUR as a tag SNP for a major quantitative trait locus (QTL) for host response 
to PRRS. WUR was associated with 15.7% and 11.2% of the total genetic variation in 
PRRS viral load (VL) and weight gain (WG) following experimental PRRSV-infection, 
indicating the potential of using WUR to select pigs for improved host response to PRRS 
(Boddicker et al., 2012). 
However, prior to implementing selection based on a genetic marker, it is 
important to validate the effect of the marker under different conditions. Thus, PHGC 
trials 4-8 were designed to estimate the effect of WUR using pigs of different breeds and 
sourced from different companies. Pigs in subsequent PHGC trials (i.e. trials 10-14) were 
challenged with a different isolate of PRRSV than pigs from the preceding trials. Trials 
analyzed in Chapters 4-6 of this thesis were designed to estimate the effect of WUR 
under yet additional conditions: following PRRS MLV vaccination and co-infection with 
PRRS and another pathogen (i.e. PCV2b).  
Results presented in Chapter 4 showed that WUR was significantly associated 
with vaccination VL, PRRS VL, and also with PCV2b VL for pigs previously vaccinated 
against PRRSV. No significant effect of WUR on ADG was detected. Results from this 
study also provided some interesting insight regarding the role of WUR in the immune 
response. Due to the unique experimental design of these co-infection trials, it was 
possible to estimate the effect of WUR on host response to infection following primary 
versus secondary PRRSV exposure. Results showed that, although the effect of WUR on 
PRRS VL did not significantly differ following primary versus secondary exposure, the 
effect of WUR on PRRS VL was numerically greater following primary PRRSV 
exposure. However, it is important to note that, for PRRS VL of Non-Vx pigs following 
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PRRSV/PCV2b co-infection, considered a primary immune response trait, PRRSV-
infection was concurrent with PCV2b-infection. Nonetheless, this is an interesting result 
because it is consistent with the biological role of guanylate binding protein 5 (GBP5), 
the putative causative gene for the observed association of WUR with host response to 
PRRS (Koltes et al., 2015). There is evidence from previous studies that GBP5 has a role 
in the innate immune response to infection (Shenoy et al., 2012), which is assumed to 
play a greater role in primary versus secondary exposure since secondary response is 
largely mediated by the fast, specific mode of action of the adaptive immune system.  
Collectively, results for analyses of the PRRSV-only PHGC trials (trials 1-15) and 
the PRRSV/PCV2b co-infection trials presented in Chapter 4 (trials 16 and 20), validated 
the effect of WUR on PRRS VL across breeds, pigs sourced from different breeding 
companies, following infection with two different isolates of PRRSV, following PRRS 
MLV vaccination, and following co-infection with PRRSV and PCV2b. However, prior 
to the research presented in this thesis, little was known regarding the effect of WUR 
under non-challenged conditions. Exceptions are recent studies that estimated the effect 
of WUR on growth rate in finishing pigs (Abella et al., 2015) and reproductive 
performance in gestating sows (Serão et al., 2014). Abella et al. (2015) showed that pigs 
with the favorable (AB) genotype for PRRS had significantly lower ADG than pigs with 
the AA genotype under non-challenged conditions. These results conflict with those 
presented in Chapter 4, which showed no significant effect of WUR on ADG for non-
vaccinated pigs prior to co-infection. However, the pigs used for the study described in 
Chapter 4 were 6 weeks younger than those used for the study conducted by Abella et al. 
(2015).  
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The study described in Chapter 7 was designed to further investigate the effect of 
WUR on economically important traits under non-challenged conditions. An additional 
motivation of this objective was to identify possible negative associations of WUR with 
these traits as an explanation for the low frequency of the favorable (B) allele under 
PRRSV-infection within commercial populations. We hypothesized that the low 
frequency of the B allele is a result of a negative association with an economically 
important reproduction or finishing trait in a clean environment, and thus, may have been 
selected against in high-health, nucleus herds. Results from the study presented in 
Chapter 7 showed that the effect of WUR was non-significant for most traits and that the 
magnitude and direction of the effect differed by trait and by line. However, no 
significant effect on overall selection index value was detected for any of the lines. In 
addition, the negative effects that were detected were not large enough to be of practical 
relevance. Of the traits with significant effects, the most consistent, negative association 
identified was the association of WUR with growth rate for one of the sire lines. 
However, since the effect on feed intake was in the same direction, no difference in feed 
efficiency was detected between pigs with the AA, AB, or BB WUR genotype. 
Furthermore, no significant effect of WUR on growth rate, backfact, or feed intake was 
detected for analyses of commercial crossbred offspring.    
Of the commercial dam lines analyzed in Chapter 7, the effect of WUR on 
farrowing survival for the D2 line was the only significant effect detected. For this line 
and trait, the interaction of WUR by PRRS vaccination status was also significant. 
Results showed no difference in farrowing survival between WUR genotypes within the 
non-vaccinated group, but within the vaccinated group, AB pigs had significantly greater 
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farrowing survival than AA pigs. Pigs within the vaccinated group originated from farms 
that routinely vaccinate sows with a PRRS MLV vaccine at day 60 of gestation, meaning 
that piglets born to vaccinated sows may have been exposed to PRRSV by their mothers. 
Therefore, this result indicates that no difference in farrowing survival was detected 
between AA and AB pigs not exposed to PRRS, but for pigs potentially exposed to 
PRRSV, AB pigs had better farrowing survival than AA pigs. This result is consistent 
with the protective effect of the B allele following PRRS MLV vaccination reported in 
the study presented in Chapter 4. In addition, failure to detect a significant association of 
WUR with any of the other reproduction traits (i.e. total number born, number stillborn, 
lactation survival, or litter mortality) is consistent with results reported by Serão et al. 
(2014) who showed no significant effect of WUR on reproduction traits for most traits 
recorded under non-challenged conditions, and no significant effect of WUR on 
reproduction traits following a natural PRRS outbreak in a commercial herd of gestating 
sows.  
Opposed to the other studies presented in this thesis, for which pigs were pre-
selected for either the AA or AB genotype, the study presented in Chapter 7 also 
provided the opportunity to assess differences between pigs with the AA versus AB 
versus BB WUR genotype for each trait. However, due to low numbers of BB compared 
to AA and AB pigs, differences between genotypic classes were not always clear. Even 
so, of the six traits for which the effect of WUR was significant, differences between 
genotypes were in the expected direction. For example, no evidence of a difference was 
detected between AB/BB pigs and AB and BB pigs were both significantly different from 
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AA pigs. Therefore, results agree with the conclusion presented by Boddicker et al. 
(2014b) that the B allele is the dominant allele.   
Taken together, results from the study presented in Chapter 7 showed few 
significant associations of WUR with reproduction or finishing traits, but for significant 
effects that were detected, the magnitude of these effects were not large enough to be of 
practical relevance. These results are certainly encouraging for using WUR to select pigs 
for improved host response to PRRS, but the reason for the low frequency of the B allele 
is still not clear. The negative association with growth rate may partially explain the low 
frequency within commercial populations, yet this negative association was only 
observed for one of the sire lines. In addition, the opposite direction of effect was 
detected for the other sire line analyzed. A possible explanation for this result may be that 
the linkage phase between the WUR SNP and QTL is opposite for these lines. One way 
to investigate this would be to calculate the linkage disequilibrium (LD) between 
adjacent SNPs to identify whether, or not, a recombination event occurred within this 
region. If results of this analysis revealed that the linkage phase was, in fact, different 
between lines, then selecting on the causal mutation, rather than WUR, would be helpful. 
This would, however, require that the causative mutation for the QTL be included on 
future versions of the SNP chip.  
 
Other regions 
Given the significant effect of WUR on vaccination VL, PRRS VL, and PCV2b 
VL of vaccinated pigs, another objective of this thesis was to identify regions other than 
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WUR associated with host response to PRRS vaccination and PRRSV and PCV2b co-
infection. Results from this study are presented in Chapter 5. 
The strongest associations identified for the study presented in Chapter 5 were 
with PCV2b VL following co-infection. Results showed that several SNPs near the swine 
major histocompatibility complex (MHC), or swine leukocyte antigen (SLA) complex, 
were genome-wise significant, regardless of previous vaccination against PRRSV. These 
associations are biologically relevant since the SLA is known to harbor many immune-
related genes (Lunney et al., 2009). Although this small subset of SNPs represents an 
opportunity to select pigs for improved host response to PRRSV/PCV2b co-infection, 
selecting for SNPs within the MHC region may not be recommended since genes within 
this region are important for response to a wide array of pathogens. There is also a 
generally accepted theory that increased genetic diversity within the MHC is associated 
with increased pathogen resistance (Murphy, 2012). This theory is based on the idea that, 
the more allelic diversity, the higher the probability that the MHC will recognize and 
bind to antigen derived from a pathogen.  
Several regions were also significantly associated with ADG following PRRS 
MLV vaccination and PRRSV/PCV2b co-infection. Most of these regions were also 
associated with ADG under non-challenged conditions in previous studies and may, 
therefore, represent opportunities to select for improved growth rate, regardless of PRRS 
challenge status. Results presented in Chapter 4 also showed a high, positive genetic 
correlation between ADG of vaccinated and non-vaccinated pigs prior to co-infection and 
after co-infection. These results indicate that, within time period, many of the same genes 
that controlled growth for vaccinated pigs also controlled growth for non-vaccinated pigs. 
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GWAS results reported in Chapter 5 revealed the few differences. For example, some 
different regions were significantly associated with ADG of vaccinated versus non-
vaccinated pigs, including one SNP identified post vaccination and one SNP identified 
post co-infection that had significantly different effects on ADG, depending on prior 
vaccination for PRRS. Contrary to results for ADG, no regions were significantly 
associated with vaccination VL or PRRS VL for the study presented in Chapter 5. These 
results are consistent with those reported by Waide et al. (2017) who also showed that, 
other than WUR, host response to PRRS VL was highly polygenic. Collectively, results 
presented by Waide et al. (2017) and those in Chapter 5 imply that regions other than 
WUR have limited effects on PRRS VL following PRRS vaccination, PRRSV-only 
infection, or PRRSV/PCV2b co-infection.  
 Another objective of identifying regions associated with host response to 
vaccination and co-infection was to identify regions that can be used to select for 
“vaccine-ready” pigs (i.e. pigs with improved host response to vaccination followed by 
infection with a field isolate of PRRSV or co-infection with PRRSV and PCV2b). Given 
that different subsets of SNPs were associated with ADG for vaccinated versus non-
vaccinated pigs following vaccination and co-infection, SNPs significantly associated 
with ADG for vaccinated pigs have potential to be used to select for “vaccine-readiness”, 
especially those with a significantly different effect on ADG, depending on prior 
vaccination for PRRS. Results presented in Chapter 4 also showed that vaccinated pigs 
with the AB WUR genotype had significantly reduced PCV2b VL following co-infection. 
However, no difference in PCV2b VL was detected between WUR genotypes for pigs not 
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previously vaccinated against PRRSV. Therefore, selecting based on WUR genotype may 
also increase “vaccine-readiness” following PRRSV/PCV2b co-infection.  
 
Genetic Selection Strategies to Breed Pigs for Improved Host Response to PRRS 
 
Taken together, results presented in Chapters 4, 5, and 7 add to previously 
reported results presented by Boddicker et al. (2012, 2014a, 2014b), Hess et al. (2016), 
and Waide et al. (2017) and make a strong case for selecting pigs based on WUR 
genotype to breed pigs for improved host response to PRRS, whether by PRRSV-only 
infection, PRRS MLV vaccination, or PRRSV/PCV2b co-infection. However, one 
question that remains is whether pigs should be selected based on WUR genotype only, 
or on WUR and other regions associated with host response to PRRS vaccination and/or 
co-infection, or using SNPs across the genome? Some possible genetic selection methods 
for these scenarios are discussed below.  
 
Marker-assisted selection  
One strategy of using WUR to select for improved host response to PRRS is to 
use marker assisted selection (MAS). Various ways of incorporating MAS into a 
breeding scheme have been described by Dekkers (2004). Dekkers (2004) highlights 
three main strategies, all of which involve the use of a molecular score, calculated based 
on genotype at a single or multiple loci. These strategies include: tandem selection, index 
selection, and pre-selection. Tandem selection is defined as selection based on molecular 
score, followed by selection on phenotype or estimated breeding value (EBV). Index 
selection is based on a combined molecular score plus phenotype or EBV, where weights 
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are applied to both the molecular score and phenotype/EBV. The third strategy, referred 
to as pre-selection, is defined as selection based on molecular score at a young age, 
followed by selection on an up-dated EBV at a later age.  
Any of the above three methods could be used to select pigs based on WUR 
genotype alone, or with other candidate SNPs for host response to PRRS or 
PRRSV/PCV2b co-infection. If based on WUR genotype alone, the molecular score 
would reflect the effect of WUR genotype only. If based on the effect of WUR and other 
candidate SNPs, such as those identified in Chapter 5, the molecular score would be a 
combined scored based on SNP genotype at multiple loci.  
An alternative MAS strategy to the options above is to use tandem selection, but 
in the reverse order. For example, the first step would be to calculate index values for all 
selection candidates without including molecular score in the index, followed by 
selecting individuals with the desired genotype from a pool of top-ranking individuals. 
For WUR, this could be implemented by calculating index values for all selection 
candidates normally, followed by selecting top-ranking sires with the BB genotype to be 
used as parents for the next generation. This strategy would be a fast and easy way to 
increase the frequency of the B allele within the population. It would be sufficient to 
perform selection for sires only, rather than for both dam and sire lines, since progeny 
would only need to inherit one copy of the B allele for increased PRRS resistance 
(Boddicker et al., 2014a,b).  
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Genomic prediction 
An alternative genetic selection strategy to MAS is genomic selection. One 
advantage of genomic selection over MAS is the ability to determine the genetic merit of 
an individual using all SNPs in the genome. This genetic selection method is particularly 
attractive for genetically improving complex traits, such as disease-related traits, which 
are often controlled by many loci with small effects (Goddard and Hayes, 2009).  
Previous research conducted by Boddicker et al. (2014a) showed that using SNPs 
within the 1-Mb window containing WUR had superior predictive ability to using SNPs 
across the genome for some cases. Follow-up analyses were conducted by Waide et al. 
(2015) to evaluate the predictive ability of training and validating on PHGC trials 
infected with one of two different isolates of PRRSV. Results from these analyses 
confirmed those reported by Boddicker et al. (2014a) and showed that, for PRRS VL, 
using SNPs within the WUR region had superior predictive ability to using SNPs across 
the genome. However, using SNPs across the genome had better predictive ability than 
using only SNPs significantly associated with PRRS VL following PRRSV-only 
infection (Waide, 2015). For WG, using SNPs within the WUR region only, or only 
significant SNPs, had lower prediction accuracy compared to using SNPs across the 
genome when training on NVSL trials and validating on KS06 trials. Therefore, to 
evaluate the feasibility of using only SNPs within the WUR region to select pigs for 
improved host response to co-infection, one objective of Chapter 6 was to assess the 
predictive ability of using only SNPs within the WUR region, versus SNPs across the 
genome, or SNPs other than those within the WUR region. The predictive ability of these 
SNP subsets was assessed using a PRRSV-only infected training population to predict 
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host response to PRRSV/PCV2b co-infection and a PRRS vaccinated training population 
to predict host response to infection with a field isolate of PRRSV.  
Results presented in Chapter 6 show that when using a PRRSV-only infected 
training population and validating on a PRRS/PCV2b co-infected population, using SNPs 
within the WUR region had better predictive ability compared to the other SNP subsets 
for vaccination VL, PRRS VL of non-vaccinated pigs, and PCV2b VL of vaccinated pigs. 
Possibly, for these traits, using SNPs across the genome included uninformative SNPs, 
which added noise and decreased prediction accuracy. These results also support results 
presented in Chapters 4 and 5. For example, results presented in Chapter 4 showed that 
WUR had a significant effect on vaccination VL, PRRS VL, and PCV2b VL of 
vaccinated pigs, but not PCV2b VL of non-vaccinated pigs. Consistent with results 
presented in Chapter 4, results from Chapter 6 also showed that training and validating on 
SNPs within the WUR region almost always had higher accuracy for vaccination VL and 
PRRS VL of non-vaccinated pigs (both indicative of primary PRRSV exposure) than 
PRRS VL of Vx pigs post co-infection (indicative of secondary exposure). The finding 
that using SNPs within the WUR region had moderate predictive ability for ADG post 
vaccination, but not ADG post co-infection, is also supported by results presented in 
Chapter 4, which showed that WUR had a significant effect on ADG post vaccination, 
but not post co-infection. Results of genomic prediction analyses also showed that, for 
ADG of Vx pigs post vaccination, using SNPs across the genome had superior predictive 
ability to using SNPs within the WUR region. This finding is supported by GWAS results 
presented in Chapter 5 which showed that regions other than WUR were associated with 
ADG following PRRS vaccination.  
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To summarize, results presented in Chapter 6 suggest that selecting on WUR 
genotype alone is best to predict VL traits following PRRS vaccination or 
PRRSV/PCV2b co-infection, that SNPs across the genome should be used to select pigs 
for improved ADG following PRRS vaccination, and that training on a PRRSV-only 
infected population had low to no predictive ability for ADG following PRRSV/PCV2b 
co-infection. Therefore, an optimal genetic selection method might be to combine 
selection based on WUR genotype with genomic selection to simultaneously improve 
host response to PRRS vaccination or PRRSV/PCV2b co-infection based on VL and 
ADG. This could be implemented using the pre-selection strategy described by Dekkers 
(2004) for which pigs could be selected based on WUR genotype at a young age, 
followed by selection based on genomic EBV (GEBV). These methods would capitalize 
on genetic variation already occurring within commercial populations to breed pigs for 
improved host response to PRRS.  
Whereas the above strategies focus on genetic selection for improved host 
response to PRRS in growing pigs, less is known regarding selection for improved 
reproductive performance in PRRSV-infected sows. A recent study conducted by Serão 
et al. (2014) showed that two regions, located on chromosome 7 from 24 to 30 Mb and 
from 128 to129 Mb, jointly explained 25% of the total genetic variation in PRRS 
antibody response in a herd of commercial sows following a natural PRRSV outbreak. 
Results from a follow-up study showed that using SNPs within these two major QTL 
could be used to predict antibody response with higher prediction accuracy than using 
SNPs across the genome (Serão et al., 2016). Since results from the initial study suggest 
that PRRS antibody response, measured as PRRS S/P (sample to positive) ratio, can be 
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used as an indicator of reproductive performance following a natural PRRSV break, 
using these QTL alone may be sufficient to predict reproductive performance in 
commercial gestating females following natural PRRSV-infection. Therefore, a combined 
molecular score for PRRS S/P ratio using loci within these two QTL could be used to 
select for improved reproductive performance in commercial females following a natural 
PRRSV outbreak. However, additional studies must be conducted to support this 
conclusion.  
Gene-Editing for PRRS Resistance 
 
 An alternative to selecting pigs for improved host response to PRRS using genetic 
variation already present within the population, is to use molecular genetic techniques to 
produce PRRS resistant pigs. As the name suggests, gene-editing can be used to: edit 
DNA by making a base pair change at a specific location in the genome, add or remove 
DNA, introduce a gene from another species, or silence a gene completely. Recent 
research conducted by groups at the University of Missouri and Kansas State University 
showed that gene editing technology can be used to create pigs with complete resistance 
to PRRS by knocking-out the CD163 gene, a receptor specific to monocytes and 
macrophages (Whitworth et al., 2015). CD163 also has a known role in viral entry and 
uncoating within the cell (Calvert et al., 2007; Van Gorp et al., 2010; Niu et al., 2016) 
and is a known member of the scavenger receptor cysteine-rich superfamily (Calvert et 
al., 2007). In their initial gene-editing study, Whitworth et al. (2015) showed that 
homozygous -/- CD163 pigs showed no evidence of PRRS viremia 35 days post-
inoculation with a type II PRRSV strain, even when grouped-housed with other 
experimentally infected pigs. In addition, -/- CD163 pigs were also negative for PRRS 
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antibody and showed no clinical signs of infection throughout the duration of the study. 
These results were certainly impressive, but since only four  -/- CD163 pigs were used for 
the study, additional follow-up studies have since been conducted (Whitworth et al., 
2015).  
The next study, performed by Wells et al. (2016), was conducted to determine 
differences in PRRSV susceptibility between the following CD163 genotypes: pigs with 
a complete knock-out for the CD163 gene, pigs with a deletion in the scavenger receptor 
cysteine rich (SRCR) domain 5 of CD163, or pigs with a substitution of SRCR domain 5 
with hCD163L1 SRCR domain 8 (a homolog of the CD163-like gene). Domain 5 was 
selected as a target for this study based on results from previous studies which showed 
that domain 5 is essential for PRRSV-infection (Van Gorp et al., 2010). Results presented 
by Wells et al. (2016) showed that pigs with the complete knock-out phenotype were 
completely resistant to all 6 type I and all 9 type II PRRSV strains used for the study. 
Pigs with the SRCR domain 5 deletion were classified as CD163-null and were also 
resistant to infection with all type I and type II strains. Pigs with the domain 8 
substitution phenotype were resistant to type I, but not type II PRRSV strains (Wells et 
al., 2016). These results confirmed results from the initial study and showed that -/- 
CD163 pigs were resistant to additional type II, as well as type I isolates. Results also 
confirmed the importance of the SRCR domain 5 of CD163 in PRRSV entry and 
uncoating within the cell. Very recently, another follow-up study conducted by Burkard 
et al. (2017) was conducted to further investigate the role SRCR domain 5. Similar to the 
study described by Wells et al. (2016), pigs with complete SRCR domain 5 deletions (i.e. 
exon 7 of CD163) were produced and challenged with different isolates of PRRSV. An 
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additional objective was to compare the growth and blood cell profile of edited versus 
wild type pigs under normal growth conditions. Remarkably, results indicated no 
differences in growth or blood cell profiles of SRCR domain 5 negative pigs versus wild 
type pigs (Burkard et al., 2017). In addition, no PRRSV replication was detected for cells 
isolated from SRCR domain 5-negative pigs following infection with any of the PRRSV 
isolates used for the study. Results also showed that macrophages were able to maintain 
proper biological function, despite deletion of the SRCR domain 5 (Burkard et al., 2017).   
Collectively, results presented by Withworth et al. (2015), Wells et al., (2016), 
and Burkard et al. (2017) show that editing the CD163 gene to produce PRRSV-resistant 
pigs is a promising PRRS control strategy. However, several points regarding the 
production of these pigs should be considered. First, as is true of most new technologies, 
there are unresolved issues with gene-editing technology in general. One of these issues 
is that, although it is possible to target a specific region in the genome to introduce an 
edit, an unintended change may also be introduced elsewhere in the genome. These 
unintended changes are made in what are referred to as “off-target” sites. Off-target 
mutations occur when the guide RNA, consisting of DNA that is complimentary to that 
of the target site, also aligns to DNA elsewhere in the genome. In such instances, editing 
will occur in both places, allowing for the possibility of unintended mutations with 
detrimental effects. One way of minimizing off-target mutations is to select unique DNA 
sequences as target locations and to alter the guide RNA accordingly. These unique 
sequences should differ from other DNA sequences in the genome by at least two 
basepairs, since results from a previous study showed that guide RNAs cannot effectively 
differentiate between on- and off-target sites differing by a single base (Cho et al., 2014). 
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It is also possible to identify off-target mutations by comparing the sequence of the 
unedited versus edited DNA.  
Aside from possible issues regarding the technology in general, there are also 
several issues regarding the use of gene-editing for PRRS, specifically, that should be 
addressed. First, one of the reasons that PRRS has historically been so difficult to control 
is because of the high mutation rate of the virus. Results from studies conducted by 
Withworth et al. (2015), Wells et al., (2016), and Burkard et al. (2017) showed that 
CD163 knock-out pigs were resistant to infection with multiple strains of PRRSV, 
indicating that these strains were unable to enter and infect host cells. However, the 
possibility that other strains can or will exist that have the ability to center host cells via 
other routes, remains. In fact, there is already evidence that cell tropism varies between 
PRRSV strains, which may indicate that certain strains are capable of entering the cell in 
other ways (Frydas et al., 2013). Knocking-out CD163 may put pressure on the virus to 
find and utilize these alternate entry points.  
As is also true for MAS, another factor that should be considered prior to 
implementing gene-editing technology to produce gene-edited pigs is whether knocking-
out CD163 will not have a negative effect on another important biological process. This 
is important for two main reasons. First, CD163 has a known role in several biological 
processes under normal conditions, and secondly, because -/- CD163 pigs have yet to be 
found in nature. Results from previous studies show that CD163 plays a role in the 
inflammatory response in humans (Van den Heuvel et al., 1999) and rats (Polfliet et al., 
2006). In humans, activation of CD163 results in the production of a variety of cytokines, 
including interleukin (IL)-6, gram stimulating factor, and IL-1β (Van den Heuvel et al., 
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1999). CD163 has also shown to act as an innate immune sensor to bacterial infection 
(Fabriek et al., 2009) and as a receptor for hemoglobin/haptoglobin complexes to remove 
excess hemoglobin from the blood (Kristiansen et al., 2001). Because previous research 
showed that CD163 is already known to be associated with these important biological 
processes, it stands to reason that knocking out CD163 may have consequences on these 
processes under non-challenged conditions, or following infection with other pathogens.  
In closing, there are still many unanswered questions regarding the use of gene-
editing technology to produce PRRSV-resistant pigs, including some related to “less 
scientific” issues, such as how gene-edited food products will be regulated. There are still 
many unknowns surrounding the approval of gene-editing, and thus, it is not yet clear 
how gene-edited food products will be regulated or marketed. Consumer acceptance is an 
additional issue--how will consumers respond to the choice of purchasing a gene-edited 
food product? Will consumers respond negatively because they want to avoid an 
“unnatural” food product? Or, will customers embrace gene-edited foods because of 
positive implications for animal welfare? 
 
Future Directions 
 
Many outstanding questions regarding selection for WUR also exist. For example, 
due to the lack of a consistent, unfavorable association of WUR with any one trait across 
lines for the study presented in Chapter 7, the reason for the low frequency of the B allele 
is still not clear. The unfavorable association of WUR with growth rate under non-
challenged conditions detected for one of the sire lines may partially explain the observed 
low frequency and analyzing additional traits, such as growth rate at different stages of 
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production, may provide some clarity on this issue. Another possibility is that the B allele 
is unfavorably associated with a trait under selection that was not analyzed in this thesis. 
Lastly, it is possible that the B allele is in low frequency because there is no selective 
advantage of the B allele in the absence of disease and, thus, has not been selected for 
since most selection is performed in clean environments.  
Another question that remains unanswered is: what is the effect of WUR under 
natural challenge conditions? Results presented by Serão et al. (2014) showed no 
significant effect of WUR on reproduction traits for a herd of commercial gestating 
females following a natural PRRSV outbreak. However, there is no information yet 
regarding the effect of WUR on growth or PRRS VL in growing pigs following natural 
PRRSV exposure. Such field trials have been conducted as additional PHGC trials and 
results from analyses of these trials should provide insight regarding the effect of WUR 
under such conditions.   
Lastly, results presented in this thesis showed that numerically, the effect of WUR 
on PRRS VL was larger following primary, rather than secondary PRRSV exposure. This 
finding is consistent with the biological role of GBP5, the putative causative gene for 
WUR, which has been shown to play a role in the innate immune response to infection 
(Shenoy et al., 2012). It is important to note, however, that for PRRS VL of Non-Vx pigs 
following PRRSV/PCV2b co-infection (considered a primary PRRSV exposure trait), 
that PRRSV-infection was concurrent with PCV2b-infection. Additional results presented 
in this thesis showed that the favorable (AB) WUR genotype for PRRS was associated 
with significantly lower PCV2b VL following PRRSV/PCV2b co-infection for pigs 
previously vaccinated against PRRSV, but not for non-vaccinated pigs. This result, along 
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with the finding that no significant association of WUR with PCV2b VL was detected 
following experimental PCV2b-only infection (Ciobanu, Univeristy of Nebraska Lincoln, 
Personal Communication), suggests that WUR may play a role in the innate immune 
response that is PRRS-specific. However, results from a separate study showed that 
GBP5 was associated with the innate antiretroviral response to infection with human 
immunodeficiency virus (Krapp et al., 2016). Therefore, the role of GBP5 in the innate 
immune response in pigs is not yet clear and experimental challenge studies with 
pathogens other than PRRSV and PCV2b must be conducted to investigate this further.  
 
Conclusions 
 
In conclusion, this thesis explored the role of host genetics in susceptibility to 
viral disease using PRRS and the co-infection with PRRSV and PCV2b to address this 
objective. PRRS was identified as an ideal virus for the studies presented in this thesis 
because it is considered the most economically devastating disease to the swine industry. 
The co-infection with PRRSV and PCV2b was also investigated, given that PRRSV-
infected pigs are rarely infected with PRRSV alone.  
Collectively, results presented by Boddicker et al. (2012, 2014a, 2014b), Hess et 
al. (2016), and Waide et al. (2017), and the results presented in Chapters 4-7, show that 
WUR can be used to select pigs for improved host response to PRRSV-infection, whether 
by PRRSV-only infection, PRRS MLV vaccination, or PRRS/PCV2 co-infection. Results 
from these studies also show that the effect of WUR applies across breeds, breeding 
companies, following infection with different PRRSV isolates, and following PRRS 
MLV vaccination and PRRSV/PCV2b co-infection. Research presented in Chapter 7 also 
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showed that, although the favorable (B) allele for PRRS resistance was unfavorably 
associated with growth and feed intake for a commercial sire line in a clean environment, 
that the magnitude of these effects were not large enough to be of practical relevance. 
Furthermore, no difference in feed efficiency was detected between AA, AB, or BB sires 
or their progeny and no significant effect of WUR on overall performance was detected 
for any of the lines.  
Taken together, these findings indicate that selection for WUR is a promising 
strategy to breed pigs for improved host response to PRRS. This conclusion prompted an 
additional study that was conducted to assess the predictive ability of using SNPs within 
the WUR region only versus other SNPs subsets to predict host response to 
PRRSV/PCV2b co-infection or infection with a field isolate of PRRSV. Results 
presented in Chapter 6 confirmed findings from previous studies that using only SNPs 
within the WUR region yielded higher prediction accuracy compared to using SNPs 
across the genome for vaccination VL, PRRS VL of Non-Vx pigs, and PCV2b VL of Vx 
pigs, but that using SNPs across the genome was best for predicting ADG following 
PRRS vaccination. 
These results make a strong case for pre-selection based on WUR genotype, 
followed by selection based on GEBV, to breed pigs for improved host response to 
PRRSV-only infection, PRRS vaccination, or PRRSV/PCV2b co-infection as an 
alternative strategy to gene-editing for PRRS resistance. This strategy would 
simultaneously capitalize on selecting individuals with the favorable allele for the major 
gene for host response to PRRS, while also making use of SNPs throughout the genome 
to select for improved growth post challenge. Compared to using gene-editing to produce 
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pigs with a genotype not known to occur naturally, pre-selection for WUR may be an 
easier and less-risky alternative to improving host response to PRRS by capitalizing on 
natural variation already occurring within commercial pig populations.  
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